General Electric (GE) 10-K 10 Feb 23 2022 FY Annual report Financial data

Cover Page

Cover Page - USD ($) $ in Billions	12 Months Ended
	Dec. 31, 2022	Jan. 31, 2023	Jun. 30, 2022
Entity Information [Line Items]
Document Type	10-K
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Dec. 31, 2022
Current Fiscal Year End Date	--12-31
Entity File Number	001-00035
Entity Registrant Name	GENERAL ELECTRIC COMPANY
Entity Incorporation, State or Country Code	NY
Entity Tax Identification Number	14-0689340
Entity Address, Address Line One	5 Necco Street
Entity Address, City or Town	Boston
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	02210
City Area Code	617
Local Phone Number	443-3000
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 68.8
Entity Common Stock, Shares Outstanding		1,089,286,553
Documents Incorporated by Reference	The definitive proxy statement relating to the registrant’s Annual Meeting of Shareholders, to be held May 3, 2023, is incorporated by reference into Part III to the extent described therein.
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2022
Entity Central Index Key	0000040545
Amendment Flag	false
Common Stock
Entity Information [Line Items]
Title of 12(b) Security	Common stock, par value $0.01 per share
Trading Symbol	GE
Security Exchange Name	NYSE
1.250% Notes Due 2023
Entity Information [Line Items]
Title of 12(b) Security	1.250% Notes due 2023
Trading Symbol	GE 23E
Security Exchange Name	NYSE
0.875% Notes Due 2025
Entity Information [Line Items]
Title of 12(b) Security	0.875% Notes due 2025
Trading Symbol	GE 25
Security Exchange Name	NYSE
1.875% Notes Due 2027
Entity Information [Line Items]
Title of 12(b) Security	1.875% Notes due 2027
Trading Symbol	GE 27E
Security Exchange Name	NYSE
1.500% Notes Due 2029
Entity Information [Line Items]
Title of 12(b) Security	1.500% Notes due 2029
Trading Symbol	GE 29
Security Exchange Name	NYSE
7.5% Guaranteed Subordinated Notes Due 2035
Entity Information [Line Items]
Title of 12(b) Security	7 1/2% Guaranteed Subordinated Notes due 2035
Trading Symbol	GE /35
Security Exchange Name	NYSE
2.125% Notes Due 2037
Entity Information [Line Items]
Title of 12(b) Security	2.125% Notes due 2037
Trading Symbol	GE 37
Security Exchange Name	NYSE

AUDIT INFORMATION

AUDIT INFORMATION	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2020
Audit Information [Abstract]
Auditor name	DELOITTE & TOUCHE LLP	KPMG LLP
Auditor firm ID	34	185
Auditor location	Boston, Massachusetts	Boston, Massachusetts

STATEMENT OF EARNINGS (LOSS)

STATEMENT OF EARNINGS (LOSS) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenues
Insurance revenues (Note 12)	$ 2,954	$ 3,106	$ 2,865
Total revenues	76,555	74,196	75,833
Costs and expenses
Selling, general and administrative expenses	12,781	11,716	12,628
Separation costs (Note 20)	973	0	0
Research and development	2,813	2,497	2,565
Interest and other financial charges	1,607	1,876	2,068
Debt extinguishment costs (Note 10)	465	6,524	301
Insurance losses, annuity benefits and other costs (Note 12)	2,734	2,410	2,519
Goodwill impairments (Note 7)	0	0	877
Non-operating benefit cost (income)	(532)	1,782	2,430
Total costs and expenses	76,375	80,702	81,259
Other income (loss) (Note 19)	1,231	2,823	11,396
Earnings (loss) from continuing operations before income taxes	1,412	(3,683)	5,970
Provision (benefit) for income taxes (Note 15)	(476)	286	487
Earnings (loss) from continuing operations	936	(3,396)	6,457
Earnings (loss) from discontinued operations, net of taxes (Note 2)	(644)	(3,195)	(911)
Net earnings (loss)	292	(6,591)	5,546
Less net earnings (loss) attributable to noncontrolling interests	67	(71)	(158)
Net earnings (loss) attributable to the Company	225	(6,520)	5,704
Preferred stock dividends	(289)	(237)	(474)
Net earnings (loss) attributable to GE common shareholders	(64)	(6,757)	5,230
Amounts attributable to GE common shareholders
Earnings (loss) from continuing operations	936	(3,396)	6,457
Less net earnings (loss) attributable to noncontrolling interests, continuing operations	67	(71)	(158)
Earnings (loss) from continuing operations attributable to the Company	869	(3,325)	6,615
Preferred stock dividends	(289)	(237)	(474)
Earnings (loss) from continuing operations attributable to GE common shareholders	581	(3,562)	6,141
Earnings (loss) from discontinued operations attributable to GE common shareholders	(644)	(3,195)	(911)
Net earnings (loss) attributable to GE common shareholders	$ (64)	$ (6,757)	$ 5,230
Earnings (loss) per share from continuing operations (Note 18)
Diluted earnings (loss) per share (in dollars per share)	$ 0.53	$ (3.25)	$ 5.46
Basic earnings (loss) per share (in dollars per share)	0.53	(3.25)	5.46
Net earnings (loss) per share (Note 18)
Diluted earnings (loss) per share (in dollars per share)	(0.05)	(6.16)	4.63
Basic earnings (loss) per share (in dollars per share)	$ (0.06)	$ (6.16)	$ 4.63
Equipment
Revenues
Sales	$ 31,976	$ 34,200	$ 37,584
Costs and expenses
Cost of sales	30,426	31,399	35,242
Services
Revenues
Sales	41,626	36,890	35,385
Costs and expenses
Cost of sales	$ 25,109	$ 22,497	$ 22,629

STATEMENT OF FINANCIAL POSITION

STATEMENT OF FINANCIAL POSITION - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Cash, cash equivalents and restricted cash	$ 17,262	$ 15,770
Investment securities (Note 3)	7,609	12,297
Current receivables (Note 4)	17,976	15,620
Inventories, including deferred inventory costs (Note 5)	17,403	15,847
Current contract assets (Note 8)	3,088	4,881
All other current assets (Note 9)	1,521	1,933
Assets of businesses held for sale (Note 2)	1,374	0
Current assets	66,234	66,348
Investment securities (Note 3)	36,048	42,209
Property, plant and equipment – net (Note 6)	14,478	15,609
Goodwill (Note 7)	25,798	26,182
Other intangible assets – net (Note 7)	7,625	9,330
Contract and other deferred assets (Note 8)	6,010	6,124
All other assets (Note 9)	16,998	19,040
Deferred income taxes (Note 15)	11,705	10,855
Assets of discontinued operations (Note 2)	2,892	3,177
Total assets	187,788	198,874
Short-term borrowings (Note 10)	3,757	4,361
Accounts payable and equipment project payables (Note 11)	18,644	16,243
Progress collections and deferred income	18,118	17,372
All other current liabilities (Note 14)	14,485	13,977
Liabilities of businesses held for sale (Note 2)	1,944	0
Current liabilities	56,947	51,953
Deferred income	2,006	1,989
Long-term borrowings (Note 10)	28,593	30,824
Insurance liabilities and annuity benefits (Note 12)	33,347	37,166
Non-current compensation and benefits	16,021	21,202
All other liabilities (Note 14)	12,154	13,240
Liabilities of discontinued operations (Note 2)	1,137	887
Total liabilities	150,206	157,262
Preferred stock (Note 16)	6	6
Common stock (Note 16)	15	15
Accumulated other comprehensive income (loss) – net attributable to GE	(1,311)	1,582
Other capital	34,173	34,691
Retained earnings	84,693	85,110
Less common stock held in treasury	(81,209)	(81,093)
Total GE shareholders’ equity	36,366	40,310
Noncontrolling interests (Note 16)	1,216	1,302
Total equity	37,582	41,612
Total liabilities and equity	$ 187,788	$ 198,874

STATEMENT OF CASH FLOWS

STATEMENT OF CASH FLOWS $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Cash flows – operating activities
Net earnings (loss)	$ 292	$ (6,591)	$ 5,546
(Earnings) loss from discontinued operations activities	644	3,195	911
Adjustments to reconcile net earnings (loss) to cash from (used for) operating activities
Depreciation and amortization of property, plant and equipment	1,802	1,871	2,128
Amortization of intangible assets (Note 7)	1,742	1,138	1,336
Goodwill impairments (Note 7)	0	0	877
(Gains) losses on purchases and sales of business interests (Note 19)	(66)	40	(12,469)
(Gains) losses on equity securities (Note 19)	144	(1,656)	2,085
Debt extinguishment costs	465	6,524	301
Principal pension plans cost (Note 13)	575	2,650	3,559
Principal pension plans employer contributions (Note 13)	(325)	(326)	(2,806)
Other postretirement benefit plans (net) (Note 13)	(1,160)	(1,144)	(893)
Provision (benefit) for income taxes (Note 15)	476	(286)	(487)
Cash recovered (paid) during the year for income taxes	(1,127)	(1,165)	(1,441)
Changes in operating working capital:
Decrease (increase) in current receivables	(3,011)	(177)	(1,319)
Decrease (increase) in inventories, including deferred inventory costs	(2,341)	(702)	1,105
Decrease (increase) in current contract assets	1,463	1,031	1,631
Increase (decrease) in accounts payable and equipment project payables	2,793	(2)	(582)
Increase (decrease) in progress collections and current deferred income	2,492	(1,052)	(247)
Financial services derivatives net collateral/settlement	(154)	(1,143)	1,897
All other operating activities	1,160	(1,317)	(109)
Cash from (used for) operating activities – continuing operations	5,864	888	1,025
Cash from (used for) operating activities – discontinued operations	52	2,444	2,543
Cash from (used for) operating activities	5,916	3,332	3,568
Cash flows – investing activities
Additions to property, plant and equipment	(1,371)	(1,250)	(1,579)
Dispositions of property, plant and equipment	209	167	203
Additions to internal-use software	(113)	(111)	(151)
Proceeds from sale of discontinued operations	0	22,356	0
Proceeds from principal business dispositions	15	1	20,562
Net cash from (payments for) principal businesses purchased	(30)	(1,550)	(85)
Sales of retained ownership interests	4,717	4,145	417
Net (purchases) dispositions of insurance investment securities	(876)	(1,290)	(1,352)
All other investing activities	(726)	1,237	1,280
Cash from (used for) investing activities – continuing operations	1,825	23,705	19,297
Cash from (used for) investing activities – discontinued operations	444	(2,397)	(2,626)
Cash from (used for) investing activities	2,270	21,308	16,671
Cash flows – financing activities
Net increase (decrease) in borrowings (maturities of 90 days or less)	65	(710)	(4,168)
Newly issued debt (maturities longer than 90 days)	8,205	364	15,028
Repayments and other debt reductions (maturities longer than 90 days)	(11,205)	(36,521)	(29,632)
Dividends paid to shareholders	(639)	(575)	(648)
Cash received (paid) for debt extinguishment costs	338	(7,196)	(335)
Purchases of GE common stock for treasury	(1,048)	(107)	(28)
All other financing activities	(1,302)	(551)	23
Cash from (used for) financing activities – continuing operations	(5,585)	(45,296)	(19,762)
Cash from (used for) financing activities – discontinued operations	0	119	(90)
Cash from (used for) financing activities	(5,585)	(45,177)	(19,852)
Effect of currency exchange rate changes on cash, cash equivalents and restricted cash	(369)	(213)	145
Increase (decrease) in cash, cash equivalents and restricted cash	2,232	(20,750)	531
Cash, cash equivalents and restricted cash at beginning of year	16,859	37,608	37,077
Cash, cash equivalents and restricted cash at December 31	19,092	16,859	37,608
Less cash, cash equivalents and restricted cash of discontinued operations at December 31	1,176	736	623
Cash, cash equivalents and restricted cash of continuing operations at December 31	17,916	16,123	36,985
Supplemental disclosure of cash flows information
Cash paid during the year for interest	$ (1,561)	$ (2,536)	$ (2,976)

STATEMENT OF COMPREHENSIVE INCO

STATEMENT OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Statement of Comprehensive Income [Abstract]
Net earnings (loss)	$ 292	$ (6,591)	$ 5,546
Less: net earnings (loss) attributable to noncontrolling interests	67	(71)	(158)
Net earnings (loss) attributable to the Company	225	(6,520)	5,704
Other comprehensive income (loss)
Currency translation adjustments	(1,355)	(174)	435
Benefit plans	2,889	9,044	1,632
Investment securities and cash flow hedges	(4,425)	2,466	(78)
Less: other comprehensive income (loss) attributable to noncontrolling interests	1	5	6
Other comprehensive income (loss) attributable to the Company	(2,893)	11,330	1,984
Comprehensive income (loss)	(2,600)	4,745	7,536
Less: comprehensive income (loss) attributable to noncontrolling interests	68	(66)	(152)
Comprehensive income (loss) attributable to the Company	$ (2,668)	$ 4,810	$ 7,688

STATEMENT OF CHANGES IN SHAREHO

STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($) $ in Millions		Total	GE shareholders' equity balance	Accumulated other comprehensive income (loss)	Currency translation adjustments	Benefit plans	Investment securities and cash flow hedges	Other capital	Retained earnings	Retained earnings Changes in accounting	Common stock held in treasury	Noncontrolling interest
Beginning balance at Dec. 31, 2019				$ (11,732)			$ 109	$ 34,405	$ 87,732	$ (175)	$ (82,797)
Increase (decrease) in shareholders' equity
Other comprehensive income (loss)					$ 433	$ 1,628	(78)
Purchases											(28)
Dispositions								(703)			864
Stock-based compensation								429
Other changes								176
Net earnings (loss) attributable to the Company		$ 5,704							5,704
Dividends and other transactions with shareholders									(1,014)
Ending balance at Dec. 31, 2020		37,073	$ 35,552	(9,749)	(4,386)	(5,395)	32	34,307	92,247	0	(81,961)	$ 1,522
Preferred stock issued		6
Common stock issued		702
Increase (decrease) in shareholders' equity
Other comprehensive income (loss)					(177)	9,041	2,466
Purchases											(107)
Dispositions								(740)			974
Stock-based compensation								429
Other changes								696
Net earnings (loss) attributable to the Company		(6,520)							(6,520)
Dividends and other transactions with shareholders									(617)
Ending balance at Dec. 31, 2021		41,612	40,310	1,582	(4,562)	3,646	2,498	34,691	85,110	$ 0	(81,093)	1,302
Preferred stock issued		6
Common stock issued		15
Increase (decrease) in shareholders' equity
Other comprehensive income (loss)					(1,353)	2,886	(4,425)
Purchases											(1,048)
Dispositions								(741)			931
Stock-based compensation								362
Other changes	[1]							(139)
Net earnings (loss) attributable to the Company		225							225
Dividends and other transactions with shareholders									(642)
Ending balance at Dec. 31, 2022		37,582	$ 36,366	$ (1,311)	$ (5,915)	$ 6,531	$ (1,927)	$ 34,173	$ 84,693		$ (81,209)	$ 1,216
Preferred stock issued		6
Common stock issued		$ 15
[1]Included $687 million related to the change in par value of issued common stock from $0.06 to $0.01 in the year ended December 31, 2021.

STATEMENT OF CHANGES IN SHARE_2

STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical) $ in Millions	12 Months Ended
	Dec. 31, 2021 USD ($) $ / shares
Common stock, par value (in dollars per share) | $ / shares	$ 0.01
Other capital
Impact of change in par value of issued common stock | $	$ 687

BASIS OF PRESENTATION AND SUMMA

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES FINANCIAL STATEMENT PRESENTATION. Our financial statements are prepared in conformity with U.S. generally accepted accounting principles (GAAP), which requires us to make estimates based on assumptions about current, and for some estimates, future, economic and market conditions which affect reported amounts and related disclosures in our financial statements. Although our current estimates contemplate current and expected future conditions, as applicable, it is reasonably possible that actual conditions could differ from our expectations, which could materially affect our results of operations, financial position and cash flows. Such changes could result in future impairments of goodwill, intangibles, long-lived assets and investment securities, revisions to estimated profitability on long-term product service agreements, incremental credit losses on receivables and debt securities, a change in the carrying amount of our tax assets and liabilities, or a change in our insurance liabilities and pension obligations as of the time of a relevant measurement event. In preparing our Statement of Cash Flows, we make certain adjustments to reflect cash flows that cannot otherwise be calculated by changes in our Statement of Financial Position. These adjustments may include, but are not limited to, the effects of currency exchange, acquisitions and dispositions of businesses, businesses classified as held for sale, the timing of settlements to suppliers for property, plant and equipment, non-cash gains/losses and other balance sheet reclassifications. We have reclassified certain prior-year amounts to conform to the current-year’s presentation, including retrospective adjustments made in 2021 to present: the remainder of our former Capital segment within Corporate, sales of spare parts within Sales of services and the related costs as Costs of services sold, and earnings per share to reflect the reverse stock split. Unless otherwise noted, tables are presented in U.S. dollars in millions. Certain columns and rows may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying numbers in millions. Earnings per share amounts are computed independently for earnings from continuing operations, earnings from discontinued operations and net earnings. As a result, the sum of per-share amounts may not equal the total. Unless otherwise indicated, information in these notes to consolidated financial statements relates to continuing operations. Certain of our operations have been presented as discontinued. We present businesses whose disposal represents a strategic shift that has, or will have, a major effect on our operations and financial results as discontinued operations when the components meet the criteria for held for sale, are sold, or spun-off. See Note 2 for further information. On January 3, 2023, General Electric Company (the Company or GE) completed the previously announced separation (the Separation) of its HealthCare business, into a separate, independent publicly traded company. See Note 28 for further information. CONSOLIDATION. Our financial statements consolidate all of our affiliates, entities where we have a controlling financial interest, most often because we hold a majority voting interest, or where we are required to apply the variable interest entity (VIE) model because we have the power to direct the most economically significant activities of entities. We reevaluate whether we have a controlling financial interest in all entities when our rights and interests change. REVENUES FROM THE SALE OF EQUIPMENT. Performance Obligations Satisfied Over Time. We recognize revenue on agreements for the sale of customized goods including power generation equipment, long-term construction projects and military development contracts on an over-time basis as we customize the customer's equipment during the manufacturing or integration process and obtain right to payment for work performed. We recognize revenue as we perform under the arrangements using the percentage of completion method, which is based on our costs incurred to date relative to our estimate of total expected costs. Our estimate of costs to be incurred to fulfill our promise to a customer is based on our history of manufacturing or constructing similar assets for customers and is updated routinely to reflect changes in quantity or pricing of the inputs. We provide for potential losses on these agreements when it is probable that we will incur the loss. Our billing terms for these over-time contracts are generally based on achieving specified milestones. The differences between the timing of our revenue recognized (based on costs incurred) and customer billings (based on contractual terms) results in changes to our contract asset or contract liability positions. See Note 8 for further information. Performance Obligations Satisfied at a Point in Time. We recognize revenue on agreements for non-customized equipment including commercial aircraft engines, healthcare equipment and other goods we manufacture on a standardized basis for sale to the market at the point in time that the customer obtains control of the product, which is generally no earlier than when the customer has physical possession. We use proof of delivery for certain large equipment with more complex logistics, whereas the delivery of other equipment is estimated based on historical averages of in-transit periods (i.e., time between shipment and delivery). Where arrangements include customer acceptance provisions based on seller or customer-specified objective criteria, we recognize revenue when we have concluded that the customer has control of the equipment and that acceptance is likely to occur. We do not provide for anticipated losses on point-in-time transactions prior to transferring control of the equipment to the customer. Our billing terms for these point-in-time equipment contracts generally coincide with delivery to the customer; however, within certain businesses, we receive progress collections from customers for large equipment purchases, to generally reserve production slots. REVENUES FROM THE SALE OF SERVICES. Consistent with our Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) discussion and the way we manage our businesses, we refer to sales under service agreements, which includes both goods (such as spare parts and equipment upgrades) and related services (such as monitoring, maintenance and repairs) as sales of “services,” which is an important part of our operations. We sometimes offer our customers financing discounts for the purchase of certain equipment when sold in contemplation of long-term service agreements. These sales are accounted for as financing arrangements when payments for the equipment are collected through higher usage-based fees from servicing the equipment. See Note 8 for further information. Performance Obligations Satisfied Over Time. We enter into long-term service agreements with our customers primarily within our Aerospace and Power segments. These agreements require us to provide preventative maintenance, overhauls, and standby "warranty-type" services that include certain levels of assurance regarding asset performance and uptime throughout the contract periods, which generally range from 5 to 25 years. We account for items that are integral to the maintenance of the equipment as part of our performance obligation, unless the customer has a substantive right to make a separate purchasing decision (e.g., equipment upgrade). We recognize revenue as we perform under the arrangements using the percentage of completion method which is based on our costs incurred to date relative to our estimate of total expected costs. Throughout the life of a contract, this measure of progress captures the nature, timing and extent of our underlying performance activities as our stand-ready services often fluctuate between routine inspections and maintenance, unscheduled service events and major overhauls at predetermined usage intervals. We provide for potential losses on these agreements when it is probable that we will incur the loss. Our billing terms for these arrangements are generally based on the utilization of the asset (e.g., per hour of usage) or upon the occurrence of a major maintenance event within the contract, such as an overhaul. The differences between the timing of our revenue recognized (based on costs incurred) and customer billings (based on contractual terms) results in changes to our contract asset or contract liability positions. See Note 8 for further information. We also enter into long-term services agreements in our HealthCare and Renewable Energy segments. Revenues are recognized for these arrangements on a straight-line basis consistent with the nature, timing and extent of our services, which primarily relate to routine maintenance and as needed equipment repairs. We generally invoice periodically as services are provided. Performance Obligations Satisfied at a Point in Time. We sell certain tangible products, largely spare parts, through our services businesses. We recognize revenues and bill our customers at the point in time that the customer obtains control of the good, which is at the point in time we deliver the spare part to the customer. COLLABORATIVE ARRANGEMENTS. Our Aerospace business enters into collaborative arrangements and joint ventures with manufacturers and suppliers of components used to build and maintain certain engines. Under these arrangements, GE and its collaborative partners share in the risks and rewards of these programs through various revenue, cost and profit sharing payment structures. GE recognizes revenue and costs for these arrangements based on the scope of work GE is responsible for transferring to its customers. GE’s payments to participants are primarily recorded as either cost of services sold ($2,898 million, $2,125 million and $2,407 million for the years ended December 31, 2022, 2021, and 2020, respectively) or as cost of equipment sold ($658 million, $751 million and $1,093 million for the years ended December 31, 2022, 2021 and 2020, respectively). Our most significant collaborative arrangement is with Safran Aircraft Engines, a subsidiary of Safran Group of France, which sells LEAP and CFM56 engines through CFM International, a jointly owned non-consolidated company. GE makes substantial sales of parts and services to CFM International based on arms-length terms. INSURANCE REVENUES. Insurance revenues are comprised primarily of premiums and investment income related to our run-off Insurance business. For traditional long-duration insurance contracts, we report premiums as revenue when due. Premiums received on non-traditional long-duration insurance contracts and investment contracts, including annuities without significant mortality risk, are not reported as revenues but rather as deposit liabilities. We recognize revenues for charges and assessments on these contracts, mostly for mortality, contract initiation, administration and surrender. Amounts credited to policyholder accounts are charged to expense. CASH, CASH EQUIVALENTS AND RESTRICTED CASH. Debt securities and money market instruments with original maturities of three months or less are included in cash, cash equivalents and restricted cash unless classified as available-for-sale investment securities. Restricted cash primarily comprised funds restricted in connection with certain ongoing litigation matters and amounted to $745 million and $317 million at December 31, 2022 and 2021, respectively. INVESTMENT SECURITIES. We report investments in available-for-sale debt securities and certain equity securities at fair value. Unrealized gains and losses on available-for-sale debt securities are recorded to other comprehensive income, net of applicable taxes and adjustments related to our insurance liabilities. Unrealized gains and losses on equity securities with readily determinable fair values are recorded to earnings. Although we generally do not have the intent to sell any specific debt securities in the ordinary course of managing our portfolio, we may sell debt securities prior to their maturities for a variety of reasons, including diversification, credit quality, yield and liquidity requirements and the funding of claims and obligations to policyholders. We regularly review investment securities for impairment. For debt securities, if we do not intend to sell the security or it is not more likely than not that we will be required to sell the security before recovery of our amortized cost, we evaluate qualitative criteria, such as the financial health of and specific prospects for the issuer, to determine whether we do not expect to recover the amortized cost basis of the security. We also evaluate quantitative criteria including determining whether there has been an adverse change in expected future cash flows. If we do not expect to recover the entire amortized cost basis of the security, we consider the security to contain an expected credit loss, and we record the difference between the security’s amortized cost basis and its recoverable amount in earnings as an allowance for credit loss and the difference between the security’s recoverable amount and fair value in other comprehensive income. If we intend to sell the security or it is more likely than not we will be required to sell the security before recovery of its amortized cost basis, the security is considered impaired, and we recognize the entire difference between the security’s amortized cost basis and its fair value in earnings. See Note 3 for further information. CURRENT RECEIVABLES. Amounts due from customers arising from the sales of equipment and services are recorded at the outstanding amount, less allowance for losses. We regularly monitor the recoverability of our receivables. See Note 4 for further information. ALLOWANCE FOR CREDIT LOSSES. When we record customer receivables, contract assets and financing receivables arising from revenue transactions, as well as commercial mortgage loans and reinsurance recoverables in our run-off insurance operations, financial guarantees and certain commitments, we record an allowance for credit losses for the current expected credit losses (CECL) inherent in the asset over its expected life. The allowance for credit losses is a valuation account deducted from the amortized cost basis of the assets to present their net carrying value at the amount expected to be collected. Each period , the allowance for credit losses is adjusted through earnings to reflect expected credit losses over the remaining lives of the assets. We evaluate debt securities with unrealized losses to determine whether any of the losses arise from concerns about the issuer’s credit or the underlying collateral and record an allowance for credit losses, if required. We estimate expected credit losses based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. When measuring expected credit losses, we pool assets with similar country risk and credit risk characteristics. Changes in the relevant information may significantly affect the estimates of expected credit losses. INVENTORIES. All inventories are stated at lower of cost or realizable values. Cost of inventories is primarily determined on a first-in, first-out (FIFO) basis. See Note 5 for further information. PROPERTY, PLANT AND EQUIPMENT. The cost of property, plant and equipment is generally depreciated on a straight-line basis over its estimated economic life. See Note 6 for further information. LEASE ACCOUNTING FOR LESSEE ARRANGEMENTS. At lease commencement, we record a lease liability and corresponding right-of-use (ROU) asset. Options to extend the lease are included as part of the ROU lease asset and liability when it is reasonably certain the Company will exercise the option. We have elected to include lease and non-lease components in determining our lease liability for all leased assets except our vehicle leases. Non-lease components are generally services that the lessor performs for the Company associated with the leased asset. The present value of our lease liability is determined using our incremental collateralized borrowing rate at lease inception. For leases with an initial term of 12 months or less, an ROU asset and lease liability is not recognized and lease expense is recognized on a straight-line basis over the lease term. We test ROU assets whenever events or changes in circumstance indicate that the asset may be impaired. GOODWILL AND OTHER INTANGIBLE ASSETS. We test goodwill at least annually for impairment at the reporting unit level. We recognize an impairment charge if the carrying amount of a reporting unit exceeds its fair value. When a portion of a reporting unit is disposed, goodwill is allocated to the gain or loss on disposition based on the relative fair values of the business or businesses disposed and the portion of the reporting unit that will be retained. For other intangible assets that are not deemed indefinite-lived, cost is generally amortized on a straight-line basis over the asset’s estimated economic life, except for individually significant customer-related intangible assets that are amortized in relation to total related sales. Amortizable intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. In these circumstances, they are tested for impairment based on undiscounted cash flows and, if impaired, written down to estimated fair value based on either discounted cash flows or appraised values. See Note 7 for further information. DERIVATIVES AND HEDGING. We use derivatives to manage a variety of risks, including risks related to interest rates, foreign exchange, certain equity investments and commodity prices. Accounting for derivatives as hedges requires that, at inception and over the term of the arrangement, the hedged item and related derivative meet the requirements for hedge accounting. In evaluating whether a particular relationship qualifies for hedge accounting, we test effectiveness at inception and each reporting period thereafter by determining whether changes in the fair value of the derivative offset, within a specified range, changes in the fair value of the hedged item. If fair value changes fail this test, we discontinue applying hedge accounting to that relationship prospectively. Fair values of both the derivative instrument and the hedged item are calculated using internal valuation models incorporating market-based assumptions, subject to third-party confirmation, as applicable. See Note 22 for further information. DEFERRED INCOME TAXES. Deferred income tax balances reflect the effects of temporary differences between the carrying amounts of assets and liabilities and their tax bases, as well as from net operating loss and tax credit carryforwards, and are stated at enacted tax rates expected to be in effect when those taxes are paid or recovered. Deferred income tax assets represent amounts available to reduce income taxes payable on taxable income in future years. We evaluate the recoverability of these future tax deductions and credits by assessing the adequacy of future expected taxable income from all sources, including reversal of taxable temporary differences, forecasted operating earnings and available tax planning strategies. To the extent we consider it more likely than not that a deferred tax asset will not be recovered, a valuation allowance is established. Deferred taxes, as needed, are provided for our investment in affiliates and associated companies when we plan to remit those earnings. See Note 15 for further information. INSURANCE LIABILITIES AND ANNUITY BENEFITS. Our run-off insurance operations include providing insurance and reinsurance for life and health risks and providing certain annuity products. Primary product types include long-term care, structured settlement annuities, life and disability insurance contracts and investment contracts. Insurance contracts are contracts with significant mortality and/or morbidity risks, while investment contracts are contracts without such risks. Liabilities for traditional long-duration insurance contracts include both future policy benefit reserves and claims reserves. Future policy benefit reserves represent the present value of future policy benefits less the present value of future gross premiums based on actuarial assumptions. Liabilities for investment contracts equal the account value, that is, the amount that accrues to the benefit of the contract or policyholder including credited interest and assessments through the financial statement date. Claim reserves are established when a claim is incurred or is estimated to have been incurred and represent our best estimate of the present value of the ultimate obligations for future claim payments and claim adjustments expenses. To the extent that unrealized gains on specific investment securities supporting our insurance contracts would result in a premium deficiency, should those gains be realized, an increase in future policy benefit reserves is recorded, with an offsetting after-tax reduction to net unrealized gains recorded in other comprehensive income. Reinsurance recoverables are recorded when we cede insurance risk to third parties but are not relieved from our primary obligation to policyholders and cedents. When losses on ceded risks give rise to claims for recovery, we establish allowances for probable losses on such receivables from reinsurers as required. See Note 12 for further information. POSTRETIREMENT BENEFIT PLANS. We sponsor a number of pension and retiree health and life insurance benefit plans that we present in three categories, principal pension plans, other pension plans and principal retiree benefit plans. We use a December 31 measurement date for these plans. On our Statement of Financial Position, we measure our plan assets at fair value and the obligations at the present value of the estimated payments to plan participants. Participants earn benefits based on their service and pay. Those estimated future payment amounts are determined based on assumptions. Differences between our actual results and what we assumed are recorded in a separate component of equity each period. These differences are amortized into earnings over the remaining average future service of active employees or the expected life of inactive participants, as applicable, who participate in the plan. See Note 13 for further information. LOSS CONTINGENCIES. Loss contingencies are existing conditions, situations or circumstances involving uncertainty as to possible loss that will ultimately be resolved when future events occur or fail to occur. Such contingencies include, but are not limited to environmental obligations, litigation, regulatory investigations and proceedings, product quality and losses resulting from other events and developments. When a loss is considered probable and reasonably estimable, we record a liability in the amount of our best estimate for the ultimate loss. When there appears to be a range of possible costs with equal likelihood, liabilities are based on the low-end of such range. Disclosure is provided for material loss contingencies when a loss is probable but a reasonable estimate cannot be made, and when it is reasonably possible that a loss will be incurred or the amount of a loss will exceed the recorded provision. We regularly review contingencies to determine whether the likelihood of loss has changed and to assess whether a reasonable estimate of the loss or range of loss can be made. See Note 24 for further information. SUPPLY CHAIN FINANCE PROGRAMS. We evaluate supply chain finance programs to ensure where we use a third-party intermediary to settle our trade payables, their involvement does not change the nature, existence, amount, or timing of our trade payables and does not provide the Company with any direct economic benefit. If any characteristics of the trade payables change or we receive a direct economic benefit, we reclassify the trade payables as borrowings. FAIR VALUE MEASUREMENTS. The following sections describe the valuation methodologies we use to measure financial and non-financial instruments accounted for at fair value including certain assets within our pension plans and retiree benefit plans. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. These inputs establish a fair value hierarchy: Level 1 – Quoted prices for identical instruments in active markets; Level 2 – Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable; and Level 3 – Significant inputs to the valuation model are unobservable. RECURRING FAIR VALUE MEASUREMENTS. For financial assets and liabilities measured at fair value on a recurring basis, primarily investment securities and derivatives, fair value is the price we would receive to sell an asset or pay to transfer a liability in an orderly transaction with a market participant at the measurement date. In the absence of active markets for the identical assets or liabilities, such measurements involve developing assumptions based on market observable data and, in the absence of such data, internal information that is consistent with what market participants would use in a hypothetical transaction that occurs at the measurement date. See Note 21 for further information. Debt Securities. When available, we use quoted market prices to determine the fair value of debt securities which are included in Level 1. For our remaining debt securities, we obtain pricing information from an independent pricing vendor. The inputs and assumptions to the pricing vendor’s models are derived from market observable sources including benchmark yields, reported trades, broker/dealer quotes, issuer spreads, benchmark securities, bids, offers and other market-related data. These investments are included in Level 2. Our pricing vendors may also provide us with valuations that are based on significant unobservable inputs, and in those circumstances, we classify the investment securities in Level 3. Annually, we conduct reviews of our primary pricing vendor to validate that the inputs used in that vendor’s pricing process are deemed to be market observable as defined in the standard. We believe that the prices received from our pricing vendor are representative of prices that would be received to sell the assets at the measurement date (exit prices) and are classified appropriately in the hierarchy. We use non-binding broker quotes and other third-party pricing services as our primary basis for valuation when there is limited, or no, relevant market activity for a specific instrument or for other instruments that share similar characteristics. Debt securities priced in this manner are included in Level 3. Equity securities with readily determinable fair values . These publicly traded equity securities are valued using quoted prices and are included in Level 1. Derivatives. The majority of our derivatives are valued using internal models. The models maximize the use of market observable inputs including interest rate curves and both forward and spot prices for currencies and commodities. Derivative assets and liabilities included in Level 2 primarily represent interest rate swaps, cross-currency swaps and foreign currency and commodity forward and option contracts. Investments in private equity, real estate and collective funds held within our pension plans . Most investments are generally valued using the net asset value (NAV) per share as a practical expedient for fair value provided certain criteria are met. The NAVs are determined based on the fair values of the underlying investments in the funds. Investments that are measured at fair value using the NAV practical expedient are not required to be classified in the fair value hierarchy. Investments classified within Level 3 primarily relate to real estate and private equities which are valued using unobservable inputs, primarily by discounting expected future cash flows, using comparative market multiples, third-party pricing sources, or a combination of these approaches as appropriate. See Note 13 for further information. NONRECURRING FAIR VALUE MEASUREMENTS. Certain assets are measured at fair value on a nonrecurring basis. These assets may include loans and long-lived assets reduced to fair value upon classification as held for sale, impaired loans based on the fair value of the underlying collateral, impaired equity securities without readily determinable fair value, equity method investments and long-lived assets, and remeasured retained investments in formerly consolidated subsidiaries upon a change in control that results in the deconsolidation of that subsidiary and retention of a noncontrolling stake in the entity. Assets written down to fair value when impaired and retained investments are not subsequently adjusted to fair value unless further impairment occurs. Equity investments without readily determinable fair value and Associated companies. Equity investments without readily determinable fair value and associated companies are valued using market observable data such as transaction prices when available. When market observable data is unavailable, investments are valued using either a discounted cash flow model, comparative market multiples, third-party pricing sources or a combination of these approaches as appropriate. These investments are generally included in Level 3. Long-lived Assets . Fair values of long-lived assets are primarily derived internally and are based on observed sales transactions for similar assets. In other instances for which we do not have comparable observed sales transaction data, collateral values are developed internally and corroborated by external appraisal information. Adjustments to third-party valuations may be performed in circumstances where market comparables are not specific to the attributes of the specific collateral or appraisal information may not be reflective of current market conditions due to the passage of time and the occurrence of market events since receipt of the information. ACCOUNTING CHANGES. The adoption of the new guidance on accounting for long duration insurance contracts on January 1, 2023 will significantly change the accounting for measurements of our long-duration insurance liabilities and reinsurance recoverables and materially affect our consolidated financial statements. We currently estimate a decrease in Shareholders’ equity at the transition date of January 1, 2021 from adoption of the new guidance to be in an after-tax range of $7 billion to $8 billion, including approximately $5.5 billion to $6 billion in Accumulated other comprehensive income (AOCI) and $1.5 billion to $2 billion in Retained earnings. As of December 31, 2022, we estimate the after-tax decrease in Shareholders' equity to be reduced to approximately $3 billion to $4 billion, primarily due to changes in the market interest rate environment subsequent to the transition date.

BUSINESSES HELD FOR SALE AND DI

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS	12 Months Ended
	Dec. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]
BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS	NOTE 2. BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS. In the first quarter of 2022, we signed a non-binding memorandum of understanding to sell a portion of our Steam business within our Power segment to Électricité de France S.A. (EDF). In the fourth quarter of 2022, we signed a binding agreement for this transaction, and we expect to complete the sale, subject to regulatory approval, in the second half of 2023. Closing the transaction is expected to result in a significant gain. In the fourth quarter of 2022, we classified our captive industrial insurance subsidiary, with assets of $638 million and liabilities of $372 million, into held for sale and recorded a loss of $17 million in Other income (loss) in our Statement of Earnings (Loss). We expect to complete the sale of this business, subject to regulatory approval, by the first half of 2024. In the fourth quarter of 2021, we completed the sale of GE's share of our boiler manufacturing business in China in our Power segment. In connection with the transaction, we recorded a loss on the disposal of this business of $170 million in Other income (loss) in our consolidated Statement of Earnings (Loss). See Note 19 for further information. On March 31, 2020, we completed the sale of our BioPharma business within our HealthCare segment for total consideration of $21,112 million (after certain working capital adjustments) and incurred $185 million of cash payments directly associated with the transaction. As a result, in 2020, we recognized a pre-tax gain of $12,362 million ($11,213 million after-tax) in our Statement of Earnings (Loss). ASSETS AND LIABILITIES OF BUSINESSES HELD FOR SALE December 31, 2022 December 31, 2021 Current receivables, inventories and contract assets $ 495 $ — Non-current captive insurance investment securities 554 — Property, plant and equipment and intangible assets - net 232 — All other assets 94 — Assets of businesses held for sale $ 1,374 $ — Progress collections and deferred income $ 1,127 $ — Insurance liabilities and annuity benefits 358 — Accounts payable, equipment project payables and all other liabilities 458 — Liabilities of businesses held for sale $ 1,944 $ — DISCONTINUED OPERATIONS primarily comprise our GE Capital Aviation Services (GECAS) business, discontinued in 2021, our mortgage portfolio in Poland, and other trailing assets and liabilities associated with prior dispositions. Results of operations, financial position and cash flows for these businesses are reported as discontinued operations for all periods presented and the notes to the financial statements have been adjusted on a retrospective basis. GECAS/AerCap. On November 1, 2021, we completed the combination of our GECAS business with AerCap Holdings N.V. (AerCap). We deconsolidated this business, reclassified its results to discontinued operations for all periods presented and recognized a non-cash after-tax loss of $3,882 million in discontinued operations for the year ended December 31, 2021. We have continuing involvement with AerCap, primarily through our ownership interest, ongoing sales or leases of products and services, and transition services that we provide to AerCap. For the year ended December 31, 2022, we had direct and indirect sales of $162 million to AerCap, primarily related to engine services and sales, and purchases of $174 million from AerCap, primarily related to engine leases. We paid net cash of $48 million to AerCap related to this activity. Bank BPH . The mortgage portfolio in Poland (Bank BPH) comprises floating rate residential mortgages, 85% of which are indexed to or denominated in foreign currencies (primarily Swiss francs). At December 31, 2022, the total portfolio had a carrying value, net of reserves, of $1,199 million. The portfolio is recorded at the lower of cost or fair value, less cost to sell, which reflects market yields as well as estimates with respect to ongoing litigation in Poland related to foreign currency-denominated mortgages and other factors. Loss from discontinued operations included $720 million, $509 million and $121 million non-cash pre-tax charges for the years ended December 31, 2022, 2021 and 2020, respectively, reflecting estimates with respect to ongoing litigation as well as market yields. To ensure appropriate capital levels, we made capital contributions in cash of $530 million and $360 million into Bank BPH during the second quarter of 2022 and fourth quarter of 2021, respectively. Future changes in the estimated legal liabilities or market yields could result in further losses and capital contributions related to these loans in future reporting periods beyond the amounts that we currently estimate. See Note 24 for further information. RESULTS OF DISCONTINUED OPERATIONS For the year ended December 31, 2022 GECAS Bank BPH & Other Total Total revenues $ — $ — $ — Cost of equipment and services sold — — — Other income, costs and expenses — (808) (808) Earnings (loss) of discontinued operations before income taxes — (808) (808) Benefit (provision) for income taxes — (32) (32) Earnings (loss) of discontinued operations, net of taxes(a) — (841) (841) Gain (loss) on disposal before income taxes (18) 75 58 Benefit (provision) for income taxes 139 — 139 Gain (loss) on disposal, net of taxes 121 75 196 Earnings (loss) from discontinued operations, net of taxes $ 121 $ (765) $ (644) For the year ended December 31, 2021 GECAS Bank BPH & Other Total Total revenues $ — $ — $ — Cost of equipment and services sold (398) — (398) Other income, costs and expenses 1,992 (599) 1,393 Earnings (loss) of discontinued operations before income taxes 1,594 (599) 995 Benefit (provision) for income taxes (258) (77) (335) Earnings (loss) of discontinued operations, net of taxes(a) 1,336 (676) 660 Gain (loss) on disposal before income taxes (3,312) 65 (3,246) Benefit (provision) for income taxes (570) (38) (608) Gain (loss) on disposal, net of taxes (3,882) 27 (3,855) Earnings (loss) from discontinued operations, net of taxes $ (2,546) $ (648) $ (3,195) For the year ended December 31, 2020 Total revenues $ — $ — $ — Cost of equipment and services sold (2,555) — (2,555) Other income, costs and expenses 1,781 (195) 1,586 Earnings (loss) of discontinued operations before income taxes (773) (195) (968) Benefit (provision) for income taxes (13) 101 89 Earnings (loss) of discontinued operations, net of taxes(a) (786) (93) (879) Gain (loss) on disposal before income taxes — (31) (31) Benefit (provision) for income taxes — (1) (1) Gain (loss) on disposal, net of taxes — (32) (32) Earnings (loss) from discontinued operations, net of taxes $ (786) $ (125) $ (911) (a) Earnings (loss) of discontinued operations from GECAS operations included zero, $359 million and $2,545 million of depreciation and amortization for the years ended December 31, 2022, 2021 and 2020, respectively. GECAS depreciation and amortization ceased on March 10, 2021. ASSETS AND LIABILITIES OF DISCONTINUED OPERATIONS December 31, 2022 December 31, 2021 Cash, cash equivalents and restricted cash $ 1,176 $ 736 Financing receivables held for sale (Polish mortgage portfolio) 1,199 1,799 Property, plant, and equipment - net 73 88 All other assets 444 554 Assets of discontinued operations $ 2,892 $ 3,177 Accounts payable and all other liabilities $ 1,137 $ 887 Liabilities of discontinued operations $ 1,137 $ 887

INVESTMENT SECURITIES

INVESTMENT SECURITIES	12 Months Ended
	Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
INVESTMENT SECURITIES	NOTE 3. INVESTMENT SECURITIES. All of our debt securities are classified as available-for-sale and substantially all are investment-grade supporting obligations to annuitants and policyholders in our run-off insurance operations. We manage the investments in our run-off insurance operations under strict investment guidelines, including limitations on asset class concentration, single issuer exposures, asset-liability duration variances, and other factors to meet credit quality, yield, liquidity and diversification requirements associated with servicing our insurance liabilities under reasonable circumstances. This process includes consideration of various asset allocation strategies and incorporates information from several external investment advisors to improve our investment yield subject to maintaining our ability to satisfy insurance liabilities when due, as well as considering our risk-based capital requirements, regulatory constraints, and tolerance for surplus volatility. Asset allocation planning is a dynamic process that considers changes in market conditions, risk appetite, liquidity needs and other factors, which are reviewed on a periodic basis by our investment team. On November 1, 2021, we received 111.5 million ordinary shares of AerCap (approximately 46% ownership interest) and an AerCap senior note as partial consideration in conjunction with the GECAS transaction, for which we have adopted the fair value option. Our investment in Baker Hughes (BKR) comprises 7.0 million shares (approximately 1% ownership interest) at December 31, 2022. Both our AerCap and BKR investments are recorded as Equity securities with readily determinable fair values. Investment securities held within insurance entities are classified as non-current as they support the long-duration insurance liabilities. December 31, 2022 December 31, 2021 Amortized Gross Gross Estimated Amortized Gross Gross Estimated Equity and note (AerCap) $ — $ — $ — $ 7,403 $ — $ — $ — $ 8,287 Equity (Baker Hughes) — — — 207 — — — 4,010 Current investment securities $ — $ — $ — $ 7,609 $ — $ — $ — $ 12,297 Debt U.S. corporate $ 26,921 $ 675 $ (2,164) $ 25,432 $ 25,182 $ 5,502 $ (33) $ 30,652 Non-U.S. corporate 2,548 18 (300) 2,266 2,361 343 (4) 2,701 State and municipal 2,898 66 (241) 2,722 2,639 573 (6) 3,205 Mortgage and asset-backed 4,442 21 (290) 4,173 3,950 117 (47) 4,019 Government and agencies 1,172 2 (147) 1,026 1,086 104 (2) 1,188 Other equity 429 — — 429 443 — — 443 Non-current investment securities $ 38,410 $ 781 $ (3,143) $ 36,048 $ 35,662 $ 6,639 $ (92) $ 42,209 The amortized cost of debt securities excludes accrued interest of $457 million and $415 million at December 31, 2022 and 2021, respectively , which is reported in All other current assets. The estimated fair value of investment securities at December 31, 2022 decreased since December 31, 2021, primarily due to higher market yields and widening credit spreads, BKR share sales, and the mark-to-market effect on our equity interest in AerCap, partially offset by new insurance investments, including related to the recapture transaction, and the mark-to-market effect on our remaining equity interest in BKR. See Note 12 for further information about the recapture transaction. Total estimated fair value of debt securities in an unrealized loss position were $21,482 million and $3,446 million, of which $3,275 million and $644 million had gross unrealized losses of $(835) million and $(42) million and had been in a loss position for 12 months or more at December 31, 2022 and 2021, respectively. Gross unrealized losses of $(3,143) million at December 31, 2022 included $(2,164) million related to U.S. corporate securities, $(182) million related to commercial mortgage-backed securities (CMBS) collateralized by pools of commercial mortgage loans on real estate, and $(106) million related to Asset-backed securities. The majority of our U.S. corporate securities' gross unrealized losses were in the consumer, electric, technology, insurance and energy industries. The majority of our CMBS and Asset-backed securities in an unrealized loss position have received investment-grade credit ratings from the major rating agencies. For our securities in an unrealized loss position, the losses are not indicative of credit losses, we currently do not intend to sell the investments, and it is not likely that we will be required to sell the investments before recovery of their amortized cost basis. Net unrealized gains (losses) for equity securities with readily determinable fair values, which are recorded in Other income (loss) within continuing operations, were $(65) million, $1,656 million and $(1,670) million for the years ended December 31, 2022, 2021 and 2020, respectively. Proceeds from debt and equity securities sales, early redemptions by issuers and principal payments on the BKR promissory note totaled $7,268 million, $6,666 million and $5,060 million for the years ended December 31, 2022, 2021 and 2020, respectively. Gross realized gains on debt securities were $34 million, $69 million and $173 million for the years ended December 31, 2022, 2021 and 2020, respectively. Gross realized losses and impairments on debt securities were $(42) million, $(11) million and $(68) million for the years ended December 31, 2022, 2021 and 2020, respectively. Cash flows associated with purchases, dispositions and maturities of insurance investment securities are as follows: For the years ended December 31 2022 2021 Purchases of investment securities $ (4,046) $ (4,286) Dispositions and maturities of investment securities 3,170 2,997 Net (purchases) dispositions of insurance investment securities $ (876) $ (1,290) Contractual maturities of our debt securities (excluding mortgage and asset-backed securities) at December 31, 2022 are as follows: Amortized cost Estimated fair value Within one year $ 413 $ 409 After one year through five years 4,287 4,247 After five years through ten years 5,910 5,869 After ten years 22,928 20,920 We expect actual maturities to differ from contractual maturities because borrowers have the right to call or prepay certain obligations. In addition to the equity securities described above, we hold $731 million and $441 million of equity securities without readily determinable fair values at December 31, 2022 and 2021, respectively, that are classified within non-current All other assets in our Statement of Financial Position. Fair value adjustments, including impairments, recorded in earnings were $(11) million, $46 million and $(141) million for the years ended December 31, 2022, 2021 and 2020, respectively. Our run-off insurance operations have approximately $800 million of assets held by states or other regulatory bodies in statutorily required deposit accounts, and approximately $29,700 million of assets held in trust accounts, including $2,300 million to be added in the first quarter of 2023, associated with reinsurance contracts and reinsurance security trust agreements in place between either Employers Reassurance Corporation (ERAC) or Union Fidelity Life Insurance Company (UFLIC) as the reinsuring entity and a number of ceding insurers. Assets in these trusts are held by an independent trustee for the benefit of the ceding insurer, and are subject to various investment guidelines as set forth in the respective reinsurance contracts and trust agreements. Some of these trust agreements may allow a ceding company to withdraw trust assets from the trust and hold these assets on its balance sheet, in an account under its control for the benefit of ERAC or UFLIC which might allow the ceding company to exercise investment control over such assets.

CURRENT AND LONG-TERM RECEIVABL

CURRENT AND LONG-TERM RECEIVABLES	12 Months Ended
	Dec. 31, 2022
Receivables [Abstract]
CURRENT AND LONG-TERM RECEIVABLES	NOTE 4. CURRENT AND LONG-TERM RECEIVABLES CURRENT RECEIVABLES December 31 2022 2021 Customer receivables $ 14,916 $ 13,079 Revenue sharing program receivables(a) 1,326 1,166 Non-income based tax receivables 1,320 1,222 Supplier advances 711 596 Receivables from disposed businesses 115 148 Other sundry receivables 447 483 Allowance for credit losses(b) (859) (1,074) Total current receivables $ 17,976 $ 15,620 (a) Revenue sharing program receivables in Aerospace are amounts due from third parties who participate in engine programs by developing and supplying certain engine components through the life of the program. The participants share in program revenues, receive a share of customer progress payments and share costs related to discounts and warranties. (b) Allowance for credit losses decreased primarily due to write-offs, recoveries and foreign currency impact, partially offset by net new provisions of $48 million. December 31 2022 2021 Aerospace $ 7,784 $ 5,812 Renewable Energy 2,415 2,218 Power 4,229 4,092 HealthCare 3,354 3,255 Corporate 195 244 Total current receivables $ 17,976 $ 15,620 Sales of customer receivables. Previously, GE businesses sold customer receivables to our Working Capital Solutions (WCS) business. These programs were discontinued in 2021. Separately, the Company from time to time sells current or long-term receivables to third parties in response to customer-sponsored requests or programs, to facilitate sales, or for risk mitigation purposes. Activity related to current customer receivables sold by GE businesses is as follows: 2022 2021 Third Parties WCS Third Parties Balance at January 1 $ 161 $ 3,618 $ 2,992 GE businesses sales to WCS — 13,773 — GE businesses sales to third parties(a) 2,061 — 1,415 WCS sales to third parties — (10,816) 10,816 Collections and other (2,163) (6,676) (15,062) Reclassification from long-term customer receivables 41 100 — Balance at December 31 $ 100 $ — $ 161 (a) The Company sold current customer receivables to third parties related primarily to our participation in customer-sponsored supply chain finance programs. Within these programs, primarily in Renewable Energy and Aerospace, the Company has no continuing involvement, fees associated with the transferred receivables are covered by the customer and cash is received at the original invoice due date. LONG-TERM RECEIVABLES December 31 2022 2021 Long-term customer receivables(a) $ 535 $ 521 Financing receivables 386 592 Supplier advances 277 309 Non-income based tax receivables 241 245 Receivables from disposed businesses 51 150 Sundry receivables 406 440 Allowance for credit losses (223) (160) Total long-term receivables $ 1,672 $ 2,097 (a) The Company sold $86 million and $53 million of long-term customer receivables to third parties for the years ended December 31, 2022 and 2021, respectively, primarily in our Gas Power business for risk mitigation purposes.

INVENTORIES, INCLUDING DEFERRED

INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS	12 Months Ended
	Dec. 31, 2022
Inventory Disclosure [Abstract]
INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS	NOTE 5. INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS December 31 2022 2021 Raw materials and work in process $ 10,356 $ 8,710 Finished goods 5,030 4,927 Deferred inventory costs(a) 2,017 2,210 Inventories, including deferred inventory costs $ 17,403 $ 15,847

PROPERTY, PLANT AND EQUIPMENT A

PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES	12 Months Ended
	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES	NOTE 6. PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES Depreciable lives Original Cost Net Carrying Value December 31 (in years) 2022 2021 2022 2021 Land and improvements 8 $ 542 $ 585 $ 530 $ 576 Buildings, structures and related equipment 8 - 40 7,913 8,311 3,483 3,728 Machinery and equipment 4 - 20 21,119 21,036 6,913 7,356 Leasehold costs and manufacturing plant under construction 1 - 10 2,059 1,971 1,415 1,343 ROU operating lease assets 2,137 2,606 Property, plant and equipment - net $ 31,633 $ 31,904 $ 14,478 $ 15,609 In the first quarter of 2022, we signed a non-binding memorandum of understanding for GE Steam Power to sell a portion of its business to EDF, which resulted in a reclassification of that business to held for sale. As a result, we recognized a non-cash pre-tax impairment charge of $59 million related to property, plant and equipment at our remaining Steam business within our Power segment. This charge was recorded by Corporate in Selling, general, and administrative expenses in our consolidated Statement of Earnings (Loss). Operating Lease Liabilities. Our consolidated operating lease liabilities, included in All other liabilities OPERATING LEASE EXPENSE 2022 2021 2020 Long-term (fixed) $ 755 $ 770 $ 827 Long-term (variable) 147 119 143 Short-term 153 192 206 Total operating lease expense $ 1,055 $ 1,081 $ 1,176 MATURITY OF LEASE LIABILITIES 2023 2024 2025 2026 2027 Thereafter Total Undiscounted lease payments $ 687 $ 567 $ 397 $ 291 $ 206 $ 603 $ 2,751 Less: imputed interest (357) Total lease liability as of December 31, 2022 $ 2,393 SUPPLEMENTAL INFORMATION RELATED TO OPERATING LEASES 2022 2021 2020 Operating cash flows used for operating leases $ 790 $ 834 $ 835 Right-of-use assets obtained in exchange for new lease liabilities 526 603 594 Weighted-average remaining lease term 6.2 years 7.2 years 6.7 years Weighted-average discount rate 3.8 % 4.0 % 4.6 %

ACQUISITIONS, GOODWILL AND OTHE

ACQUISITIONS, GOODWILL AND OTHER INTANGIBLE ASSETS	12 Months Ended
	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
ACQUISITIONS, GOODWILL AND OTHER INTANGIBLE ASSETS	NOTE 7. ACQUISITIONS, GOODWILL AND OTHER INTANGIBLE ASSETS ACQUISITIONS. On December 21, 2021 our HealthCare business acquired BK Medical, a leader in surgical ultrasound imaging and guidance technology, for $1,455 million. The final purchase price allocation resulted in goodwill of $997 million, amortizable intangible assets of $398 million and indefinite-lived intangible assets of $23 million. CHANGES IN GOODWILL BALANCES Balance at December 31, 2020 Acquisitions Currency exchange and other Balance at December 31, 2021 Dispositions Currency exchange and other Balance at December 31, 2022 Aerospace $ 9,247 $ — $ (234) $ 9,013 $ (6) $ (171) $ 8,835 Renewable Energy 3,401 — (169) 3,231 — (30) 3,201 Power 146 — (1) 145 — (1) 144 HealthCare 11,855 1,064 (40) 12,879 — (80) 12,799 Corporate(a) 876 43 (4) 914 — (96) 818 Total $ 25,524 $ 1,106 $ (448) $ 26,182 $ (6) $ (378) $ 25,798 (a) Corporate balance at December 31, 2022 and 2021 comprises our Digital business. In the fourth quarter of 2022, we performed our annual impairment test. Based on the results of this test, the fair values of each of our reporting units exceeded their carrying values, however, we identified two reporting units for which the fair values were not substantially in excess of their carrying values. The fair values of our Digital reporting unit at Corporate and the Additive reporting unit in our Aerospace segment were in excess of their carrying values by 16% and 21%, respectively. At December 31, 2022, our Digital and Additive reporting units had goodwill of $818 million and $239 million, respectively. Determining the fair value of reporting units requires the use of estimates and significant judgments that are based on a number of factors including actual operating results. It is reasonably possible that the judgments and estimates described above could change in future periods. 2022 2021 INTANGIBLE ASSETS SUBJECT TO AMORTIZATION December 31 Useful lives Gross carrying Accumulated Net Gross carrying Accumulated Net Customer-related(a) 3-15 $ 6,063 $ (3,475) $ 2,587 $ 6,400 $ (3,250) $ 3,150 Patents and technology 5-15 8,432 (5,018) 3,415 8,592 (4,361) 4,230 Capitalized software 3-10 5,288 (3,824) 1,464 5,764 (3,999) 1,765 Trademarks & other 2-50 419 (322) 97 449 (313) 136 Total $ 20,202 $ (12,639) $ 7,563 $ 21,205 $ (11,923) $ 9,282 (a) Balance includes payments made to our customers, primarily within our Aerospace business. December 31 2022 2021 Aerospace $ 4,748 $ 5,019 Renewable Energy 183 229 Power 958 1,965 HealthCare 1,520 1,847 Corporate 216 271 Total other intangible assets, net(a) $ 7,625 $ 9,330 (a) Balances include indefinite-lived intangible assets. Substantially all other intangible assets are subject to amortization. Intangible assets decreased $1,705 million in 2022, primarily as a result of amortization partially offset by the acquisition of capitalized software and patents and technology mainly at Aerospace and HealthCare of $209 million. Consolidated amortization expense was $1,742 million, $1,138 million and $1,336 million for the years ended December 31, 2022, 2021 and 2020, respectively. In the first quarter of 2022, we signed a non-binding memorandum of understanding for GE Steam Power to sell a portion of its business to EDF, which resulted in a reclassification of that business to held for sale. As a result, we recognized a non-cash pre-tax impairment charge of $765 million related to intangible assets at our remaining Steam business within our Power segment. We determined the fair value of these intangible assets using an income approach. This charge was recorded by Corporate in Selling, general, and administrative expenses Estimated consolidated annual pre-tax amortization for intangible assets over the next five calendar years are as follows: ESTIMATED 5 YEAR CONSOLIDATED AMORTIZATION 2023 2024 2025 2026 2027 Estimated annual pre-tax amortization $ 1,025 $ 919 $ 848 $ 751 $ 648

CONTRACT AND OTHER DEFERRED ASS

CONTRACT AND OTHER DEFERRED ASSETS & PROGRESS COLLECTIONS AND DEFERRED INCOME	12 Months Ended
	Dec. 31, 2022
Contractors [Abstract]
CONTRACT AND OTHER DEFERRED ASSETS & PROGRESS COLLECTIONS AND DEFERRED INCOME	NOTE 8. CONTRACT AND OTHER DEFERRED ASSETS & PROGRESS COLLECTIONS AND DEFERRED INCOME Contract and other deferred assets decreased $1,907 million in the year ended December 31, 2022 primarily due to decreased long-term service agreements and the timing of billing milestones ahead of revenue recognition on long-term equipment contracts. Our long-term service agreements decreased primarily due to billings of $11,665 million, partially offset by revenues recognized of $9,680 million and net favorable changes in estimated profitability of $85 million at Aerospace and $303 million at Power, primarily attributable to contractual increases in billings, partially offset by cost inflation. December 31, 2022 Aerospace Renewable Energy Power HealthCare Corporate Total Revenues in excess of billings $ 2,363 $ — $ 5,403 $ — $ — $ 7,766 Billings in excess of revenues (6,681) — (1,763) — — (8,443) Long-term service agreements $ (4,318) $ — $ 3,640 $ — $ — $ (677) Short-term and other service agreements 391 108 56 174 245 973 Equipment contract revenues 42 955 1,348 447 — 2,792 Current contract assets $ (3,884) $ 1,063 $ 5,044 $ 621 $ 245 $ 3,088 Nonrecurring engineering costs(a) 2,513 17 4 30 — 2,563 Customer advances and other(b) 2,519 — 724 204 — 3,447 Non-current contract and other deferred assets $ 5,032 $ 17 $ 728 $ 234 $ — $ 6,010 Total contract and other deferred assets $ 1,148 $ 1,079 $ 5,772 $ 854 $ 245 $ 9,098 December 31, 2021 Revenues in excess of billings $ 2,478 $ — $ 5,495 $ — $ — $ 7,972 Billings in excess of revenues (5,731) — (1,614) — — (7,346) Long-term service agreements $ (3,253) $ — $ 3,880 $ — $ — $ 627 Short-term and other service agreements 340 87 80 166 256 928 Equipment contract revenues 33 1,297 1,709 287 — 3,326 Current contract assets $ (2,881) $ 1,384 $ 5,669 $ 453 $ 256 $ 4,881 Nonrecurring engineering costs(a) 2,479 28 12 31 — 2,550 Customer advances and other(b) 2,620 — 801 154 — 3,574 Non-current contract and other deferred assets $ 5,099 $ 28 $ 813 $ 184 $ — $ 6,124 Total contract and other deferred assets $ 2,218 $ 1,412 $ 6,482 $ 637 $ 256 $ 11,005 (a) Included costs incurred prior to production (such as requisition engineering) for equipment production contracts, primarily within our Aerospace segment, which are amortized ratably over each unit produced. (b) Included amounts due from customers at Aerospace for the sales of engines, spare parts and services, and at Power, for the sale of services upgrades, which we collect through incremental fixed or usage-based fees from servicing the equipment under long-term service agreements. Progress collections and deferred income increased $763 million primarily due new collections received in excess of revenue recognition at Aerospace, including increased collections to support higher production, and at Renewable Energy, partially offset by a decrease at Power due to the reclassification of a portion of our GE Steam Power business to held for sale. Revenues recognized for contracts included in a liability position at the beginning of the year were $13,863 million and $14,884 million for the years ended December 31, 2022 and 2021, respectively. December 31, 2022 Aerospace Renewable Energy Power HealthCare Corporate Total Progress collections on equipment contracts $ 74 $ 2,464 $ 3,973 $ — $ — $ 6,511 Other progress collections 5,740 2,731 541 511 131 9,654 Current deferred income 233 208 13 1,391 107 1,952 Progress collections and deferred income $ 6,047 $ 5,404 $ 4,527 $ 1,902 $ 238 $ 18,118 Non-current deferred income 1,110 183 104 597 12 2,006 Total Progress collections and deferred income $ 7,157 $ 5,586 $ 4,632 $ 2,499 $ 250 $ 20,124 December 31, 2021 Aerospace Renewable Energy Power HealthCare Corporate Total Progress collections on equipment contracts $ 142 $ 1,843 $ 5,198 $ — $ — $ 7,183 Other progress collections 4,469 2,866 385 522 111 8,354 Current deferred income 170 198 33 1,336 99 1,835 Progress collections and deferred income $ 4,782 $ 4,907 $ 5,615 $ 1,858 $ 210 $ 17,372 Non-current deferred income 1,090 194 110 592 3 1,989 Total Progress collections and deferred income $ 5,871 $ 5,101 $ 5,725 $ 2,450 $ 213 $ 19,361

ALL OTHER ASSETS

ALL OTHER ASSETS	12 Months Ended
	Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
ALL OTHER ASSETS	NOTE 9. ALL OTHER ASSETS December 31 2022 2021 Derivative instruments (Note 22) $ 482 $ 684 Assets held for sale 95 208 Prepaid taxes and deferred charges 395 341 Cash collateral on derivatives — 76 Accrued interest and investment income 457 426 Other 93 199 All other current assets $ 1,521 $ 1,933 Equity method and other investments 8,554 7,840 Long-term receivables (Note 4) 1,672 2,097 Prepaid taxes and deferred charges 670 800 Insurance receivables 2,315 4,705 Insurance cash and cash equivalents(a) 619 353 Pension surplus 2,578 2,784 Other 591 461 All other non-current assets $ 16,998 $ 19,040 Total All other assets $ 18,520 $ 20,973 (a) Cash and cash equivalents in our insurance entities are subject to regulatory restrictions and used for operations of those entities. Therefore, the balance is included in All other assets. Equity method investments . Unconsolidated entities over which we have significant influence are accounted for as equity method investments and presented on a one-line basis in All other assets on our Statement of Financial Position. Equity method income includes our share of the results of unconsolidated entities, gains (loss) from sales and impairments of investments, which is included in Other income and in Insurance revenues in our Statement of Earnings (Loss). See Note 1 for further information. Equity method investment balance Equity method income (loss) December 31 2022 2021 2022 2021 2020 Aerospace $ 1,931 $ 2,000 $ 149 $ 58 $ (41) Renewable Energy 752 739 32 39 13 Power 960 977 89 23 43 HealthCare 182 223 13 27 7 Corporate(a) 3,991 3,451 103 68 23 Total consolidated $ 7,815 $ 7,391 $ 386 $ 215 $ 46 (a) Equity method investments within Corporate include investments held by EFS of $1,975 million and $1,943 million and held by our run-off insurance operations of $1,980 million and $1,480 million as of December 31, 2022 and 2021, respectively.

BORROWINGS

BORROWINGS	12 Months Ended
	Dec. 31, 2022
Debt Disclosure [Abstract]
BORROWINGS	NOTE 10. BORROWINGS December 31 2022 2021 Amount Average Rate Amount Average Rate Current portion of long-term borrowings Senior notes issued by GE $ 473 1.04 % $ 1,249 1.39 % Senior and subordinated notes assumed by GE 1,973 1.50 1,645 2.05 Senior notes issued by GE Capital 1,188 1.54 1,370 0.63 Other 124 97 Total short-term borrowings $ 3,757 $ 4,361 Maturities Amount Average Rate Amount Average Rate Senior notes issued by GE 2024-2052 $ 12,927 4.75 % $ 5,373 2.87 % Senior and subordinated notes assumed by GE 2024-2054 8,406 4.71 11,306 3.73 Senior notes issued by GE Capital 2024-2042 6,289 3.95 13,274 4.26 Other 971 870 Total long-term borrowings $ 28,593 $ 30,824 Total borrowings $ 32,350 $ 35,186 The Company has provided a full and unconditional guarantee on the payment of the principal and interest on all senior and subordinated outstanding long-term debt securities issued by subsidiaries of GE Capital, our former financial services business. This guarantee applied to $5,258 million and $13,719 million of senior notes and other debt issued by GE Capital at December 31, 2022 and 2021, respectively. In the fourth quarter of 2022, GE HealthCare issued a total of $8,250 million in aggregate principal amount of senior unsecured debt, comprising $1,000 million of 5.55% Notes due 2024, $1,500 million of 5.60% Notes due 2025, $1,750 million of 5.65% Notes due 2027, $1,250 million of 5.857% Notes due 2030, $1,750 million of 5.905% Notes due 2032, and $1,000 million of 6.377% Notes due 2052. GE used the majority of the proceeds to complete a debt tender to repurchase a total of $7,234 million of debt, comprising $6,106 million of Capital issued debt with maturities ranging from 2032 through 2035, and $1,128 million of GE assumed debt due 2032. See Note 22 for further information about borrowings and associated interest rate swaps. Long-term debt maturities over the next five years follow. 2023 2024 2025 2026 2027 Debt issued by GE $ 473 $ 1,217 $ 2,357 $ 49 $ 2,450 Debt assumed by GE 1,973 512 237 1,136 222 Debt issued by GE Capital 1,188 (a) 112 694 149 624 (a) Fixed and floating rate notes of $363 million contain put options with exercise dates in 2023, which have final maturity beyond 2034.

ACCOUNTS PAYABLE AND EQUIPMENT

ACCOUNTS PAYABLE AND EQUIPMENT PROJECT PAYABLES	12 Months Ended
	Dec. 31, 2022
Payables and Accruals [Abstract]
ACCOUNTS PAYABLE AND EQUIPMENT PROJECT PAYABLES	NOTE 11. ACCOUNTS PAYABLE AND EQUIPMENT PROJECT PAYABLES December 31 2022 2021 Trade payables $ 12,479 $ 10,970 Supply chain finance programs 4,081 3,402 Equipment project payables(a) 1,469 1,341 Non-income based tax payables 616 531 Accounts payable and equipment project payables $ 18,644 $ 16,243 (a) Primarily related to projects in our Power and Renewable Energy segments.

INSURANCE LIABILITIES AND ANNUI

INSURANCE LIABILITIES AND ANNUITY BENEFITS	12 Months Ended
	Dec. 31, 2022
Insurance [Abstract]
INSURANCE LIABILITIES AND ANNUITY BENEFITS	NOTE 12. INSURANCE LIABILITIES AND ANNUITY BENEFITS. Insurance liabilities and annuity benefits comprise substantially all obligations to annuitants and insureds in our run-off insurance operations. Our insurance operations (net of eliminations) generated revenues of $2,954 million, $3,106 million and $2,865 million, profit was $60 million, $566 million and $197 million and net earnings was $44 million, $444 million and $143 million for the years ended December 31, 2022, 2021 and 2020, respectively. These operations were supported by assets of $44,197 million and $49,894 million at December 31, 2022 and 2021, respectively. A summary of our insurance contracts is presented below: December 31, 2022 Long-term care Structured settlement annuities & life Other contracts Other adjustments(a) Total Future policy benefit reserves $ 17,357 $ 8,678 $ 187 $ — $ 26,223 Claim reserves 4,596 254 307 — 5,156 Investment contracts — 864 907 — 1,771 Unearned premiums and other 18 174 5 — 197 Total $ 21,971 $ 9,970 $ 1,406 $ — $ 33,347 December 31, 2021 Future policy benefit reserves $ 17,097 $ 8,902 $ 188 $ 3,394 $ 29,581 Claim reserves(b) 4,546 258 585 — 5,389 Investment contracts — 955 954 — 1,909 Unearned premiums and other 15 184 89 — 287 Total $ 21,658 $ 10,299 $ 1,815 $ 3,394 $ 37,166 (a) The decrease in Other adjustments of $3,394 million is a result of the decline in unrealized gains on investment securities. (b) Other contracts included claim reserves of $242 million related to short-duration contracts at Electric Insurance Company (EIC), net of eliminations, at December 31, 2021. EIC is a property and casualty insurance company primarily providing insurance to GE and its employees. Claim reserve activity included incurred claims of $1,481 million, $1,699 million and $1,801 million, of which insignificant amounts related to the recognition of adjustments to prior year claim reserves arising from our periodic reserve evaluation in the years ended December 31, 2022, 2021 and 2020, respectively. Paid claims were $1,518 million, $1,709 million and $1,728 million in the years ended December 31, 2022, 2021 and 2020, respectively. Reinsurance recoveries are recorded as a reduction of insurance losses and annuity benefits in our Statement of Earnings (Loss) and amounted to $321 million, $351 million and $350 million for the years ended December 31, 2022, 2021 and 2020, respectively. Reinsurance recoverables, net of allowances of an insignificant amount and $1,654 million, are included in non-current All other assets in our Statement of Financial Position, and amounted to $132 million and $2,651 million at December 31, 2022 and 2021, respectively. In the third quarter of 2022, we agreed to terminate substantially all long-term care insurance exposures previously ceded to a single reinsurance company (recapture transaction) and recorded an increase to our allowance for credit losses on such reinsurance recoverables of $415 million (pre-tax) ($328 million (after-tax)) which is unrelated to changes in claim experience or projections of future policy benefit reserves. Upon closing of the recapture transaction in the fourth quarter of 2022, we received a net portfolio of investment securities with an estimated fair value of $2,396 million in complete settlement of reinsurance recoverables previously recognized under retrocession agreements with the reinsurance company, which represented substantially all of our reinsurance recoverables balance as of September 30, 2022 and recorded an incremental loss of $56 million (pre-tax) ($44 million (after-tax)). The recapture transaction reduces both our financial and operational risks by removing the future inherent risk of collectability of reinsurance recoverables, eliminating retrocession contracts having complex terms and conditions, assuming direct control of the portfolio of investment securities held in a trust for our benefit and redeploying those assets consistent with our portfolio realignment strategy and establishing administration service standards intended to enhance claim administration and innovation efforts. The effect of the recapture agreement does not increase our long-term care insurance liabilities as under the existing retrocession agreements we were not previously relieved of our primary obligation to companies from which we originally assumed the liabilities. In addition, we do not expect changes to projected statutory funding as a result of the recapture transaction. Premium Deficiency Testing . We completed our annual premium deficiency testing in the aggregate across our run-off insurance portfolio in the third quarter of 2022. These procedures included updating certain experience studies since our last test completed in the third quarter of 2021, independent actuarial analysis (principally on long-term care insurance exposures) and review of industry benchmarks. Using updated assumptions, the 2022 premium deficiency testing results indicated a positive margin of about 10% of the related future policy benefit reserves recorded at September 30, 2022, or approximately equivalent to the 2021 premium deficiency testing results. The premium deficiency testing margin in 2022 was impacted by a lower discount rate in our ERAC portfolio due to the recapture transaction, as explained above, partially offset by higher prevailing benchmark interest rates in the U.S. The portfolio of investment securities expected to be received from the recapture transaction were assumed to be invested at yields below ERAC’s current portfolio yield before ultimately grading to the long-term average investment yield as we reinvest the portfolio over time. This effect was partially offset by the net impact from assumed moderately higher near-term mortality related to COVID-19 in the aggregate across our run-off insurance products (i.e., for life insurance products, higher mortality increases the present value of expected future benefit payments, while for annuity and long-term care insurance contracts, higher mortality decreases the present value of expected future benefit payments). Excluding the net impact from assumed moderately higher near-term mortality related to COVID-19, we have made no substantial change to our assumptions concerning morbidity, morbidity improvement, mortality, mortality improvement, terminations, or long-term care insurance premium rate increases in 2022. We regularly monitor emerging experience and industry developments, including these factors, to help us refine all our reserve assumptions, which may result in future changes to those assumptions. Statutory accounting practices, not GAAP, determine the required statutory capital levels of our insurance legal entities. Statutory accounting practices are set forth by the National Association of Insurance Commissioners (NAIC) as well as state laws, regulation and general administrative rules and differ in certain respects from GAAP. We annually perform statutory asset adequacy testing and expect our December 31, 2022 testing process to be completed in the first quarter of 2023, the results of which may affect the amount or timing of capital contributions from GE to the insurance legal entities. Following approval of a statutory permitted accounting practice in 2018 by our primary regulator, the Kansas Insurance Department (KID), we provided a total of $11,400 million of capital contributions to our run-off insurance subsidiaries. We expect to provide further capital contributions of approximately $3,600 million through 2024 (of which approximately $1,800 million is expected to be contributed in the first quarter of 2023, pending completion of our December 31, 2022 statutory reporting process, which includes asset adequacy testing), subject to ongoing monitoring by KID. GE is a party to capital maintenance agreements with its run-off insurance subsidiaries under which GE is required to maintain their statutory capital levels at 300% of their year-end Authorized Control Level risk-based capital requirements as defined from time to time by the NAIC.

POSTRETIREMENT BENEFIT PLANS

POSTRETIREMENT BENEFIT PLANS	12 Months Ended
	Dec. 31, 2022
Retirement Benefits [Abstract]
POSTRETIREMENT BENEFIT PLANS	NOTE 13. POSTRETIREMENT BENEFIT PLANS PENSION BENEFITS AND RETIREE HEALTH AND LIFE BENEFITS. We sponsor a number of pension and retiree health and life insurance benefit plans that we present in three categories, principal pension plans, other pension plans and principal retiree benefit plans. Smaller pension plans with pension assets or obligations that have not reached $50 million and other retiree benefit plans are not presented. Information in this Note is as of a December 31 measurement date for these plans and does not reflect the impact of the GE HealthCare Separation, including the legal split and the transfer of certain postretirement benefit plans. See Note 28 for information regarding the legal split and the transfer of certain postretirement benefit plans to GE HealthCare in connection with the Separation. DESCRIPTION OF OUR PLANS Plan Category Participants Funding Comments Principal Pension Plans GE Pension Plan Covers U.S. participants ~177,000 retirees and beneficiaries, ~82,500 vested former employees and ~23,000 active employees Our funding policy is to contribute amounts sufficient to meet minimum funding requirements under employee benefit and tax laws. We may decide to contribute additional amounts beyond this level. This plan has been closed to new participants since 2012. Benefits for ~20,000 employees with salaried benefits were frozen effective January 1, 2021, and thereafter these employees receive increased company contributions in the company sponsored defined contribution plan in lieu of participation in a defined benefit plan (announced October 2019). GE Supplementary Pension Plan Provides supplementary benefits to higher-level, longer-service U.S. employees This plan is unfunded. We pay benefits from company cash. The annuity benefit has been closed to new participants since 2011 and has been replaced by an installment benefit (which was closed to new executives after 2020). Benefits for ~700 employees who became executives before 2011 were frozen effective January 1, 2021, and thereafter these employees accrue the installment benefit. Other Pension Plans(a) 41 U.S. and non-U.S. pension plans with pension assets or obligations that have reached $50 million Covers ~58,000 retirees and beneficiaries, ~48,500 vested former employees and ~14,000 active employees Our funding policy is to contribute amounts sufficient to meet minimum funding requirements under employee benefit and tax laws in each country. We may decide to contribute additional amounts beyond this level. We pay benefits for some plans from company cash. In certain countries, benefit accruals have ceased and/or have been closed to new hires as of various dates. Principal Retiree Benefit Plans Provides health and life insurance benefits to certain eligible participants Covers U.S. participants ~151,500 retirees and dependents and ~21,500 active employees We fund retiree health benefits on a pay-as-you-go basis and the retiree life insurance trust at our discretion. Participants share in the cost of the healthcare benefits. (a) Plans that reach $50 million are not removed from the presentation unless part of a disposition or plan termination. FUNDING STATUS BY PLAN TYPE Benefit Obligation Fair Value of Assets Deficit/(Surplus) 2022 2021 2022 2021 2022 2021 Principal Pension Plans: GE Pension Plan (subject to regulatory funding) $ 48,134 $ 65,073 $ 44,993 $ 60,990 $ 3,141 $ 4,083 GE Supplementary Pension Plan (not subject to regulatory funding) 5,457 7,226 — — 5,457 7,226 53,591 72,299 44,993 60,990 8,598 11,309 Other Pension Plans: Subject to regulatory funding 12,078 19,698 14,512 22,280 (2,434) (2,582) Not subject to regulatory funding 1,838 2,558 151 210 1,687 2,348 Principal retiree benefit plans (not subject to regulatory funding) 3,304 4,308 10 42 3,294 4,266 Total plans subject to regulatory funding 60,212 84,771 59,505 83,270 707 1,501 Total plans not subject to regulatory funding 10,599 14,092 161 252 10,438 13,840 Total plans $ 70,811 $ 98,863 $ 59,666 $ 83,522 $ 11,145 $ 15,341 FUNDING. The Employee Retirement Income Security Act (ERISA) determines minimum funding requirements in the U.S. No contributions were required or made for the GE Pension Plan during 2022 or 2021 and based on our current assumptions, we do not anticipate having to make additional required contributions to the plan in the near future. On an ERISA basis, our estimate is that the GE Pension Plan was 92.8% and 107.3% funded for 2022 and 2021, respectively. The GAAP funded status is 93.5% and 93.7% for 2022 and 2021, respectively. As of the measurement date of December 31, we would expect to pay approximately $370 million fo r benefit payments under our GE Supplementary Pension Plan and administrative expenses of our principal pension plans and would expect to contribute approximately $170 million to other pension plans in 2023. We fund retiree health benefits on a pay-as-you-go basis and the retiree life insurance trust at our discretio n. As of the measurement date of December 31, we would expect to contribute approximately $365 mil lion in 2023 to fund such benefits. ACTIONS. Pension benefits for approximately 2,700 United Kingdom (UK) participants have been frozen effective January 1, 2022. In addition, pension benefits for approximately 800 Canadian participants will be frozen effective December 31, 2023. These transactions were reflected as a curtailment loss in 2021 upon announcement. COST OF OUR BENEFITS PLANS 2022 2021 2020 AND ASSUMPTIONS Principal pension Other pension Principal retiree benefit Principal pension Other pension Principal retiree benefit Principal pension Other pension Principal retiree benefit Components of expense (income) Service cost - operating $ 221 $ 86 $ 39 $ 237 $ 233 $ 44 $ 657 $ 243 $ 59 Interest cost 2,069 398 108 1,951 383 103 2,350 422 150 Expected return on plan assets (3,142) (967) — (3,049) (1,194) — (2,993) (1,082) (11) Amortization of net loss (gain) 1,422 101 (115) 3,483 403 (79) 3,399 434 (82) Amortization of prior service cost (credit) 5 (8) (235) 28 (3) (236) 146 1 (234) Curtailment / settlement loss (gain) — (6) — — 76 — — 12 — Non-operating $ 354 $ (482) $ (242) $ 2,413 $ (335) $ (212) $ 2,902 $ (213) $ (177) Net periodic expense (income) $ 575 $ (396) $ (203) $ 2,650 $ (102) $ (168) $ 3,559 $ 30 $ (118) Weighted-average benefit obligations assumptions Discount rate 5.53 % 4.59 % 5.43 % 2.94 % 1.93 % 2.64 % 2.61 % 1.44 % 2.15 % Compensation increases 3.07 2.44 3.12 3.05 2.35 2.63 2.95 3.06 2.82 Initial healthcare trend rate(a) N/A N/A 6.40 N/A N/A 5.70 N/A N/A 5.90 Weighted-average benefit cost assumptions Discount rate 2.94 1.93 2.64 2.61 1.44 2.15 3.36 1.97 3.05 Expected rate of return on plan assets 6.00 4.80 — 6.25 5.69 1.25 6.25 6.10 7.00 (a) For 2022, ultimately declining to 5% for 2030 and thereafter. As of the measurement date of December 31, we would e xpect 2023 net periodic benefit income for principal pension, other pension and principal retiree benefit plans to be about $2,010 million, which is an increase of approximately $1,985 million in income from 2022. The increase would primarily be due to the discount rate. The components of net periodic benefit costs, other than the service cost component, are included in Non-operating benefit cost (income) in our Statement of Earnings (Loss). PLAN FUNDED STATUS AND AMOUNTS RECORDED IN ACCUMULATED OTHER COMPREHENSIVE LOSS (INCOME) 2022 2021 Principal pension Other pension Principal retiree benefit Principal pension Other pension Principal retiree benefit Change in benefit obligations Balance at January 1 $ 72,299 $ 22,256 $ 4,308 $ 76,298 $ 24,658 $ 5,019 Service cost 221 86 39 237 233 44 Interest cost 2,069 398 108 1,951 383 103 Participant contributions 14 19 54 15 24 60 Plan amendments — — — — (1) — Actuarial loss (gain) - net (17,281) (a) (6,282) (a) (778) (a) (2,448) (a) (1,561) (a) (446) Benefits paid (3,731) (920) (438) (3,754) (998) (472) Curtailments — — — — (74) — Dispositions/acquisitions/other - net — — 11 — (188) — Exchange rate adjustments — (1,641) — — (220) — Balance at December 31 $ 53,591 (b) $ 13,916 $ 3,304 (c) $ 72,299 (b) $ 22,256 $ 4,308 (c) Change in plan assets Balance at January 1 $ 60,990 $ 22,490 $ 42 $ 58,843 $ 21,506 $ 134 Actual gain (loss) on plan assets (12,605) (5,334) — 5,559 1,602 41 Employer contributions 325 209 352 327 594 279 Participant contributions 14 19 54 15 24 60 Benefits paid (3,731) (920) (438) (3,754) (998) (472) Dispositions/acquisitions/other - net — — — — (138) — Exchange rate adjustments — (1,801) — — (100) — Balance at December 31 $ 44,993 $ 14,663 $ 10 $ 60,990 $ 22,490 $ 42 Funded status - surplus (deficit) $ (8,598) $ 747 $ (3,294) $ (11,309) $ 234 $ (4,266) Amounts recorded in Non-current assets - other $ — $ 2,591 $ — $ — $ 2,898 $ — Current liabilities - other (351) (101) (355) (337) (107) (362) Non-current liabilities - compensation and benefits (8,247) (1,743) (2,939) (10,972) (2,557) (3,904) Net amount recorded $ (8,598) $ 747 $ (3,294) $ (11,309) $ 234 $ (4,266) Amounts recorded in Accumulated other comprehensive loss (income) Prior service cost (credit) $ (113) $ (42) $ (1,677) $ (109) $ (52) $ (1,912) Net loss (gain) (5,710) 1,787 (1,705) (2,754) 2,012 (1,042) Total recorded in Accumulated other comprehensive loss (income) $ (5,823) $ 1,745 $ (3,382) $ (2,863) $ 1,960 $ (2,954) (a) Principally associated with discount rate changes. (b) The benefit obligation for the GE Supplementary Pension Plan, which is an unfunded plan, was $5,457 million and $7,226 million at December 31, 2022 and 2021, respectively. (c) The benefit obligation for retiree health plans was $1,991 million and $2,548 million at December 31, 2022 and 2021, respectively. ASSUMPTIONS USED IN CALCULATIONS. Our defined benefit pension plans are accounted for on an actuarial basis, which requires the selection of various assumptions, including a discount rate, a compensation assumption, an expected return on assets, mortality rates of participants and expectation of mortality improvement. Projected benefit obligations are measured as the present value of expected benefit payments. We discount those cash payments using a discount rate. We determine the discount rate using the weighted-average yields on high-quality fixed-income securities with maturities that correspond to the payment of benefits. Lower discount rates increase present values and generally increase subsequent-year pension expense; higher discount rates decrease present values and generally reduce subsequent-year pension expense. The compensation assumption is used to estimate the annual rate at which pay of plan participants will grow. If the rate of growth assumed increases, the size of the pension obligations will increase, as will the amount recorded in AOCI in our Statement of Financial Position and amortized into earnings in subsequent periods. The expected return on plan assets is the estimated long-term rate of return that will be earned on the investments used to fund the benefit obligations. To determine the expected long-term rate of return on pension plan assets, we consider our asset allocation, as well as historical and expected returns on various categories of plan assets. In developing future long-term return expectations for our principal benefit plans’ assets, we formulate views on the future economic environment, both in the U.S. and abroad. We evaluate general market trends and historical relationships among a number of key variables that impact asset class returns such as expected earnings growth, inflation, valuations, yields and spreads, using both internal and external sources. We also take into account expected volatility by asset class and diversification across classes to determine expected overall portfolio results given our asset allocation. Based on our analysis, we have assumed a 6.00% and 6.25% long-term expected return on the GE Pension Plan assets for cost recognition in 2022 and 2021, respectively. For 2023 cost recognition, based on GE Pension Plan assets at December 31, 2022, we have assumed a 7.00% long-term expected return. The Society of Actuaries issued new mortality improvement tables during 2021 that were used to update mortality assumptions in the U.S. These changes in assumptions increased the December 31, 2021 U.S. pension and retiree benefit plans' obligations by $278 million. The healthcare trend assumptions primarily apply to our pre-65 retiree medical plans. Most participants in our post-65 retiree plan have a fixed subsidy and therefore are not subject to healthcare inflation. We evaluate these critical assumptions at least annually on a plan and country-specific basis. We periodically evaluate other assumptions involving demographics factors such as retirement age and turnover, and update them to reflect our actual experience and expectations for the future. Actual results in any given year will often differ from actuarial assumptions because of economic and other factors. Differences between our actual results and what we assumed are recorded in AOCI each period. These differences are amortized into earnings over the remaining average future service of active participating employees or the expected life of inactive participants, as applicable. For the principal pension plans, gains and losses are amortized using a straight-line method with a separate layer for each year’s gains and losses. For most other pension plans and principal retiree benefit plans, gains and losses are amortized using a straight-line or a corridor amortization method. SENSITIVITIES TO KEY ASSUMPTIONS. Fluctuations in discount rates can significantly impact pension cost and obligations. As of the December 31 measurement date, we would expect a 25 basis point decrease in discount rate would increase principal pension plan cost in the following year by approximately $130 million and would also expect an increase in the principal pension plan projected benefit obligation at year-end by approximately $1,300 million. The deficit sensitivity to the discount rate would be lower than the projected benefit obligation sensitivity as a result of the liability hedging program incorporated in the plan's asset allocation. A 50 basis point decrease in the expected return on assets would increase principal pension plan cost in the following year by approximately $260 million. THE COMPOSITION OF OUR PLAN ASSETS. The fair value of our pension plans' investments is presented below. The inputs and valuation techniques used to measure the fair value of these assets are described in Note 1 and have been applied consistently. 2022 2021 Principal pension Other pension Principal pension Other pension Global equities $ 3,918 $ 1,097 $ 7,778 $ 3,589 Debt securities Fixed income and cash investment funds 4,918 6,506 7,665 10,527 U.S. corporate(a) 8,715 382 10,324 468 Other debt securities(b) 7,853 443 7,331 492 Real estate 1,486 53 2,510 89 Private equities and other investments 1,245 364 1,515 943 Total 28,135 8,845 37,123 16,108 Plan assets measured at net asset value Global equities $ 3,285 $ 1,029 $ 9,517 $ 1,172 Debt securities 3,469 1,024 5,269 1,287 Real estate 1,624 1,976 1,408 2,126 Private equities and other investments 8,480 1,789 7,673 1,797 Total plan assets at fair value $ 44,993 $ 14,663 $ 60,990 $ 22,490 (a) Primarily represented investment-grade bonds of U.S. issuers from diverse industries. (b) Primarily represented investments in residential and commercial mortgage-backed securities, non-U.S. corporate and government bonds and U.S. government, federal agency, state and municipal debt. Plan assets that were measured at fair value using NAV as a practical expedient were excluded from the fair value hierarchy. GE Pension Plan investments with a fair value of $2,255 million and $3,872 million at December 31, 2022 and 2021, respectively, were classified within Level 3 and primarily relate to private equities and real estate. The remaining investments were substantially all considered Level 1 and 2. Investments with a fair value of $6,759 million and $12,377 million at December 31, 2022 and 2021, respectively, were classified within Level 1 and primarily relate to global equities and cash. Investments with a fair value of $18,606 million and $20,942 million at December 31, 2022 and 2021, respectively, were classified within Level 2 and primarily relate to debt securities. Other pension plans investments with a fair value of $81 million and $138 million at December 31, 2022 and 2021, respectively, were classified within Level 3 and primarily relate to private equities and real estate. The remaining investments were substantially all considered Level 1 and 2. Investments with a fair value of $841 million and $1,312 million at December 31, 2022 and 2021, respectively, were classified within Level 1 and primarily relate to global equities and cash. Investments with a fair value of $7,580 million and $13,802 million at December 31, 2022 and 2021, respectively, were classified within Level 2 and primarily relate to debt securities. Principal retiree benefit plan investments have a fair value of $10 million and $42 million at December 31, 2022 and 2021, respectively. There were no Level 3 principal retiree benefit plan investments held in 2022 and 2021. ASSET ALLOCATION OF PENSION PLANS 2022 Target allocation 2022 Actual allocation Principal Pension Other Pension (weighted average) Principal Pension Other Pension (weighted average) Global equities 14.0 - 34.0 % 17 % 16 % 14 % Debt securities (including cash equivalents) 31.0 - 81.5 60 55 57 Real estate 1.0 - 10.0 8 7 14 Private equities & other investments 6.0 - 30.0 15 22 15 Plan fiduciaries of the GE Pension Plan set investment policies and strategies for the GE Pension Trust and oversee its investment allocation, which includes selecting investment managers and setting long-term strategic targets. The plan fiduciaries' primary strategic investment objectives are balancing investment risk and return and monitoring the plan’s liquidity position in order to meet the plan's near-term benefit payment and other cash needs. The plan has incorporated de-risking objectives and liability hedging programs as part of its long-term investment strategy. The plan utilizes a combination of long-dated corporate bonds, treasuries, strips and derivatives to implement its investment strategies as well as for hedging asset and liability risks. Target allocation percentages are established at an asset class level by plan fiduciaries. Target allocation ranges are guidelines, not limitations, and occasionally plan fiduciaries will approve allocations above or below a target range. GE securities represented 0.7% and 0.6% of the GE Pension Trust assets at December 31, 2022 and 2021, respectively. The GE Pension Trust has a broadly diversified portfolio of investments in equities, fixed income, private equities and real estate; these investments are both U.S. and non-U.S. in nature. ANNUALIZED RETURNS 1 year 5 years 10 years 25 years GE Pension Plan (20.5) % 2.7 % 5.4 % 5.8 % EXPECTED FUTURE BENEFIT PAYMENTS OF OUR BENEFIT PLANS(a) Principal pension Other pension Principal retiree benefit 2023 $ 3,830 $ 850 $ 375 2024 3,865 845 360 2025 3,890 855 345 2026 3,910 870 330 2027 3,920 885 325 2028-2032 19,510 4,585 1,375 (a) As of the measurement date of December 31, 2022 DEFINED CONTRIBUTION PLAN. We have a defined contribution plan for eligible U.S. employees that provides employer contributions which were $444 million, $418 million and $318 million for the years ended December 31, 2022, 2021, and 2020, respectively. COST OF POSTRETIREMENT BENEFIT PLANS AND CHANGES IN OTHER COMPREHENSIVE INCOME For the years ended December 31 2022 2021 2020 (Pre-tax) Principal pension Other pension Principal retiree benefit Principal pension Other pension Principal retiree benefit Principal pension Other pension Principal retiree benefit Cost (income) of postretirement benefit plans $ 575 $ (396) $ (203) $ 2,650 $ (102) $ (168) $ 3,559 $ 30 $ (118) Changes in other comprehensive loss (income) Prior service cost (credit) - current year — — — — (1) — — 27 (7) Net loss (gain) - current year (1,533) (128) (778) (4,959) (2,104) (488) 1,124 529 119 Reclassifications out of AOCI Curtailment/settlement gain (loss) — 6 — — (68) — — (3) — Dispositions — — — — (68) — — (166) — Amortization of net gain (loss) (1,422) (101) 115 (3,483) (403) 79 (3,399) (434) 82 Amortization of prior service credit (cost) (5) 8 235 (28) 3 236 (146) (1) 234 Total changes in other comprehensive loss (income) (2,960) (215) (428) (8,470) (2,641) (173) (2,421) (48) 428 Cost (income) of postretirement benefit plans and changes in other comprehensive loss (income) $ (2,385) $ (611) $ (631) $ (5,820) $ (2,743) $ (341) $ 1,138 $ (18) $ 310

ALL OTHER LIABILITIES

ALL OTHER LIABILITIES	12 Months Ended
	Dec. 31, 2022
Other Liabilities Disclosure [Abstract]
ALL OTHER LIABILITIES	NOTE 14. ALL OTHER LIABILITIES December 31 2022 2021 Sales discounts and allowances(a) $ 4,042 $ 4,020 Equipment projects and other commercial liabilities 1,652 1,618 Product warranties (Note 24) 1,268 1,091 Employee compensation and benefit liabilities 4,662 4,677 Interest payable 400 276 Taxes payable 743 500 Environmental, health and safety liabilities (Note 24) 282 386 Derivative instruments (Note 22) 589 212 Other 847 1,196 All other current liabilities $ 14,485 $ 13,977 Equipment projects and other commercial liabilities $ 2,229 $ 2,451 Product warranties (Note 24) 885 800 Operating lease liabilities (Note 6) 2,393 2,848 Uncertain and other income taxes and related liabilities 2,581 3,041 Alstom legacy legal matters (Note 24) 455 567 Environmental, health and safety liabilities (Note 24) 2,404 2,274 Redeemable noncontrolling interests (Note 16) 132 148 Interest payable — 179 Other 1,076 934 All other non-current liabilities $ 12,154 $ 13,240 Total All other liabilities $ 26,639 $ 27,217 (a) Primarily comprise amounts payable to airlines based on future aircraft deliveries by airframers and discounts on spare parts and repair sales at our Aerospace segment.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
INCOME TAXES	NOTE 15. INCOME TAXES . GE files a consolidated U.S. federal income tax return which enables GE's businesses to use tax deductions and credits of one member of the group to reduce the tax that otherwise would have been payable by another member of the group. The effective tax rate reflects the benefit of these tax reductions in the consolidated return. Cash payments are made to GE's businesses for tax reductions and from GE's businesses for tax increases . Our businesses are subject to regulation under a wide variety of U.S. federal, state and foreign tax laws, regulations and policies. Changes to these laws or regulations may affect our tax liability, return on investments and business operations. On August 16, 2022, the U.S. enacted the Inflation Reduction Act that includes a new alternative minimum tax based upon financial statement income (book minimum tax), an excise tax on stock buybacks and tax incentives for energy and climate initiatives, among other provisions. The new book minimum tax is expected to slow but not eliminate the favorable tax impact of our deferred tax assets, resulting in higher cash tax in some years that would generate future tax credits. The impact of the book minimum tax will depend on our facts in each year and anticipated guidance from the U.S. Department of the Treasury. Separately, we continue to assess tax incentives in the legislation which could change our pre-tax or tax amounts and impact our tax rate. EARNINGS (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES 2022 2021 2020 U.S. earnings (loss) $ (238) $ (2,959) $ (4,823) Non-U.S. earnings (loss) 1,650 (724) 10,793 Total $ 1,412 $ (3,683) $ 5,970 PROVISION (BENEFIT) FOR INCOME TAXES 2022 2021 2020 Current U.S. Federal $ 62 $ (1,347) $ 865 Non-U.S. 1,040 1,154 1,276 U.S. State 4 (85) 152 Deferred U.S. Federal (956) (567) (1,898) Non-U.S. 466 608 (810) U.S. State (141) (50) (72) Total $ 476 $ (286) $ (487) Income taxes paid were $1,128 million, $1,330 million and $1,291 million for the years ended December 31, 2022, 2021 and 2020, respectively, including payments reported in discontinued operations. RECONCILIATION OF U.S. FEDERAL STATUTORY INCOME TAX RATE TO ACTUAL INCOME TAX RATE 2022 2021 2020 Amount Rate Amount Rate Amount Rate U.S. federal statutory income tax rate $ 297 21.0 % $ (773) 21.0 % $ 1,254 21.0 % Tax on global activities including exports 342 24.2 155 (4.2) (47) (0.8) U.S. business credits(a) (246) (17.4) (189) 5.1 (169) (2.8) Debt tender and related valuation allowances 30 2.1 940 (25.5) — — Deductible stock and restructuring losses — — (583) 15.8 (203) (3.4) Sale of Biopharma business (13) (0.9) (5) 0.1 (1,447) (24.2) Goodwill impairments — — — — 184 3.1 All other – net(b)(c)(d) 66 4.7 169 (4.5) (59) (1.1) 179 12.7 487 (13.2) (1,741) (29.2) Actual income tax rate $ 476 33.7 % $ (286) 7.8 % $ (487) (8.2) % (a) U.S. general business credits, primarily the credit for energy produced from renewable sources and the credit for research performed in the U.S. (b) For the year ended December 31, 2022, included $134 million for separation income tax costs of which $66 million was due to the repatriation of previously reinvested earnings. (c) For the year ended December 31, 2020, included $(140) million for the resolution of the IRS audit of our consolidated U.S. income tax returns for 2014-2015. (d) Included for each period, the expense or benefit for U.S. state taxes reported above in the consolidated (benefit) provision for income taxes, net of 21.0% federal effect. UNRECOGNIZED TAX POSITIONS. Annually, we file over 2,600 income tax returns in over 270 global taxing jurisdictions. We are under examination or engaged in tax litigation in many of these jurisdictions. The IRS is currently auditing our consolidated U.S. income tax returns for 2016-2018. In December 2020, the IRS completed the audit of our consolidated U.S. income tax returns for 2014-2015. The Company recognized a continuing operations benefit of $140 million plus an additional net interest benefit of $96 million. In addition, the Company recorded a benefit in discontinued operations of $130 million of tax benefits and $25 million of net interest benefits. See Note 2 for further information. In September 2021, GE resolved its dispute with the United Kingdom tax authority, HM Revenue & Customs (HMRC) in connection with interest deductions claimed by GE Capital for the years 2004-2015. As previously disclosed, HMRC had proposed to disallow interest deductions with a potential impact of approximately $1,100 million, which included a possible assessment of tax and reduction of deferred tax assets, not including interest and penalties. As part of the settlement, GE and HMRC agreed that a portion of the interest deductions claimed were disallowed, with no fault or blame attributed to either party. The resolution concluded the dispute in its entirety without interest or penalties. The adjustments result in no current tax payment to HMRC, but a deferred tax charge of $112 million as part of discontinued operations as a result of a reduction of available tax attributes, which had previously been recorded as deferred tax assets. The balance of unrecognized tax benefits, the amount of related interest and penalties we have provided and what we believe to be the range of reasonably possible changes in the next 12 months (excluding the expected decrease to the GE balance of $552 million due to the spin-off of GE HealthCare) were: UNRECOGNIZED TAX BENEFITS December 31 2022 2021 2020 Unrecognized tax benefits $ 3,951 $ 4,224 $ 4,191 Portion that, if recognized, would reduce tax expense and effective tax rate(a) 3,072 3,351 2,986 Accrued interest on unrecognized tax benefits 614 597 628 Accrued penalties on unrecognized tax benefits 111 146 179 Reasonably possible reduction to the balance of unrecognized tax benefits in succeeding 12 months 0-650 0-250 0-350 Portion that, if recognized, would reduce tax expense and effective tax rate(a) 0-600 0-200 0-250 (a) Some portion of such reduction may be reported as discontinued operations. UNRECOGNIZED TAX BENEFITS RECONCILIATION 2022 2021 2020 Balance at January 1 $ 4,224 $ 4,191 $ 4,169 Additions for tax positions of the current year 62 396 836 Additions for tax positions of prior years 120 327 326 Reductions for tax positions of prior years (393) (585) (863) Settlements with tax authorities (8) (33) (127) Expiration of the statute of limitations (54) (71) (151) Balance at December 31 $ 3,951 $ 4,224 $ 4,191 We classify interest on tax deficiencies as interest expense; we classify income tax penalties as provision for income taxes. For the years ended December 31, 2022, 2021 and 2020, $36 million, $17 million and $(30) million of interest expense (income), respectively, and $(26) million, $(29) million and $(13) million of tax expense (income) related to penalties, respectively, were recognized in our Statement of Earnings (Loss). DEFERRED INCOME TAXES. As part of the Tax Cuts and Jobs Act of 2017 (U.S. tax reform), the U.S. has enacted a minimum tax on foreign earnings (global intangible low tax income). We have not made an accrual for the deferred tax aspects of this provision. We also have not provided deferred taxes on cumulative net earnings of non-U.S. affiliates and associated companies of approximately $14 billion that have been reinvested indefinitely. Given U.S. tax reform, substantially all of our prior unrepatriated net earnings were subject to U.S. tax and accordingly we expect to have the ability to repatriate available non-U.S. cash without additional federal tax cost, and any foreign withholding tax on a repatriation to the U.S. would potentially be partially offset by a U.S. foreign tax credit. Most of these earnings have been reinvested in active non-U.S. business operations and it is not practicable to determine the income tax liability that would be payable if such earnings were not reinvested indefinitely. We reassess reinvestment of earnings on an ongoing basis. In 2022, in connection with the execution of the Company’s plans to prepare for the spin-off of GE HealthCare, we incurred $66 million of tax due to repatriation of previously reinvested earnings. The total deferred tax asset as of December 31, 2022 includes $714 million related to the required capitalization of research costs for U.S. tax purposes effective January 1, 2022. The Company has pending accounting method changes which, if approved, are expected to offset the impact of this required capitalization. This deferred tax asset includes $279 million related to GE HealthCare, which became a deferred asset of the separate company upon spin-off in the first quarter of 2023. In the event capitalization of research costs is adjusted through retroactive legislation effective for 2022, GE will record a tax provision benefit related to GE HealthCare research costs as a result of the benefit in the consolidated GE 2022 tax return without payment under the Tax Matters Agreement. The following table presents our net deferred tax assets and net deferred tax liabilities attributable to different tax jurisdictions or different tax paying components. DEFERRED INCOME TAXES December 31 2022 2021 Total assets $ 12,325 $ 11,587 Total liabilities (620) (732) Net deferred income tax asset (liability) $ 11,705 $ 10,855 COMPONENTS OF THE NET DEFERRED INCOME TAX ASSET (LIABILITY) December 31 2022 2021 Deferred tax assets Accrued expenses and reserves $ 2,538 $ 2,635 Progress collections, contract assets and deferred items 2,520 2,093 Deferred expenses 1,925 1,597 Principal pension plans 1,806 2,375 Insurance company loss reserves 1,782 1,700 Non-U.S. loss carryforwards(a) 1,240 1,354 Other compensation and benefits 975 1,397 Investment securities 516 (1,278) Principal retiree benefit plans 692 896 Other(b) 703 1,329 Total deferred tax assets $ 14,697 $ 14,098 Deferred tax liabilities Investment in global operations $ (1,011) $ (1,775) Other (1,981) (1,468) Total deferred tax liabilities (2,992) (3,243) Net deferred income tax asset (liability) $ 11,705 $ 10,855 (a) Net of valuation allowances of $7,171 million and $7,081 million as of December 31, 2022 and 2021, respectively. Of the net deferred tax asset as of December 31, 2022 of $1,240 million, $8 million relates to net operating loss carryforwards that expire in various years ending from December 31, 2023 through December 31, 2025; $427 million relates to net operating losses that expire in various years ending from December 31, 2026 through December 31, 2042; and $805 million relates to net operating loss carryforwards that may be carried forward indefinitely. (b) Included valuation allowances related to assets other than non-U.S. loss carryforwards of $3,325 million and $1,653 million as of December 31, 2022 and 2021, respectively. These primarily relate to excess capital loss carryforwards.

SHAREHOLDERS' EQUITY

SHAREHOLDERS' EQUITY	12 Months Ended
	Dec. 31, 2022
Equity [Abstract]
SHAREHOLDERS' EQUITY	NOTE 16. SHAREHOLDERS’ EQUITY ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) 2022 2021 2020 Beginning balance $ (4,562) $ (4,386) $ (4,818) AOCI before reclasses – net of taxes of $127, $(91) and $(25) (1,355) (104) (255) Reclasses from AOCI – net of taxes of $—, $87 and $—(a) — (71) 691 AOCI (1,355) (174) 435 Less AOCI attributable to noncontrolling interests (2) 2 2 Currency translation adjustments AOCI $ (5,915) $ (4,562) $ (4,386) Beginning balance $ 3,646 $ (5,395) $ (7,024) AOCI before reclasses – net of taxes of $597, $1,643 and $(283) 2,117 6,225 (1,256) Reclasses from AOCI – net of taxes of $216, $793 and $805(a) 772 2,819 2,888 AOCI 2,889 9,044 1,632 Less AOCI attributable to noncontrolling interests 3 3 4 Benefit plans AOCI $ 6,531 $ 3,646 $ (5,395) Beginning balance $ 2,498 $ 32 $ 109 AOCI before reclasses – net of taxes of $(1,141), $615 and $21(b) (4,461) 2,422 (39) Reclasses from AOCI – net of taxes of $(20), $23 and $(25)(a) 36 44 (39) AOCI (4,425) 2,466 (78) Investment securities and cash flow hedges AOCI $ (1,927) $ 2,498 $ 32 AOCI at December 31 $ (1,311) $ 1,582 $ (9,749) Dividends declared per common share $ 0.32 $ 0.32 $ 0.32 (a) The total reclassification from AOCI included $836 million, including currency translation of $688 million, net of taxes, in 2020, related to the sale of our BioPharma business within our HealthCare segment. (b) Included adjustments of $2,674 million, $3,535 million and $(1,979) million for the years ended December 31, 2022, 2021 and 2020, respectively, related to insurance liabilities and annuity benefits in our run-off insurance operations to reflect the effects that would have been recognized had the related unrealized investment security gains been realized. See Note 12 for further information. Preferred stock. GE has 50 million authorized shares of preferred stock ($1.00 par value), of which 5,795,444 shares are outstanding as of December 31, 2022 and 5,939,875 shares are outstanding as of both December 31, 2021 and 2020. Preferred stock outstanding comprises $5,550 million of GE Series D preferred stock, in addition to $245 million of existing GE Series A, B and C preferred stock. The total carrying value of GE preferred stock at December 31, 2022 was $5,795 million. Dividends on GE preferred stock are payable semi-annually in June and December and accretion is recorded on a quarterly basis. Dividends on GE preferred stock totaled $289 million, including cash dividends of $284 million, $237 million, including cash dividends of $220 million, and $474 million, including cash dividends of $295 million, for the years ended December 31, 2022, 2021 and 2020, respectively. On January 21, 2021, the GE Series D preferred stock became callable and its dividends converted from 5% fixed rate to 3-month LIBOR plus 3.33%. As of the filing date of this Form 10-K for the year ended December 31, 2022, the GE Series D preferred stock has not been called. From time to time we repurchase outstanding shares of preferred stock, and we repurchased $144 million of GE Series D preferred stock in the year ended December 31, 2022. Common stock. GE's authorized common stock consists of 1,650 million shares having a par value of $0.01 each, with 1,462 million shares issued. Common stock shares outstanding were 1,089,107,878 and 1,099,027,213 at December 31, 2022 and 2021, respectively. We repurchased 13.6 million and 0.5 million shares, for a total of $1,000 million and $36 million for the years ended December 31, 2022 and 2021, respectively. Redeemable noncontrolling interests. Our redeemable noncontrolling interests, presented within All other liabilities in our Statement of Financial Position, include common shares issued by our affiliates that are redeemable at the option of the holder of those interests and amounted to $132 million and $148 million, primarily related to our HealthCare segment, as of December 31, 2022 and 2021, respectively.

SHARE-BASED COMPENSATION

SHARE-BASED COMPENSATION	12 Months Ended
	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
SHARE-BASED COMPENSATION	NOTE 17. SHARE-BASED COMPENSATION. We grant stock options, restricted stock units and performance share units to employees under the 2007 and 2022 Long-Term Incentive Plans. Grants made under all plans must be approved by the Management Development and Compensation Committee of GE’s Board of Directors, which is composed entirely of independent directors. We record compensation expense for awards expected to vest over the vesting period. We estimate forfeitures based on experience and adjust expense to reflect actual forfeitures. When options are exercised, restricted stock units vest, and performance share awards are earned, we issue shares from treasury stock. Stock options provide employees the opportunity to purchase GE shares in the future at the market price of our stock on the date the award is granted (the strike price). The options become exercisable over the vesting period, typically three years, and expire 10 years from the grant date if not exercised. Restricted stock units (RSU) provide an employee with the right to receive one share of GE stock when the restrictions lapse over the vesting period. Upon vesting, each RSU is converted into one share of GE common stock for each unit. Performance share units (PSU) and performance shares provide an employee with the right to receive shares of GE stock based upon achievement of certain performance or market metrics. Upon vesting, each PSU earned is converted into shares of GE common stock. We value stock options using a Black-Scholes option pricing model, RSUs using market price on grant date, and PSUs and performance shares using market price on grant date and a Monte Carlo simulation as needed based on performance metrics. WEIGHTED AVERAGE GRANT DATE FAIR VALUE 2022 2021 2020 Stock options $ 34.03 $ 40.64 $ 28.64 RSUs 87.68 104.98 63.28 PSUs/Performance shares 95.40 108.51 63.28 Key assumptions used in the Black-Scholes valuation for stock options include: risk free rates of 1.6%, 1.1%, and 1.0%, dividend yields of 0.4%, 0.3%, and 0.4%, expected volatility of 37%, 40%, and 36%, expected lives of 6.8 years, 6.2 years, and 6.1 years, and strike prices of $92.33, $105.12, and $84.48 for 2022, 2021, and 2020, respectively. STOCK-BASED COMPENSATION ACTIVITY Stock options RSUs Shares (in thousands) Weighted average exercise price Weighted average contractual term (in years) Intrinsic value (in millions) Shares (in thousands) Weighted average grant date fair value Weighted average contractual term (in years) Intrinsic value (in millions) Outstanding at January 1, 2022 38,414 $ 144.97 8,057 $ 77.90 Granted 435 92.33 4,110 87.68 Exercised (951) 64.45 (1,630) 89.08 Forfeited (266) 95.12 (850) 81.92 Expired (6,609) 165.67 N/A N/A Outstanding at December 31, 2022 31,023 $ 142.68 3.8 $ 88 9,687 $ 79.82 1.2 $ 812 Exercisable at December 31, 2022 28,723 $ 146.94 3.4 $ 83 N/A N/A N/A N/A Expected to vest 2,151 $ 90.14 7.7 $ 5 8,476 $ 80.03 1.2 $ 710 Total outstanding target PSUs and performance shares at December 31, 2022 were 3,667 thousand shares with a weighted average fair value of $78.31. The intrinsic value and weighted average contractual term of target PSUs and performance shares outstanding were $307 million and 1.7 years, respectively. 2022 2021 2020 Compensation expense (after-tax)(a)(b) $ 305 $ 361 $ 353 Cash received from stock options exercised 62 93 6 Intrinsic value of stock options exercised and RSU/PSUs vested 170 217 81 (a) Unrecognized compensation cost related to unvested equity awards as of December 31, 2022 was $420 million, which will be amortized over a weighted average period of 1.0 year. (b) Income tax benefit recognized in earnings was $17 million, $9 million and $10 million in 2022, 2021, and 2020, respectively.

EARNINGS PER SHARE INFORMATION

EARNINGS PER SHARE INFORMATION	12 Months Ended
	Dec. 31, 2022
Earnings Per Share [Abstract]
EARNINGS PER SHARE INFORMATION	NOTE 18. EARNINGS PER SHARE INFORMATION 2022 2021 2020 (Earnings for per-share calculation, shares in millions, per-share amounts in dollars) Diluted Basic Diluted Basic Diluted Basic Earnings (loss) from continuing operations $ 869 $ 869 $ (3,326) $ (3,326) $ 6,601 $ 6,601 Preferred stock dividends (289) (289) (237) (237) (474) (474) Accretion of redeemable noncontrolling interests, net of tax — — (9) (9) (151) (151) Accretion of preferred share repurchase 4 4 — — — — Earnings (loss) from continuing operations attributable to common shareholders 584 584 (3,571) (3,571) 5,975 5,975 Earnings (loss) from discontinued operations (644) (644) (3,195) (3,195) (909) (909) Net earnings (loss) attributable to GE common shareholders (60) (60) (6,766) (6,766) 5,066 5,066 Shares of GE common stock outstanding 1,096 1,096 1,098 1,098 1,094 1,094 Employee compensation-related shares (including stock options) 6 — — — 1 — Total average equivalent shares 1,101 1,096 1,098 1,098 1,095 1,094 Earnings (loss) from continuing operations $ 0.53 $ 0.53 $ (3.25) $ (3.25) $ 5.46 $ 5.46 Earnings (loss) from discontinued operations (0.58) (0.59) (2.91) (2.91) (0.83) (0.83) Net earnings (loss) per share (0.05) (0.06) (6.16) (6.16) 4.63 4.63 Potentially dilutive securities(a) 44 41 56 (a) Outstanding stock awards not included in the computation of diluted earnings (loss) per share because their effect was antidilutive.

OTHER INCOME (LOSS)

OTHER INCOME (LOSS)	12 Months Ended
	Dec. 31, 2022
Other Income and Expenses [Abstract]
OTHER INCOME (LOSS)	NOTE 19. OTHER INCOME (LOSS) 2022 2021 2020 Purchases and sales of business interests(a) $ 66 $ (40) $ 12,468 Licensing and royalty income 203 192 161 Equity method income 233 (96) 7 Investment in Baker Hughes realized and unrealized gain (loss) 912 938 (2,037) Investment in and note with AerCap unrealized gain (loss) (865) 711 — Other net interest and investment income (loss)(b) 456 621 590 Other items 226 497 207 Total other income (loss) $ 1,231 $ 2,823 $ 11,396 (a) Included a pre-tax loss of $170 million related to the sale of our boiler manufacturing business in China in our Power segment in 2021. Included a pre-tax gain of $12,362 million on the sale of our BioPharma business in 2020. See Note 2 for further information. (b) Included interest income associated with customer advances of $162 million, $167 million and $146 million in 2022, 2021 and 2020, respectively. See Note 8 for further information.

RESTRUCTURING CHARGES AND SEPAR

RESTRUCTURING CHARGES AND SEPARATION COSTS	12 Months Ended
	Dec. 31, 2022
Restructuring and Related Activities [Abstract]
RESTRUCTURING CHARGES AND SEPARATION COSTS	NOTE 20. RESTRUCTURING CHARGES AND SEPARATION COSTS RESTRUCTURING AND OTHER CHARGES. This table is inclusive of all restructuring charges in our segments and at Corporate, and the charges are shown below for the business where they originated. Separately, in our reported segment results, significant, higher-cost restructuring programs are excluded from measurement of segment operating performance for internal and external purposes; those excluded amounts are reported in Restructuring and other charges for Corporate. RESTRUCTURING AND OTHER CHARGES 2022 2021 2020 Workforce reductions $ 348 $ 695 $ 856 Plant closures & associated costs and other asset write-downs 615 145 332 Acquisition/disposition net charges and other 30 (21) 66 Total restructuring and other charges $ 993 $ 819 $ 1,254 Cost of equipment/services $ 250 $ 394 $ 570 Selling, general and administrative expenses 774 499 697 Other (income) loss (31) (75) (13) Total restructuring and other charges $ 993 $ 819 $ 1,254 Aerospace $ 20 $ 70 $ 397 Renewable Energy 177 204 213 Power 155 369 236 HealthCare 148 155 137 Corporate 494 20 270 Total restructuring and other charges $ 993 $ 819 $ 1,254 Restructuring and other charges cash expenditures $ 492 $ 781 $ 1,175 An analysis of changes in the liability for restructuring follows. 2022 2021 2020 Balance at January 1 $ 1,026 $ 1,337 $ 1,746 Additions 578 655 860 Payments (385) (670) (997) Remeasurement (4) (245) (212) Effect of foreign currency and other (31) (52) (60) Balance at December 31 (a) $ 1,183 $ 1,026 $ 1,337 (a) Includes actuarial determined post-employment severance benefits reserve of $475 million, $464 million and $722 million as of December 31, 2022, 2021 and 2020, respectively. For the year ended December 31, 2022, restructuring and other initiatives primarily included exit activities related to the restructuring program announced in the fourth quarter reflecting lower Corporate shared-service and footprint needs as GE HealthCare prepared to become independent. It also includes exit activities associated with the plan announced in October 2022 to undertake a restructuring program across our businesses planned to be part of GE Vernova, primarily reflecting the selectivity strategy to operate in fewer markets and to simplify and standardize product variants at Renewable Energy. We recorded total charges of $993 million, consisting of $416 million primarily in non-cash impairment, accelerated depreciation and other charges, not reflected in the table above, and $578 million primarily in employee workforce reduction and contract related charges, which are reflected in the table above. We incurred $492 million in cash outflows related to restructuring actions, primarily for employee severance payments. For the year ended December 31, 2021, restructuring and other initiatives primarily included exit activities at our Power business related to our new coal build wind-down actions, which included the exit of certain product lines, closing certain manufacturing and office facilities and other workforce reduction programs. We recorded total charges of $819 million, consisting of $164 million primarily in non-cash impairment, accelerated depreciation and other charges, not reflected in the table above, and $655 million primarily in employee workforce reduction charges, which are reflected in the table above. We incurred $781 million in cash outflows related to restructuring actions, primarily for employee severance payments. For the year ended December 31, 2020, restructuring and other initiatives primarily included actions related to the impacts of the COVID-19 pandemic on our Aerospace business and Corporate cost reduction programs, which included closing certain manufacturing and office facilities and other workforce reduction programs. We recorded total charges of $1,254 million, consisting of $394 million in non-cash asset impairments and other charges, not reflected in the table above, and $860 million primarily in workforce reduction charges, which are reflected in the table above. We incurred $1,175 million in cash outflows related to restructuring actions, primarily for employee severance payments. SEPARATION COSTS. In November 2021, the company announced its plan to form three industry-leading, global public companies focused on the growth sectors of aviation, healthcare, and energy. As a result of this plan, we expect to incur separation, transition, and operational costs, which will depend on specifics of the transactions.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	12 Months Ended
	Dec. 31, 2022
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	NOTE 21. FAIR VALUE MEASUREMENTS Our assets and liabilities measured at fair value on a recurring basis include debt securities mainly supporting obligations to annuitants and policyholders in our run-off insurance operations, our equity interests in AerCap and Baker Hughes, and derivatives. ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON A RECURRING BASIS Level 1 Level 2 Level 3(a) Netting Net balance(b) December 31 2022 2021 2022 2021 2022 2021 2022 2021 2022 2021 Investment securities $ 6,754 $ 11,434 $ 30,483 $ 35,849 $ 6,421 $ 7,222 $ — $ — $ 43,657 $ 54,506 Derivatives — — 1,340 1,357 1 17 (859) (691) 482 684 Total assets $ 6,754 $ 11,434 $ 31,823 $ 37,207 $ 6,421 $ 7,239 $ (859) $ (691) $ 44,139 $ 55,189 Derivatives $ — $ — $ 1,444 $ 891 $ 7 $ 1 $ (862) $ (681) $ 589 $ 212 Other(c) — — 627 863 — — — — 627 863 Total liabilities $ — $ — $ 2,071 $ 1,754 $ 7 $ 1 $ (862) $ (681) $ 1,216 $ 1,075 (a) Included $3,548 million of U.S. corporate debt securities, $1,386 million of Mortgage and asset-backed debt securities, and the $900 million AerCap note at December 31, 2022. Included $4,228 million of U.S. corporate debt securities, $1,427 million of Mortgage and asset-backed debt securities, and the $993 million AerCap note at December 31, 2021. (b) See Notes 3 and 22 for further information on the composition of our investment securities and derivative portfolios. (c) Primarily represents the liabilities associated with certain of our deferred incentive compensation plans. (d) The netting of derivative receivables and payables is permitted when a legally enforceable master netting agreement exists. Amounts include fair value adjustments related to our own and counterparty non-performance risk. LEVEL 3 INSTRUMENTS. The majority of our Level 3 balances comprised debt securities classified as available-for-sale with changes in fair value recorded in Other comprehensive income. Balance at Net realized/unrealized gains(losses)(a) Purchases(b) Sales & Settlements Transfers Transfers Balance at 2022 Investment securities $ 7,222 $ (1,002) $ 973 $ (628) $ 57 $ (201) $ 6,421 2021 Investment securities $ 5,866 $ (261) $ 2,589 $ (943) $ 6 $ (35) $ 7,222 (a) Primarily included net unrealized gains (losses) of $(994) million and $(288) million in Other comprehensive income for the years ended December 31, 2022 and 2021, respectively. (b) Included $508 million of U.S. corporate debt securities and $302 million of Mortgage and asset-backed debt securities for the year ended December 31, 2022. Included $1,084 million of Mortgage and asset-backed debt securities and $1,000 million AerCap senior note received as partial consideration on the completion of the GECAS transaction for the year ended December 31, 2021.

FINANCIAL INSTRUMENTS

FINANCIAL INSTRUMENTS	12 Months Ended
	Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
FINANCIAL INSTRUMENTS	NOTE 22. FINANCIAL INSTRUMENTS. The following table provides information about assets and liabilities not carried at fair value and excludes finance leases, equity securities without readily determinable fair value and non-financial assets and liabilities. Substantially all of these assets are considered to be Level 3 and the vast majority of our liabilities’ fair value are considered Level 2. December 31, 2022 December 31, 2021 Carrying Estimated Carrying Estimated Assets Loans and other receivables $ 2,695 $ 2,560 $ 2,706 $ 2,853 Liabilities Borrowings (Note 10) $ 32,350 $ 31,410 $ 35,186 $ 41,207 Investment contracts (Note 12) 1,771 1,822 1,909 2,282 Assets and liabilities that are reflected in the accompanying financial statements at fair value are not included in the above disclosures; such items include cash and equivalents, investment securities and derivative financial instruments. DERIVATIVES AND HEDGING. Our policy requires that derivatives are used solely for managing risks and not for speculative purposes. We use derivatives to manage currency risks related to foreign exchange, and interest rate and currency risk between financial assets and liabilities, and certain equity investments and commodity prices. We use cash flow hedges primarily to reduce or eliminate the effects of foreign exchange rate changes, net investment hedges to hedge investments in foreign operations as well as fair value hedges to hedge the effects of interest rate and currency changes on debt it has issued. We also use derivatives not designated as hedges from an accounting standpoint (and therefore we do not apply hedge accounting to the relationship) but otherwise serve the same economic purpose as other hedging arrangements. We use economic hedges when we have exposures to currency exchange risk for which we are unable to meet the requirements for hedge accounting or when changes in the carrying amount of the hedged item are already recorded in earnings in the same period as the derivative making hedge accounting unnecessary. Even though the derivative is an effective economic hedge, there may be a net effect on earnings in each period due to differences in the timing of earnings recognition between the derivative and the hedged item. FAIR VALUE OF DERIVATIVES December 31, 2022 December 31, 2021 Gross Notional All other assets All other liabilities Gross Notional All other assets All other liabilities Currency exchange contracts $ 8,484 $ 164 $ 312 $ 7,214 $ 114 $ 122 Interest rate contracts 2,071 75 4 Derivatives accounted for as hedges $ 8,484 $ 164 $ 312 $ 9,285 $ 188 $ 126 Currency exchange contracts $ 56,950 $ 977 $ 1,118 $ 64,097 $ 794 $ 756 Interest rate contracts 43 — 1 1,369 5 1 Other contracts 914 200 20 1,674 387 10 Derivatives not accounted for as hedges $ 57,907 $ 1,178 $ 1,139 $ 67,140 $ 1,186 $ 767 Gross derivatives $ 66,392 $ 1,341 $ 1,451 $ 76,425 $ 1,374 $ 893 Netting and credit adjustments $ (859) $ (862) $ (637) $ (639) Cash collateral adjustments — — (54) (42) Net derivatives recognized in statement of financial position $ 482 $ 589 $ 684 $ 212 Net accrued interest $ — $ (4) $ 10 $ 5 Securities held as collateral — — (2) — Net amount $ 482 $ 585 $ 691 $ 217 FAIR VALUE HEDGES. As of December 31, 2022, all fair value hedges were terminated due to exposure management actions, including debt maturities. Gains (losses) associated with the terminated hedging relationships will continue to amortize into interest expense until the bonds mature. The cumulative amount of hedging adjustments of $1,240 million (all on discontinued hedging relationships) was included in the carrying amount of the previously hedged liability of $9,933 million. At December 31, 2021, the cumulative amount of hedging adjustments of $2,072 million (including $2,073 million on discontinued hedging relationships) was included in the carrying amount of the previously hedged liability of $16,819 million. The cumulative amount of hedging adjustments was primarily recorded in long-term borrowings. CASH FLOW HEDGES AND NET INVESTMENT HEDGES Gain (loss) recognized in AOCI for the year ended December 31 2022 2021 2020 Cash flow hedges(a) $ (206) $ (86) $ (61) Net investment hedges(b) 230 487 (675) (a) Primarily related to currency exchange contracts. (b) The carrying value of foreign currency debt designated as net investment hedges was $3,329 million and $4,061 million at December 31, 2022 and 2021, respectively. The total reclassified from AOCI into earnings was zero, $(87) million and zero for the years ended December 31, 2022, 2021 and 2020, respectively. Changes in the fair value of cash flow hedges are recorded in AOCI and recorded in earnings in the period in which the hedged transaction occurs. The total amount in AOCI related to cash flow hedges of forecasted transactions was a $111 million loss at December 31, 2022. We expect to reclassify $106 million of loss to earnings in the next 12 months contemporaneously with the earnings effects of the related forecasted transactions. At December 31, 2022, the maximum term of derivative instruments that hedge forecasted transactions was approximately 12 years. The table below presents the gains (losses) of our derivative financial instruments in the Statement of Earnings (Loss): 2022 2021 Revenues Debt Extinguishment Costs Interest Expense SG&A Other(a) Revenues Debt Extinguishment Costs Interest Expense SG&A Other(a) $ 76,555 $ 465 $ 1,607 $ 12,781 $ 56,766 $ 74,196 $ 6,524 $ 1,876 $ 11,716 $ 56,719 Effect of cash flow hedges $ (23) $ — $ (20) $ (2) $ (34) $ 27 $ — $ (40) $ 1 $ (67) Hedged items 127 70 1,413 Derivatives designated as hedging instruments (143) (66) (1,549) Effect of fair value hedges $ (16) $ 3 $ (135) Currency exchange contracts $ 5 $ — $ — $ (133) $ (737) $ (6) $ (16) $ (18) $ (127) $ 44 Interest rate, commodity 1 159 (4) (135) 161 1 52 (3) 183 191 Effect of derivatives not designated as hedges $ 7 $ 159 $ (4) $ (269) $ (575) $ (5) $ 35 $ (22) $ 56 $ 235 (a) Amounts are inclusive of cost of sales and other income (loss). (b) SG&A was primarily driven by hedges of deferred incentive compensation, Other Income (loss) by hedges of Baker Hughes equity sale, and Debt Extinguishment Costs by hedges of debt tenders. These hedging programs were to offset the earnings impact of the underlying. COUNTERPARTY CREDIT RISK. Our exposures to counterparties (including accrued interest), net of collateral we held, was $308 million and $564 million at December 31, 2022 and December 31, 2021, respectively. Counterparties' exposures to our derivative liability (including accrued interest), net of collateral posted by us, was $505 million and $159 million at December 31, 2022 and December 31, 2021, respectively.

VARIABLE INTEREST ENTITIES

VARIABLE INTEREST ENTITIES	12 Months Ended
	Dec. 31, 2022
Variable Interest Entities [Abstract]
VARIABLE INTEREST ENTITIES	NOTE 23. VARIABLE INTEREST ENTITIES. In our Statement of Financial Position, we have assets of $401 million and $491 million and liabilities of $206 million and $206 million at December 31, 2022 and December 31, 2021, respectively, in consolidated Variable Interest Entities (VIEs). These entities were created to help our customers facilitate or finance the purchase of GE equipment and services and have no features that could expose us to losses that would significantly exceed the difference between the consolidated assets and liabilities.

COMMITMENTS, GUARANTEES, PRODUC

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES	12 Months Ended
	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES	NOTE 24. COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES COMMITMENTS. We had total investment commitments of $3,877 million at December 31, 2022. The commitments primarily comprise investments by our run-off insurance operations in investment securities and other assets of $3,778 million and included within these commitments are obligations to make investments in unconsolidated VIEs of $3,773 million. See Note 23 for further information. As of December 31, 2022, in our Aerospace segment, we have committed to provide financing assistance of $2,390 million of future customer acquisitions of aircraft equipped with our engines. GUARANTEES. At December 31, 2022, we were committed under the following guarantee arrangements: Credit support. We have provided $1,143 million of credit support on behalf of certain customers or associated companies, predominantly joint ventures and partnerships, using arrangements such as standby letters of credit and performance guarantees. The liability for such credit support was $32 million. Indemnification agreements - Continuing Operations. We have $534 million of indemnification commitments, including representations and warranties in sales of business assets, for which we recorded a liability of $80 million. Indemnification agreements - Discontinued Operations . We have provided specific indemnities to buyers of assets of our business that, in the aggregate, represent a maximum potential claim of $717 million with related reserves of $77 million. PRODUCT WARRANTIES. We provide for estimated product warranty expenses when we sell the related products. Because warranty estimates are forecasts that are based on the best available information, mostly historical claims experience, claims costs may differ from amounts provided. An analysis of changes in the liability for product warranties follows. 2022 2021 2020 Balance at January 1 $ 1,891 $ 2,054 $ 2,165 Current-year provisions(a) 1,319 862 788 Expenditures (967) (945) (913) Other changes (90) (81) 14 Balance at December 31 $ 2,153 $ 1,891 $ 2,054 (a) The increase in current-year provisions is primarily related to Renewable Energy, which was substantially all due to changes in estimates on pre-existing warranties and related to the deployment of repairs and other corrective measures. LEGAL MATTERS. In the normal course of our business, we are involved from time to time in various arbitrations, class actions, commercial litigation, investigations and other legal, regulatory or governmental actions, including the significant matters described below that could have a material impact on our results of operations. In many proceedings, including the specific matters described below, it is inherently difficult to determine whether any loss is probable or even reasonably possible or to estimate the size or range of the possible loss, and accruals for legal matters are not recorded until a loss for a particular matter is considered probable and reasonably estimable. Given the nature of legal matters and the complexities involved, it is often difficult to predict and determine a meaningful estimate of loss or range of loss until we know, among other factors, the particular claims involved, the likelihood of success of our defenses to those claims, the damages or other relief sought, how discovery or other procedural considerations will affect the outcome, the settlement posture of other parties and other factors that may have a material effect on the outcome. For these matters, unless otherwise specified, we do not believe it is possible to provide a meaningful estimate of loss at this time. Moreover, it is not uncommon for legal matters to be resolved over many years, during which time relevant developments and new information must be continuously evaluated. Alstom legacy legal matters. In 2015, we acquired the Steam Power, Renewables and Grid businesses from Alstom, which prior to our acquisition were the subject of significant cases involving anti-competitive activities and improper payments. We had reserves of $455 million and $567 million at December 31, 2022 and 2021, respectively, for legal and compliance matters related to the legacy business practices that were the subject of cases in various jurisdictions. Allegations in these cases relate to claimed anti-competitive conduct or improper payments in the pre-acquisition period as the source of legal violations or damages. Given the significant litigation and compliance activity related to these matters and our ongoing efforts to resolve them, it is difficult to assess whether the disbursements will ultimately be consistent with the reserve established. The estimation of this reserve may not reflect the full range of uncertainties and unpredictable outcomes inherent in litigation and investigations of this nature, and at this time we are unable to develop a meaningful estimate of the range of reasonably possible additional losses beyond the amount of this reserve. Factors that can affect the ultimate amount of losses associated with these and related matters include the way cooperation is assessed and valued, prosecutorial discretion in the determination of damages, formulas for determining disgorgement, fines or penalties, the duration and amount of legal and investigative resources applied, political and social influences within each jurisdiction, and tax consequences of any settlements or previous deductions, among other considerations. Actual losses arising from claims in these and related matters could exceed the amount provided. Shareholder and related lawsuits. Since November 2017, several putative shareholder class actions under the federal securities laws have been filed against GE and certain affiliated individuals and consolidated into a single action currently pending in the U.S. District Court for the Southern District of New York (the Hachem case). In October 2019, the lead plaintiff filed a fifth amended consolidated class action complaint naming as defendants GE and current and former GE executive officers. It alleges violations of Sections 10(b) and 20(a) and Rule 10b-5 of the Securities Exchange Act of 1934 related to insurance reserves and accounting for long-term service agreements and seeks damages on behalf of shareholders who acquired GE stock between February 27, 2013 and January 23, 2018. GE filed a motion to dismiss in December 2019. In January 2021, the court granted defendants’ motion to dismiss as to the majority of the claims. Specifically, the court dismissed all claims related to insurance reserves, as well as all claims related to accounting for long-term service agreements, with the exception of certain claims about historic disclosures related to factoring in the Power business that survive as to GE and its former CFO Jeffrey S. Bornstein. All other individual defendants have been dismissed from the case. In April 2022, the court granted the plaintiffs' motion for class certification for shareholders who acquired stock between February 26, 2016 and January 23, 2018, and granted the plaintiffs’ request to amend their complaint. In September 2022, GE filed a motion for summary judgment on the plaintiffs' remaining claims. Since February 2018, multiple shareholder derivative lawsuits have been filed against current and former GE executive officers and members of GE’s Board of Directors and GE (as nominal defendant). These lawsuits have alleged violations of securities laws, breaches of fiduciary duties, unjust enrichment, waste of corporate assets, abuse of control and gross mismanagement, although the specific matters underlying the allegations in the lawsuits have varied. Two shareholder derivative lawsuits are currently pending: the Lindsey and Priest/Tola cases, which were filed in New York state court. The allegations in these two cases relate to substantially the same facts as those underlying the Hachem case. The plaintiffs seek unspecified damages and improvements in GE’s corporate governance and internal procedures. The Lindsey case has been stayed by agreement of the parties, and GE filed a motion to dismiss the Priest/Tola complaint in March 2021. In July 2018, a putative class action (the Mahar case) was filed in New York state court naming as defendants GE, former GE executive officers, a former member of GE’s Board of Directors and KPMG. It alleged violations of Sections 11, 12 and 15 of the Securities Act of 1933 based on alleged misstatements related to insurance reserves and performance of GE’s business segments in GE Stock Direct Plan registration statements and documents incorporated therein by reference and seeks damages on behalf of shareholders who acquired GE stock between July 20, 2015 and July 19, 2018 through the GE Stock Direct Plan. In February 2019, this case was dismissed. In March 2019, plaintiffs filed an amended derivative complaint naming the same defendants. In April 2019, GE filed a motion to dismiss the amended complaint. In October 2019, the court denied GE's motion to dismiss and stayed the case pending the outcome of the Hachem case. In November 2019, the plaintiffs moved to re-argue to challenge the stay, and GE cross-moved to re-argue the denial of the motion to dismiss and filed a notice of appeal. The court denied both motions for re-argument, and in November 2020, the Appellate Division First Department affirmed the court's denial of GE's motion to dismiss. In January 2021, GE filed a motion for leave to appeal to the New York Court of Appeals, and that motion was denied in March 2021. In February 2019, a securities action (the Touchstone case) was filed in the U.S. District Court for the Southern District of New York naming as defendants GE and current and former GE executive officers. It alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Section 1707.43 of the Ohio Securities Act and common law fraud based on alleged misstatements regarding insurance reserves, GE Power’s revenue recognition practices related to long term service agreements, GE’s acquisition of Alstom, and the goodwill recognized in connection with that transaction. The lawsuit seeks damages on behalf of six institutional investors who purchased GE common stock between August 1, 2014 and October 30, 2018 and rescission of those purchases. In May 2021, the plaintiffs filed an amended complaint, and GE in June 2021 filed a motion to dismiss that complaint. In September 2022, the court granted GE’s motion to the dismiss the plaintiffs’ case with no opportunity to replead their case. In January 2023, the plaintiffs filed an appeal of the court’s dismissal of their case with the U.S. Court of Appeals for the Second Circuit. As previously reported by Baker Hughes, in March 2019, two derivative lawsuits were filed in the Delaware Court of Chancery naming as defendants GE, directors of Baker Hughes (including former members of GE’s Board of Directors and current and former GE executive officers) and Baker Hughes (as nominal defendant), and the court issued an order consolidating these two actions (the Schippnick case). The complaint as amended in May 2019 alleges, among other things, that GE and the Baker Hughes directors breached their fiduciary duties, and that GE was unjustly enriched by entering into transactions and agreements related to GE's sales of approximately 12% of its ownership interest in Baker Hughes in November 2018. The complaint seeks declaratory relief, disgorgement of profits, an award of damages, pre- and post-judgment interest and attorneys’ fees and costs. In May 2019, the plaintiffs voluntarily dismissed their claims against the directors who were members of the Baker Hughes Conflicts Committee and a former Baker Hughes director. In October 2019, the Court denied the remaining defendants’ motions to dismiss, except with respect to the unjust enrichment claim against GE, which has been dismissed. In November 2019, the defendants filed their answer to the complaint, and a special litigation committee of the Baker Hughes Board of Directors moved for an order staying all proceedings in this action pending completion of the committee's investigation of the allegations and claims asserted in the complaint. In October 2020, the special litigation committee filed a report with the Court recommending that the derivative action be terminated. In January 2021, the special committee filed a motion to terminate the action. GE Retirement Savings Plan class actions . Four putative class action lawsuits have been filed regarding the oversight of the GE RSP, and those class actions have been consolidated into a single action in the U.S. District Court for the District of Massachusetts. The consolidated complaint names as defendants GE, GE Asset Management, current and former GE and GE Asset Management executive officers and employees who served on fiduciary bodies responsible for aspects of the GE RSP during the class period. Like similar lawsuits that have been brought against other companies in recent years, this action alleges that the defendants breached their fiduciary duties under the Employee Retirement Income Security Act (ERISA) in their oversight of the GE RSP, principally by retaining five proprietary funds that plaintiffs allege were underperforming as investment options for plan participants and by charging higher management fees than some alternative funds. The plaintiffs seek unspecified damages on behalf of a class of GE RSP participants and beneficiaries from September 26, 2011 through the date of any judgment. In August and December 2018, the court issued orders dismissing one count of the complaint and denying GE's motion to dismiss the remaining counts. In September 2022, both GE and the plaintiffs filed motions for summary judgment on the remaining claims. Bank BPH . As previously reported, Bank BPH, along with other Polish banks, has been subject to ongoing litigation in Poland related to its portfolio of floating rate residential mortgage loans, with cases brought by individual borrowers seeking relief related to their foreign currency indexed or denominated mortgage loans in various courts throughout Poland. At December 31, 2022, approximately 85% of the Bank BPH portfolio is indexed to or denominated in foreign currencies (primarily Swiss francs), and the total portfolio had a carrying value, net of reserves, of $1,199 million. We continue to observe an increase in the number of lawsuits being brought against Bank BPH and other banks in Poland, and we expect this to continue in future reporting periods. We estimate potential losses for Bank BPH in connection with borrower litigation cases that are pending by recording legal reserves, as well as in connection with potential future cases or other adverse developments as part of our ongoing valuation of the Bank BPH portfolio, which we record at the lower of cost or fair value, less cost to sell. The total amount of estimated losses was $1,359 million and $755 million at December 31, 2022 and 2021, respectively. We update our assumptions underlying the amount of estimated losses based primarily on the number of lawsuits filed and estimated to be filed in the future, whether liability will be established in lawsuits and the nature of the remedy ordered by courts if liability is established. The increase in the amount of estimated losses during 2022 was driven primarily by increases in the number of lawsuits filed and estimated to be filed in the future and increased findings of liability. We expect the trends we have previously reported of an increasing number of lawsuits being filed, more findings of liability and more severe remedies being ordered against Polish banks (including Bank BPH) to continue in future reporting periods, although Bank BPH is unable at this time to develop a meaningful estimate of reasonably possible losses associated with active and inactive Bank BPH mortgage loans beyond the amounts currently recorded. Additional factors may also affect our estimated losses over time, including: potentially significant judicial decisions or binding resolutions by the European Court of Justice (ECJ) or the Polish Supreme Court; the impact of any of these or other future or recent decisions or resolutions (including an expected ECJ ruling that could adversely impact the remedy cost to Polish banks upon a finding of liability, and the Polish Supreme Court binding resolution delivered verbally in May 2021 with written reasoning issued in July 2021) on how Polish courts will interpret and apply the law in particular cases and how borrower behavior may change in response, neither of which are known immediately upon the issuance of a decision or resolution; financial, economic and other conditions in Poland that may adversely affect borrowers; uncertainty related to a proposal by the Chairman of the Polish Financial Supervisory Authority in December 2020 that banks voluntarily offer borrowers an opportunity to convert their foreign currency indexed or denominated mortgage loans to Polish zlotys using an exchange rate applicable at the date of loan origination, and about the various settlement strategies or other approaches that Polish banks have increasingly adopted or will adopt, or that Bank BPH may adopt in the future, in response to this proposal or other factors, the approaches that regulators and other government authorities will adopt in response, the receptivity of borrowers to settlement offers; and the financial and capital impact on banks that adopt settlement programs; and any potential legislation that may be passed in Poland relating to foreign exchange indexed or denominated mortgage loans. In addition, there is continued uncertainty arising from investigations of the Polish Office of Competition and Consumer Protection (UOKiK), including existing or anticipated UOKiK and court decisions resulting from those investigations, particularly UOKiK's investigation into the adequacy of disclosure of foreign exchange risk by banks (including BPH) and the legality under Polish law of unlimited foreign exchange risk on customers. Future adverse developments related to any of the foregoing, or other adverse developments such as actions by regulators, legislators or other governmental authorities (including UOKiK), likely would have a material adverse effect on Bank BPH and the carrying value of its mortgage loan portfolio as well as result in additional required capital contributions to Bank BPH or significant losses beyond the amounts that we currently estimate. ENVIRONMENTAL, HEALTH AND SAFETY MATTERS . Our operations, like operations of other companies engaged in similar businesses, involve the use, disposal and cleanup of substances regulated under environmental protection laws and nuclear decommissioning regulations. We have obligations for ongoing and future environmental remediation activities, such as the Housatonic River cleanup described below, and may incur additional liabilities in connection with previously remediated sites, such as natural resource damages for the Hudson River where GE completed dredging in 2019. Additionally, like many other industrial companies, we and our subsidiaries are defendants in various lawsuits related to alleged worker exposure to asbestos or other hazardous materials. Liabilities for environmental remediation, nuclear decommissioning and worker exposure claims exclude possible insurance recoveries. It is reasonably possible that our exposure will exceed amounts accrued. However, due to uncertainties about the status of laws, regulations, technology and information related to individual sites and lawsuits, such amounts are not reasonably estimable. Total reserves related to environmental remediation, nuclear decommissioning and worker exposure claims were $2,686 million and $2,660 million at December 31, 2022 and 2021, respectively. As previously reported, in 2000, GE and the Environmental Protection Agency (EPA) entered into a consent decree relating to PCB cleanup of the Housatonic River in Massachusetts. In October 2016, EPA issued its final decision pursuant to the consent decree. In January 2018, the EPA’s Environmental Appeals Board (EAB) remanded the decision back to the EPA with instruction to reissue a revised final remedy. After successful mediation with key stakeholders (including EPA, GE, certain towns, and environmental groups), public comment and further review by the EAB, the final revised permit (issued in January 2021) became effective in March 2022. In May 2022, two environmental advocacy groups petitioned the U.S. Court of Appeals for the First Circuit to review the EPA’s final permit. As of December 31, 2022 and based on its assessment of current facts and circumstances and its defenses, GE believes that it has recorded adequate reserves to cover future obligations associated with the proposed final remedy. Expenditures for site remediation, nuclear decommissioning and worker exposure claims amounted to approximately $231 million, $193 million and $180 million for the years ended December 31, 2022, 2021 and 2020, respectively. We presently expect that such expenditures will be approximately $250 million and $300 million in 2023 and 2024, respectively.

OPERATING SEGMENTS

OPERATING SEGMENTS	12 Months Ended
	Dec. 31, 2022
Segment Reporting [Abstract]
OPERATING SEGMENTS	NOTE 25. OPERATING SEGMENTS BASIS FOR PRESENTATION. Our operating businesses are organized based on the nature of markets and customers. Segment accounting policies are the same as described and referenced in Note 1. A description of our operating segments as of December 31, 2022 can be found in the Segment Operations section within MD&A. REVENUES Total revenues Intersegment revenues External revenues Years ended December 31 2022 2021 2020 2022 2021 2020 2022 2021 2020 Aerospace $ 26,050 $ 21,310 $ 22,042 $ 660 $ 1,036 $ 1,445 $ 25,390 $ 20,274 $ 20,597 Renewable Energy 12,977 15,697 15,666 80 138 142 12,896 15,559 15,523 Power 16,262 16,903 17,589 267 345 352 15,995 16,558 17,237 HealthCare 18,461 17,725 18,009 — 1 1 18,461 17,724 18,008 Corporate 2,806 2,561 2,528 (1,008) (1,520) (1,941) 3,814 4,081 4,468 Total $ 76,555 $ 74,196 $ 75,833 $ — $ — $ — $ 76,555 $ 74,196 $ 75,833 Years ended December 31 2022 2021 2020 Equipment Services Total Equipment Services Total Equipment Services Total Aerospace $ 7,842 $ 18,207 $ 26,050 $ 7,531 $ 13,780 $ 21,310 $ 8,582 $ 13,460 $ 22,042 Renewable Energy 10,191 2,785 12,977 13,224 2,473 15,697 12,859 2,807 15,666 Power 4,737 11,526 16,262 5,035 11,868 16,903 6,707 10,883 17,589 HealthCare 9,643 8,818 18,461 9,104 8,620 17,725 9,992 8,017 18,009 Total segment revenues $ 32,413 $ 41,336 $ 73,749 $ 34,894 $ 36,741 $ 71,635 $ 38,140 $ 35,166 $ 73,306 SEGMENT REVENUES Years ended December 31 2022 2021 2020 Commercial Engines & Services $ 18,665 $ 14,360 $ 14,479 Military 4,410 4,136 4,572 Systems & Other 2,975 2,814 2,991 Aerospace $ 26,050 $ 21,310 $ 22,042 Onshore Wind $ 8,373 $ 11,026 $ 10,881 Grid Solutions equipment and services 3,086 3,207 3,585 Hydro, Offshore Wind and Hybrid Solutions 1,518 1,464 1,200 Renewable Energy $ 12,977 $ 15,697 $ 15,666 Gas Power $ 12,072 $ 12,080 $ 12,655 Steam Power 2,643 3,241 3,557 Power Conversion, Nuclear and other 1,547 1,582 1,378 Power $ 16,262 $ 16,903 $ 17,589 Healthcare Systems $ 16,489 $ 15,694 $ 15,387 Pharmaceutical Diagnostics 1,972 2,031 1,792 BioPharma — — 830 HealthCare $ 18,461 $ 17,725 $ 18,009 Total segment revenues $ 73,749 $ 71,635 $ 73,306 Corporate $ 2,806 $ 2,561 $ 2,528 Total revenues $ 76,555 $ 74,196 $ 75,833 Revenues are classified according to the region to which equipment and services are sold. For purposes of this analysis, the U.S. is presented separately from the remainder of the Americas. Year ended December 31, 2022 Aerospace Renewable Energy Power HealthCare Corporate Total U.S. $ 10,722 $ 6,265 $ 5,121 $ 8,078 $ 2,850 $ 33,036 Non-U.S. Europe 6,013 3,023 3,484 3,697 68 16,284 China region 2,154 216 1,173 2,525 (5) 6,062 Asia (excluding China region) 2,731 1,396 2,101 2,225 (129) 8,324 Americas 1,713 1,120 1,931 1,038 (14) 5,788 Middle East and Africa 2,719 956 2,453 897 36 7,060 Total Non-U.S. $ 15,328 $ 6,711 $ 11,142 $ 10,383 $ (44) $ 43,519 Total geographic revenues $ 26,050 $ 12,977 $ 16,262 $ 18,461 $ 2,806 $ 76,555 Non-U.S. revenues as a % of total revenues 59 % 52 % 69 % 56 % 57 % Year ended December 31, 2021 Aerospace Renewable Energy Power HealthCare Corporate Total U.S. $ 9,675 $ 7,275 $ 6,186 $ 7,229 $ 2,473 $ 32,838 Non-U.S. Europe 3,920 3,651 3,621 3,702 52 14,946 China region 2,419 464 1,145 2,700 16 6,744 Asia (excluding China region) 1,758 1,959 2,090 2,345 (45) 8,107 Americas 1,310 1,009 1,239 923 (4) 4,476 Middle East and Africa 2,228 1,340 2,622 826 69 7,085 Total Non-U.S. $ 11,635 $ 8,422 $ 10,717 $ 10,496 $ 88 $ 41,358 Total geographic revenues $ 21,310 $ 15,697 $ 16,903 $ 17,725 $ 2,561 $ 74,196 Non-U.S. revenues as a % of total revenues 55 % 54 % 63 % 59 % 56 % Year ended December 31, 2020 U.S. $ 11,239 $ 7,846 $ 6,186 $ 7,611 $ 2,336 $ 35,217 Non-U.S. Europe 4,288 3,047 2,895 3,952 159 14,342 China region 2,078 1,156 1,253 2,455 35 6,978 Asia (excluding China region) 1,842 1,484 2,707 2,264 (55) 8,241 Americas 882 819 1,483 879 1 4,064 Middle East and Africa 1,713 1,314 3,064 848 52 6,991 Total Non-U.S. $ 10,803 $ 7,820 $ 11,403 $ 10,398 $ 192 $ 40,616 Total geographic revenues $ 22,042 $ 15,666 $ 17,589 $ 18,009 $ 2,528 $ 75,833 Non-U.S. revenues as a % of total revenues 49 % 50 % 65 % 58 % 54 % REMAINING PERFORMANCE OBLIGATION. As of December 31, 2022, the aggregate amount of the contracted revenues allocated to our unsatisfied (or partially unsatisfied) performance obligations was $250,997 million. We expect to recognize revenue as we satisfy our remaining performance obligations as follows: 1) equipment-related remaining performance obligation of $48,936 million of which 59%, 81% and 98% is expected to be recognized within 1, 2 and 5 years, respectively, and the remaining thereafter; and 2) services-related remaining performance obligations of $202,061 million of which 13%, 46%, 70% and 84% is expected to be recognized within 1, 5, 10 and 15 years, respectively, and the remaining thereafter. Contract modifications could affect both the timing to complete as well as the amount to be received as we fulfill the related remaining performance obligations. Total sales of equipment and services to agencies of the U.S. Government were 6%, 6% and 7% of total revenues for the years ended December 31, 2022, 2021 and 2020, respectively. Within our Aerospace segment, defense-related sales were 5%, 5% and 6% of total revenues for the years ended December 31, 2022, 2021 and 2020, respectively. PROFIT AND EARNINGS For the years ended December 31 2022 2021 2020 Aerospace $ 4,775 $ 2,882 $ 1,229 Renewable Energy (2,240) (795) (715) Power 1,217 726 274 HealthCare 2,705 2,966 3,060 Total segment profit (loss) 6,456 5,778 3,848 Corporate(a) (3,413) 892 8,061 Interest and other financial charges (1,552) (1,813) (2,018) Debt extinguishment costs (465) (6,524) (301) Non-operating benefit income (cost) 532 (1,782) (2,430) Goodwill impairments — — (877) Benefit (provision) for income taxes (689) 124 333 Preferred stock dividends (289) (237) (474) Earnings (loss) from continuing operations attributable to GE common shareholders 581 (3,562) 6,141 Earnings (loss) from discontinued operations attributable to GE common shareholders (644) (3,195) (911) Net earnings (loss) attributable to GE common shareholders $ (64) $ (6,757) $ 5,230 (a) Includes interest and other financial charges of $54 million, $63 million and $50 million and benefit for income taxes of $213 million, $162 million and $154 million related to EFS within Corporate for the years ended December 31, 2022, 2021, and 2020, respectively. Assets Property, plant and Depreciation and amortization At December 31 For the years ended December 31 For the years ended December 31 2022 2021 2020 2022 2021 2020 2022 2021 2020 Aerospace $ 39,243 $ 38,298 $ 38,634 $ 543 $ 445 $ 737 $ 1,037 $ 1,074 $ 1,142 Renewable Energy 15,719 14,804 15,927 275 349 302 412 432 413 Power 22,173 23,569 24,453 210 189 245 506 692 749 HealthCare 26,070 24,770 22,229 310 278 256 640 641 628 Corporate(b)(c) 81,692 94,256 114,220 34 25 40 948 168 531 Total continuing $ 184,896 $ 195,697 $ 215,463 $ 1,371 $ 1,286 $ 1,579 $ 3,543 $ 3,009 $ 3,464 (a) Additions to property, plant and equipment include amounts relating to principal businesses purchased. (b) Depreciation and amortization included the Steam asset sale impairment in the first quarter of 2022. (c) Included deferred income taxes that are presented as assets for purposes of our Statement of Financial Position presentation. We classify certain assets that cannot meaningfully be associated with specific geographic areas as “Other Global” for this purpose. December 31 2022 2021 U.S. $ 126,005 $ 130,956 Non-U.S. Europe 36,603 42,213 Asia 11,317 11,534 Americas 6,405 6,406 Other Global 4,566 4,588 Total Non-U.S. $ 58,892 $ 64,741 Total assets (Continuing operations) $ 184,896 $ 195,697 The decrease in continuing assets in 2022 was primarily driven by decreases in estimated fair value of our debt securities, depreciation and amortization on property, plant and equipment and intangible assets, including the Steam asset sale impairment, and the effects of a stronger U.S. dollar. Property, plant and equipment – net associated with operations based in the United States were $7,508 million and $8,411 million at December 31, 2022 and 2021, respectively. Property, plant and equipment – net associated with operations based outside the United States were $6,970 million and $7,198 million at December 31, 2022 and 2021, respectively.

SUMMARIZED FINANCIAL INFORMATIO

SUMMARIZED FINANCIAL INFORMATION	12 Months Ended
	Dec. 31, 2022
Equity Method Investments and Joint Ventures [Abstract]
SUMMARIZED FINANCIAL INFORMATION	NOTE 26. SUMMARIZED FINANCIAL INFORMATION . We account for our remaining interest in Baker Hughes (comprising 7 million shares with approximately 1% ownership interest as of December 31, 2022) at fair value. As of November 3, 2021, our investment in BKR ownership reduced below 20%, and as a result, we no longer have significant influence in BKR. The fair value of our interest in Baker Hughes at December 31, 2022 and 2021 was $207 million and $4,010 million, respectively. We recognized a realized and unrealized pre-tax gain of $912 million ($702 million after-tax) based on a share price of $29.53, a realized and unrealized pre-tax gain of $938 million ($696 million after-tax) based on a share price of $24.06, and a realized and unrealized pre-tax loss of $2,037 million ($1,562 million after-tax) based on a share price of $20.85 for the years ended December 31, 2022, 2021 and 2020, respectively. The 2022 gain, 2021 gain and 2020 loss included a $109 million pre-tax derivative gain, a $129 million pre-tax derivative gain and a $54 million pre-tax derivative loss, respectively, associated with the forward sale of Baker Hughes shares pursuant to our previously announced program to monetize our Baker Hughes position. During the years ended December 31, 2022, 2021 and 2020, we completed forward sales of 160 million, 183 million and 28 million shares and received proceeds of $4,717 million, $4,145 million and $417 million, respectively. In January 2023, we sold our remaining 7 million shares and received net proceeds of $216 million. See Notes 2, 3 and 19 for further information. Summarized financial information of Baker Hughes is as follows. For the years ended December 31 2022(a) 2021(b) 2020 Revenues $ — $ 16,997 $ 20,705 Gross Profit — 3,276 3,199 Net income (loss) — (546) (15,761) Net income (loss) attributable to the entity — (407) (9,940) (a) As of November 3, 2021, our investment in BKR reduced below 20%, and as a result, we no longer have significant influence. (b) Financial information is from January 1, 2021 to November 3, 2021 (date investment in BKR reduced below 20%). On November 1, 2021, we received 111.5 million ordinary shares of AerCap (approximately 46% ownership interest) and an AerCap senior note as partial consideration in conjunction with the GECAS transaction, for which we have adopted the fair value option. The fair value of our interest in AerCap, including the note, at December 31, 2022 and 2021 was $7,403 million and $8,287 million, respectively. We recognized an unrealized pre-tax loss of $865 million ($1,052 million after-tax) based on a share price of $58.32 and an unrealized pre-tax and after-tax gain of $711 million based on a share price of $65.42 related to our interest in AerCap for the years ended December 31, 2022 and 2021, respectively. See Notes 2, 3 and 19 for further information. Given AerCap summarized financial information is not available as of the date of this filing, this information is reported on a one quarter lag. Summarized financial information of AerCap is as follows. For the year ended December 31 2022(a) Revenues $ 6,627 Net income (loss) (1,128) Net income (loss) attributable to the entity (1,132) (a) As we are unable to obtain monthly financial data for AerCap to match the exact period of ownership, we reported summarized financial information for AerCap starting October 1, 2021 instead of November 1, 2021. As of December 31 2022(a) Flight equipment held for operating leases, net $ 54,611 Other 15,200 Total assets $ 69,811 Debt $ 47,350 Other 6,817 Total liabilities $ 54,167 Noncontrolling interests $ 77 (a) Financial information is from September 30, 2022. Baker Hughes and AerCap are SEC registrants with separate filing requirements, and their respective financial information can be obtained from www.sec.gov. GE, within its Aerospace segment, has interests in certain joint ventures formed to manufacture and service commercial jet engines and engine parts, collectively referred to herein as the Commercial Aerospace Joint Ventures. These interests include: CFM International Inc., CFM International SA and CFM Materials, LP, joint operations of the CFM56 and LEAP engine programs with Safran Aircraft Engines, a subsidiary of Safran Group of France; Engine Alliance, LLC, a joint operation of the GP7200 engine program with Raytheon Technologies Corporation via their Pratt & Whitney segment; GE Honda Aero Engines, LLC, a joint operation of the HF120 engine program with Honda Aero, Inc; and Advanced Atomization Technologies, LLC, a joint operation for engine fuel nozzles with Parker-Hannifin Corporation. GE recognizes revenue on sales to these Commercial Aerospace Joint Ventures upon the transfer of its products and services, of which the timing and the amount of revenue recognized could be different than that of the joint ventures. Summarized financial information of these Commercial Aerospace Joint Ventures is as follows. For the years ended December 31 2022 2021 2020 Revenues $ 23,317 $ 17,118 $ 15,931 Gross Profit 312 284 359 Net income (loss) 249 (123) 327 Net income (loss) attributable to the entity 237 (140) 312 As of December 31 2022 2021 Current assets $ 13,328 $ 8,845 Total assets $ 14,327 $ 9,941 Current liabilities $ 12,828 $ 8,435 Total liabilities $ 12,887 $ 8,470 Noncontrolling interests $ 153 $ 147

QUARTERLY INFORMATION (UNAUDITE

QUARTERLY INFORMATION (UNAUDITED)	12 Months Ended
	Dec. 31, 2022
Quarterly Financial Information Disclosure [Abstract]
QUARTERLY INFORMATION (UNAUDITED)	NOTE 27. QUARTERLY INFORMATION (UNAUDITED) First quarter Second quarter Third quarter Fourth quarter (Per-share amounts in dollars) 2022 2021 2022 2021 2022 2021 2022 2021 Total revenues $ 17,040 $ 17,071 $ 18,646 $ 18,253 $ 19,084 $ 18,569 $ 21,786 $ 20,303 Sales of equipment and services 16,272 16,316 17,880 17,470 18,438 17,813 21,011 19,492 Cost of equipment and services sold 12,453 12,538 13,244 13,618 14,371 13,401 15,467 14,338 Earnings (loss) from continuing operations (729) 97 (561) (571) (76) 582 2,302 (3,504) Earnings (loss) from discontinued operations (286) (2,894) (210) (564) (85) 602 (64) (339) Net earnings (loss) (1,014) (2,798) (771) (1,135) (160) 1,184 2,238 (3,843) Less net earnings (loss) attributable to noncontrolling interests 28 5 19 (3) 4 (73) 16 1 Net earnings (loss) attributable to the Company $ (1,042) $ (2,802) $ (790) $ (1,131) $ (165) $ 1,257 $ 2,222 $ (3,843) Per-share amounts – earnings (loss) from continuing operations Diluted earnings (loss) per share $ (0.74) $ 0.02 $ (0.59) $ (0.57) $ (0.14) $ 0.54 $ 1.99 $ (3.24) Basic earnings (loss) per share (0.74) 0.02 (0.59) (0.57) (0.14) 0.54 2.01 (3.24) Per-share amounts – earnings (loss) from discontinued operations Diluted earnings (loss) per share (0.26) (2.63) (0.19) (0.51) (0.08) 0.54 (0.06) (0.31) Basic earnings (loss) per share (0.26) (2.64) (0.19) (0.51) (0.08) 0.55 (0.06) (0.31) Per-share amounts – net earnings (loss) Diluted earnings (loss) per share (0.99) (2.61) (0.78) (1.08) (0.21) 1.08 1.93 (3.55) Basic earnings (loss) per share (0.99) (2.62) (0.78) (1.08) (0.21) 1.09 1.95 (3.55) Dividends declared 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 Earnings-per-share amounts are computed independently each quarter for earnings (loss) from continuing operations, earnings (loss) from discontinued operations and net earnings (loss). As a result, the sum of each quarter’s per-share amount may not equal the total per-share amount for the respective year; and the sum of per-share amounts from continuing operations and discontinued operations may not equal the total per-share amounts for net earnings (loss) for the respective quarters.

SUBSEQUENT EVENT

SUBSEQUENT EVENT	12 Months Ended
	Dec. 31, 2022
Subsequent Events [Abstract]
SUBSEQUENT EVENT	NOTE 28. SUBSEQUENT EVENT. On January 3, 2023 (the Distribution Date), GE completed the previously announced separation of its HealthCare business, into a separate, independent publicly traded company, GE HealthCare Technologies, Inc. (GE HealthCare). The Separation was structured as a tax-free spin-off, and was achieved through GE's pro-rata distribution of approximately 80.1% of the outstanding shares of GE HealthCare to holders of GE common stock. On the Distribution Date, each holder of record of GE common stock received one share of GE HealthCare common stock for every three shares of GE common stock held. As a result of the Separation, GE HealthCare became an independent public company that trades under the symbol “GEHC” on The Nasdaq Stock Market LLC and we will no longer consolidate GE HealthCare into our financial results. In connection with the Separation, the historical results of GE HealthCare and certain assets and liabilities included in the Separation will be reported in GE's consolidated financial statements as discontinued operations beginning in the first quarter of 2023. GE will prospectively measure its retained ownership interest of approximately 19.9% in GE HealthCare common stock at fair value. This equity ownership interest and the related earnings impact from subsequent changes in its fair value will be recognized in continuing operations. In addition, we expect to fully monetize our stake in GE HealthCare over time. Also in connection with the Separation, the Company entered into various agreements to effect the Separation and provide a framework for the relationship between GE and GE HealthCare, including a Separation and Distribution Agreement (SDA), a Tax Matters Agreement and a Transition Services Agreement (TSA). In connection with the Separation and as a result of the legal split of certain plans as set forth in Note 13, net liabilities of approximately $4.0 billion associated with GE's postretirement benefit plans, including a portion of the principal pension plans, the principal retiree benefit plans and other pension plans were transferred to GE HealthCare. Deferred compensation arrangements and other compensation and benefits obligations of approximately $0.7 billion were also transferred to GE HealthCare. The legal split and transfer of the plans and the related liabilities and obligations to GE HealthCare will impact our assumptions and projections used to determine the funding and costs of GE’s remaining plans. In connection with the Separation, GE received $1.5 billion of cash funded by GE HealthCare's additional $2.0 billion of indebtedness incurred on January 3, 2023.

BASIS OF PRESENTATION AND SUM_2

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
FINANCIAL STATEMENT PRESENTATION	FINANCIAL STATEMENT PRESENTATION. Our financial statements are prepared in conformity with U.S. generally accepted accounting principles (GAAP), which requires us to make estimates based on assumptions about current, and for some estimates, future, economic and market conditions which affect reported amounts and related disclosures in our financial statements. Although our current estimates contemplate current and expected future conditions, as applicable, it is reasonably possible that actual conditions could differ from our expectations, which could materially affect our results of operations, financial position and cash flows. Such changes could result in future impairments of goodwill, intangibles, long-lived assets and investment securities, revisions to estimated profitability on long-term product service agreements, incremental credit losses on receivables and debt securities, a change in the carrying amount of our tax assets and liabilities, or a change in our insurance liabilities and pension obligations as of the time of a relevant measurement event. In preparing our Statement of Cash Flows, we make certain adjustments to reflect cash flows that cannot otherwise be calculated by changes in our Statement of Financial Position. These adjustments may include, but are not limited to, the effects of currency exchange, acquisitions and dispositions of businesses, businesses classified as held for sale, the timing of settlements to suppliers for property, plant and equipment, non-cash gains/losses and other balance sheet reclassifications.
RECLASSIFICATIONS	We have reclassified certain prior-year amounts to conform to the current-year’s presentation, including retrospective adjustments made in 2021 to present: the remainder of our former Capital segment within Corporate, sales of spare parts within Sales of services and the related costs as Costs of services sold, and earnings per share to reflect the reverse stock split. Unless otherwise noted, tables are presented in U.S. dollars in millions. Certain columns and rows may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying numbers in millions. Earnings per share amounts are computed independently for earnings from continuing operations, earnings from discontinued operations and net earnings. As a result, the sum of per-share amounts may not equal the total. Unless otherwise indicated, information in these notes to consolidated financial statements relates to continuing operations. Certain of our operations have been presented as discontinued. We present businesses whose disposal represents a strategic shift that has, or will have, a major effect on our operations and financial results as discontinued operations when the components meet the criteria for held for sale, are sold, or spun-off.
CONSOLIDATION	CONSOLIDATION. Our financial statements consolidate all of our affiliates, entities where we have a controlling financial interest, most often because we hold a majority voting interest, or where we are required to apply the variable interest entity (VIE) model because we have the power to direct the most economically significant activities of entities. We reevaluate whether we have a controlling financial interest in all entities when our rights and interests change.
REVENUES FROM THE SALE OF EQUIPMENT AND SALE OF SERVICES	REVENUES FROM THE SALE OF EQUIPMENT. Performance Obligations Satisfied Over Time. We recognize revenue on agreements for the sale of customized goods including power generation equipment, long-term construction projects and military development contracts on an over-time basis as we customize the customer's equipment during the manufacturing or integration process and obtain right to payment for work performed. We recognize revenue as we perform under the arrangements using the percentage of completion method, which is based on our costs incurred to date relative to our estimate of total expected costs. Our estimate of costs to be incurred to fulfill our promise to a customer is based on our history of manufacturing or constructing similar assets for customers and is updated routinely to reflect changes in quantity or pricing of the inputs. We provide for potential losses on these agreements when it is probable that we will incur the loss. Our billing terms for these over-time contracts are generally based on achieving specified milestones. The differences between the timing of our revenue recognized (based on costs incurred) and customer billings (based on contractual terms) results in changes to our contract asset or contract liability positions. See Note 8 for further information. Performance Obligations Satisfied at a Point in Time. We recognize revenue on agreements for non-customized equipment including commercial aircraft engines, healthcare equipment and other goods we manufacture on a standardized basis for sale to the market at the point in time that the customer obtains control of the product, which is generally no earlier than when the customer has physical possession. We use proof of delivery for certain large equipment with more complex logistics, whereas the delivery of other equipment is estimated based on historical averages of in-transit periods (i.e., time between shipment and delivery). Where arrangements include customer acceptance provisions based on seller or customer-specified objective criteria, we recognize revenue when we have concluded that the customer has control of the equipment and that acceptance is likely to occur. We do not provide for anticipated losses on point-in-time transactions prior to transferring control of the equipment to the customer. Our billing terms for these point-in-time equipment contracts generally coincide with delivery to the customer; however, within certain businesses, we receive progress collections from customers for large equipment purchases, to generally reserve production slots. REVENUES FROM THE SALE OF SERVICES. Consistent with our Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) discussion and the way we manage our businesses, we refer to sales under service agreements, which includes both goods (such as spare parts and equipment upgrades) and related services (such as monitoring, maintenance and repairs) as sales of “services,” which is an important part of our operations. We sometimes offer our customers financing discounts for the purchase of certain equipment when sold in contemplation of long-term service agreements. These sales are accounted for as financing arrangements when payments for the equipment are collected through higher usage-based fees from servicing the equipment. See Note 8 for further information. Performance Obligations Satisfied Over Time. We enter into long-term service agreements with our customers primarily within our Aerospace and Power segments. These agreements require us to provide preventative maintenance, overhauls, and standby "warranty-type" services that include certain levels of assurance regarding asset performance and uptime throughout the contract periods, which generally range from 5 to 25 years. We account for items that are integral to the maintenance of the equipment as part of our performance obligation, unless the customer has a substantive right to make a separate purchasing decision (e.g., equipment upgrade). We recognize revenue as we perform under the arrangements using the percentage of completion method which is based on our costs incurred to date relative to our estimate of total expected costs. Throughout the life of a contract, this measure of progress captures the nature, timing and extent of our underlying performance activities as our stand-ready services often fluctuate between routine inspections and maintenance, unscheduled service events and major overhauls at predetermined usage intervals. We provide for potential losses on these agreements when it is probable that we will incur the loss. Our billing terms for these arrangements are generally based on the utilization of the asset (e.g., per hour of usage) or upon the occurrence of a major maintenance event within the contract, such as an overhaul. The differences between the timing of our revenue recognized (based on costs incurred) and customer billings (based on contractual terms) results in changes to our contract asset or contract liability positions. See Note 8 for further information. We also enter into long-term services agreements in our HealthCare and Renewable Energy segments. Revenues are recognized for these arrangements on a straight-line basis consistent with the nature, timing and extent of our services, which primarily relate to routine maintenance and as needed equipment repairs. We generally invoice periodically as services are provided. Performance Obligations Satisfied at a Point in Time. We sell certain tangible products, largely spare parts, through our services businesses. We recognize revenues and bill our customers at the point in time that the customer obtains control of the good, which is at the point in time we deliver the spare part to the customer.
COLLABORATIVE ARRANGEMENTS	COLLABORATIVE ARRANGEMENTS. Our Aerospace business enters into collaborative arrangements and joint ventures with manufacturers and suppliers of components used to build and maintain certain engines. Under these arrangements, GE and its collaborative partners share in the risks and rewards of these programs through various revenue, cost and profit sharing payment structures. GE recognizes revenue and costs for these arrangements based on the scope of work GE is responsible for transferring to its customers.
INSURANCE REVENUES	INSURANCE REVENUES. Insurance revenues are comprised primarily of premiums and investment income related to our run-off Insurance business. For traditional long-duration insurance contracts, we report premiums as revenue when due. Premiums received on non-traditional long-duration insurance contracts and investment contracts, including annuities without significant mortality risk, are not reported as revenues but rather as deposit liabilities. We recognize revenues for charges and assessments on these contracts, mostly for mortality, contract initiation, administration and surrender. Amounts credited to policyholder accounts are charged to expense.
CASH, CASH EQUIVALENTS AND RESTRICTED CASH	CASH, CASH EQUIVALENTS AND RESTRICTED CASH. Debt securities and money market instruments with original maturities of three months or less are included in cash, cash equivalents and restricted cash unless classified as available-for-sale investment securities.
INVESTMENT SECURITIES	INVESTMENT SECURITIES. We report investments in available-for-sale debt securities and certain equity securities at fair value. Unrealized gains and losses on available-for-sale debt securities are recorded to other comprehensive income, net of applicable taxes and adjustments related to our insurance liabilities. Unrealized gains and losses on equity securities with readily determinable fair values are recorded to earnings. Although we generally do not have the intent to sell any specific debt securities in the ordinary course of managing our portfolio, we may sell debt securities prior to their maturities for a variety of reasons, including diversification, credit quality, yield and liquidity requirements and the funding of claims and obligations to policyholders.
CURRENT RECEIVABLES	CURRENT RECEIVABLES. Amounts due from customers arising from the sales of equipment and services are recorded at the outstanding amount, less allowance for losses. We regularly monitor the recoverability of our receivables.
ALLOWANCE FOR CREDIT LOSSES	ALLOWANCE FOR CREDIT LOSSES. When we record customer receivables, contract assets and financing receivables arising from revenue transactions, as well as commercial mortgage loans and reinsurance recoverables in our run-off insurance operations, financial guarantees and certain commitments, we record an allowance for credit losses for the current expected credit losses (CECL) inherent in the asset over its expected life. The allowance for credit losses is a valuation account deducted from the amortized cost basis of the assets to present their net carrying value at the amount expected to be collected. Each period , the allowance for credit losses is adjusted through earnings to reflect expected credit losses over the remaining lives of the assets. We evaluate debt securities with unrealized losses to determine whether any of the losses arise from concerns about the issuer’s credit or the underlying collateral and record an allowance for credit losses, if required. We estimate expected credit losses based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. When measuring expected credit losses, we pool assets with similar country risk and credit risk characteristics. Changes in the relevant information may significantly affect the estimates of expected credit losses.
INVENTORIES	INVENTORIES. All inventories are stated at lower of cost or realizable values. Cost of inventories is primarily determined on a first-in, first-out (FIFO) basis.
PROPERTY, PLANT AND EQUIPMENT	PROPERTY, PLANT AND EQUIPMENT. The cost of property, plant and equipment is generally depreciated on a straight-line basis over its estimated economic life.
LEASE ACCOUNTING FOR LESSEE ARRANGEMENTS	LEASE ACCOUNTING FOR LESSEE ARRANGEMENTS. At lease commencement, we record a lease liability and corresponding right-of-use (ROU) asset. Options to extend the lease are included as part of the ROU lease asset and liability when it is reasonably certain the Company will exercise the option. We have elected to include lease and non-lease components in determining our lease liability for all leased assets except our vehicle leases. Non-lease components are generally services that the lessor performs for the Company associated with the leased asset. The present value of our lease liability is determined using our incremental collateralized borrowing rate at lease inception. For leases with an initial term of 12 months or less, an ROU asset and lease liability is not recognized and lease expense is recognized on a straight-line basis over the lease term. We test ROU assets whenever events or changes in circumstance indicate that the asset may be impaired.
GOODWILL AND OTHER INTANGIBLE ASSETS	GOODWILL AND OTHER INTANGIBLE ASSETS. We test goodwill at least annually for impairment at the reporting unit level. We recognize an impairment charge if the carrying amount of a reporting unit exceeds its fair value. When a portion of a reporting unit is disposed, goodwill is allocated to the gain or loss on disposition based on the relative fair values of the business or businesses disposed and the portion of the reporting unit that will be retained.
DERIVATIVES AND HEDGING	DERIVATIVES AND HEDGING. We use derivatives to manage a variety of risks, including risks related to interest rates, foreign exchange, certain equity investments and commodity prices. Accounting for derivatives as hedges requires that, at inception and over the term of the arrangement, the hedged item and related derivative meet the requirements for hedge accounting. In evaluating whether a particular relationship qualifies for hedge accounting, we test effectiveness at inception and each reporting period thereafter by determining whether changes in the fair value of the derivative offset, within a specified range, changes in the fair value of the hedged item. If fair value changes fail this test, we discontinue applying hedge accounting to that relationship prospectively. Fair values of both the derivative instrument and the hedged item are calculated using internal valuation models incorporating market-based assumptions, subject to third-party confirmation, as applicable.
DEFERRED INCOME TAXES	DEFERRED INCOME TAXES. Deferred income tax balances reflect the effects of temporary differences between the carrying amounts of assets and liabilities and their tax bases, as well as from net operating loss and tax credit carryforwards, and are stated at enacted tax rates expected to be in effect when those taxes are paid or recovered. Deferred income tax assets represent amounts available to reduce income taxes payable on taxable income in future years. We evaluate the recoverability of these future tax deductions and credits by assessing the adequacy of future expected taxable income from all sources, including reversal of taxable temporary differences, forecasted operating earnings and available tax planning strategies. To the extent we consider it more likely than not that a deferred tax asset will not be recovered, a valuation allowance is established. Deferred taxes, as needed, are provided for our investment in affiliates and associated companies when we plan to remit those earnings.
INSURANCE LIABILITIES AND ANNUITY BENEFITS	INSURANCE LIABILITIES AND ANNUITY BENEFITS. Our run-off insurance operations include providing insurance and reinsurance for life and health risks and providing certain annuity products. Primary product types include long-term care, structured settlement annuities, life and disability insurance contracts and investment contracts. Insurance contracts are contracts with significant mortality and/or morbidity risks, while investment contracts are contracts without such risks. Liabilities for traditional long-duration insurance contracts include both future policy benefit reserves and claims reserves. Future policy benefit reserves represent the present value of future policy benefits less the present value of future gross premiums based on actuarial assumptions. Liabilities for investment contracts equal the account value, that is, the amount that accrues to the benefit of the contract or policyholder including credited interest and assessments through the financial statement date. Claim reserves are established when a claim is incurred or is estimated to have been incurred and represent our best estimate of the present value of the ultimate obligations for future claim payments and claim adjustments expenses. To the extent that unrealized gains on specific investment securities supporting our insurance contracts would result in a premium deficiency, should those gains be realized, an increase in future policy benefit reserves is recorded, with an offsetting after-tax reduction to net unrealized gains recorded in other comprehensive income.
POSTRETIREMENT BENEFIT PLANS	POSTRETIREMENT BENEFIT PLANS. We sponsor a number of pension and retiree health and life insurance benefit plans that we present in three categories, principal pension plans, other pension plans and principal retiree benefit plans. We use a December 31 measurement date for these plans. On our Statement of Financial Position, we measure our plan assets at fair value and the obligations at the present value of the estimated payments to plan participants. Participants earn benefits based on their service and pay. Those estimated future payment amounts are determined based on assumptions. Differences between our actual results and what we assumed are recorded in a separate component of equity each period. These differences are amortized into earnings over the remaining average future service of active employees or the expected life of inactive participants, as applicable, who participate in the plan.
LOSS CONTINGENCIES	LOSS CONTINGENCIES. Loss contingencies are existing conditions, situations or circumstances involving uncertainty as to possible loss that will ultimately be resolved when future events occur or fail to occur. Such contingencies include, but are not limited to environmental obligations, litigation, regulatory investigations and proceedings, product quality and losses resulting from other events and developments. When a loss is considered probable and reasonably estimable, we record a liability in the amount of our best estimate for the ultimate loss. When there appears to be a range of possible costs with equal likelihood, liabilities are based on the low-end of such range. Disclosure is provided for material loss contingencies when a loss is probable but a reasonable estimate cannot be made, and when it is reasonably possible that a loss will be incurred or the amount of a loss will exceed the recorded provision. We regularly review contingencies to determine whether the likelihood of loss has changed and to assess whether a reasonable estimate of the loss or range of loss can be made.
SUPPLY CHAIN FINANCE PROGRAMS	SUPPLY CHAIN FINANCE PROGRAMS. We evaluate supply chain finance programs to ensure where we use a third-party intermediary to settle our trade payables, their involvement does not change the nature, existence, amount, or timing of our trade payables and does not provide the Company with any direct economic benefit. If any characteristics of the trade payables change or we receive a direct economic benefit, we reclassify the trade payables as borrowings.
FAIR VALUE MEASUREMENTS	FAIR VALUE MEASUREMENTS. The following sections describe the valuation methodologies we use to measure financial and non-financial instruments accounted for at fair value including certain assets within our pension plans and retiree benefit plans. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. These inputs establish a fair value hierarchy: Level 1 – Quoted prices for identical instruments in active markets; Level 2 – Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable; and Level 3 – Significant inputs to the valuation model are unobservable. RECURRING FAIR VALUE MEASUREMENTS. For financial assets and liabilities measured at fair value on a recurring basis, primarily investment securities and derivatives, fair value is the price we would receive to sell an asset or pay to transfer a liability in an orderly transaction with a market participant at the measurement date. In the absence of active markets for the identical assets or liabilities, such measurements involve developing assumptions based on market observable data and, in the absence of such data, internal information that is consistent with what market participants would use in a hypothetical transaction that occurs at the measurement date. See Note 21 for further information. Debt Securities. When available, we use quoted market prices to determine the fair value of debt securities which are included in Level 1. For our remaining debt securities, we obtain pricing information from an independent pricing vendor. The inputs and assumptions to the pricing vendor’s models are derived from market observable sources including benchmark yields, reported trades, broker/dealer quotes, issuer spreads, benchmark securities, bids, offers and other market-related data. These investments are included in Level 2. Our pricing vendors may also provide us with valuations that are based on significant unobservable inputs, and in those circumstances, we classify the investment securities in Level 3. Annually, we conduct reviews of our primary pricing vendor to validate that the inputs used in that vendor’s pricing process are deemed to be market observable as defined in the standard. We believe that the prices received from our pricing vendor are representative of prices that would be received to sell the assets at the measurement date (exit prices) and are classified appropriately in the hierarchy. We use non-binding broker quotes and other third-party pricing services as our primary basis for valuation when there is limited, or no, relevant market activity for a specific instrument or for other instruments that share similar characteristics. Debt securities priced in this manner are included in Level 3. Equity securities with readily determinable fair values . These publicly traded equity securities are valued using quoted prices and are included in Level 1. Derivatives. The majority of our derivatives are valued using internal models. The models maximize the use of market observable inputs including interest rate curves and both forward and spot prices for currencies and commodities. Derivative assets and liabilities included in Level 2 primarily represent interest rate swaps, cross-currency swaps and foreign currency and commodity forward and option contracts. Investments in private equity, real estate and collective funds held within our pension plans . Most investments are generally valued using the net asset value (NAV) per share as a practical expedient for fair value provided certain criteria are met. The NAVs are determined based on the fair values of the underlying investments in the funds. Investments that are measured at fair value using the NAV practical expedient are not required to be classified in the fair value hierarchy. Investments classified within Level 3 primarily relate to real estate and private equities which are valued using unobservable inputs, primarily by discounting expected future cash flows, using comparative market multiples, third-party pricing sources, or a combination of these approaches as appropriate. See Note 13 for further information. NONRECURRING FAIR VALUE MEASUREMENTS. Certain assets are measured at fair value on a nonrecurring basis. These assets may include loans and long-lived assets reduced to fair value upon classification as held for sale, impaired loans based on the fair value of the underlying collateral, impaired equity securities without readily determinable fair value, equity method investments and long-lived assets, and remeasured retained investments in formerly consolidated subsidiaries upon a change in control that results in the deconsolidation of that subsidiary and retention of a noncontrolling stake in the entity. Assets written down to fair value when impaired and retained investments are not subsequently adjusted to fair value unless further impairment occurs. Equity investments without readily determinable fair value and Associated companies. Equity investments without readily determinable fair value and associated companies are valued using market observable data such as transaction prices when available. When market observable data is unavailable, investments are valued using either a discounted cash flow model, comparative market multiples, third-party pricing sources or a combination of these approaches as appropriate. These investments are generally included in Level 3. Long-lived Assets . Fair values of long-lived assets are primarily derived internally and are based on observed sales transactions for similar assets. In other instances for which we do not have comparable observed sales transaction data, collateral values are developed internally and corroborated by external appraisal information. Adjustments to third-party valuations may be performed in circumstances where market comparables are not specific to the attributes of the specific collateral or appraisal information may not be reflective of current market conditions due to the passage of time and the occurrence of market events since receipt of the information.
ACCOUNTING CHANGES	ACCOUNTING CHANGES. The adoption of the new guidance on accounting for long duration insurance contracts on January 1, 2023 will significantly change the accounting for measurements of our long-duration insurance liabilities and reinsurance recoverables and materially affect our consolidated financial statements.

BUSINESSES HELD FOR SALE AND _2

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS (Tables)	12 Months Ended
	Dec. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]
Financial Information for Assets and Liabilities of Businesses Held for Sale	ASSETS AND LIABILITIES OF BUSINESSES HELD FOR SALE December 31, 2022 December 31, 2021 Current receivables, inventories and contract assets $ 495 $ — Non-current captive insurance investment securities 554 — Property, plant and equipment and intangible assets - net 232 — All other assets 94 — Assets of businesses held for sale $ 1,374 $ — Progress collections and deferred income $ 1,127 $ — Insurance liabilities and annuity benefits 358 — Accounts payable, equipment project payables and all other liabilities 458 — Liabilities of businesses held for sale $ 1,944 $ —
Financial Information for Discontinued Operations	RESULTS OF DISCONTINUED OPERATIONS For the year ended December 31, 2022 GECAS Bank BPH & Other Total Total revenues $ — $ — $ — Cost of equipment and services sold — — — Other income, costs and expenses — (808) (808) Earnings (loss) of discontinued operations before income taxes — (808) (808) Benefit (provision) for income taxes — (32) (32) Earnings (loss) of discontinued operations, net of taxes(a) — (841) (841) Gain (loss) on disposal before income taxes (18) 75 58 Benefit (provision) for income taxes 139 — 139 Gain (loss) on disposal, net of taxes 121 75 196 Earnings (loss) from discontinued operations, net of taxes $ 121 $ (765) $ (644) For the year ended December 31, 2021 GECAS Bank BPH & Other Total Total revenues $ — $ — $ — Cost of equipment and services sold (398) — (398) Other income, costs and expenses 1,992 (599) 1,393 Earnings (loss) of discontinued operations before income taxes 1,594 (599) 995 Benefit (provision) for income taxes (258) (77) (335) Earnings (loss) of discontinued operations, net of taxes(a) 1,336 (676) 660 Gain (loss) on disposal before income taxes (3,312) 65 (3,246) Benefit (provision) for income taxes (570) (38) (608) Gain (loss) on disposal, net of taxes (3,882) 27 (3,855) Earnings (loss) from discontinued operations, net of taxes $ (2,546) $ (648) $ (3,195) For the year ended December 31, 2020 Total revenues $ — $ — $ — Cost of equipment and services sold (2,555) — (2,555) Other income, costs and expenses 1,781 (195) 1,586 Earnings (loss) of discontinued operations before income taxes (773) (195) (968) Benefit (provision) for income taxes (13) 101 89 Earnings (loss) of discontinued operations, net of taxes(a) (786) (93) (879) Gain (loss) on disposal before income taxes — (31) (31) Benefit (provision) for income taxes — (1) (1) Gain (loss) on disposal, net of taxes — (32) (32) Earnings (loss) from discontinued operations, net of taxes $ (786) $ (125) $ (911) (a) Earnings (loss) of discontinued operations from GECAS operations included zero, $359 million and $2,545 million of depreciation and amortization for the years ended December 31, 2022, 2021 and 2020, respectively. GECAS depreciation and amortization ceased on March 10, 2021. ASSETS AND LIABILITIES OF DISCONTINUED OPERATIONS December 31, 2022 December 31, 2021 Cash, cash equivalents and restricted cash $ 1,176 $ 736 Financing receivables held for sale (Polish mortgage portfolio) 1,199 1,799 Property, plant, and equipment - net 73 88 All other assets 444 554 Assets of discontinued operations $ 2,892 $ 3,177 Accounts payable and all other liabilities $ 1,137 $ 887 Liabilities of discontinued operations $ 1,137 $ 887

INVESTMENT SECURITIES (Tables)

INVESTMENT SECURITIES (Tables)	12 Months Ended
	Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Schedule of Investment Securities	December 31, 2022 December 31, 2021 Amortized Gross Gross Estimated Amortized Gross Gross Estimated Equity and note (AerCap) $ — $ — $ — $ 7,403 $ — $ — $ — $ 8,287 Equity (Baker Hughes) — — — 207 — — — 4,010 Current investment securities $ — $ — $ — $ 7,609 $ — $ — $ — $ 12,297 Debt U.S. corporate $ 26,921 $ 675 $ (2,164) $ 25,432 $ 25,182 $ 5,502 $ (33) $ 30,652 Non-U.S. corporate 2,548 18 (300) 2,266 2,361 343 (4) 2,701 State and municipal 2,898 66 (241) 2,722 2,639 573 (6) 3,205 Mortgage and asset-backed 4,442 21 (290) 4,173 3,950 117 (47) 4,019 Government and agencies 1,172 2 (147) 1,026 1,086 104 (2) 1,188 Other equity 429 — — 429 443 — — 443 Non-current investment securities $ 38,410 $ 781 $ (3,143) $ 36,048 $ 35,662 $ 6,639 $ (92) $ 42,209
Schedule of Cash Flows Associated Investment Securities	Cash flows associated with purchases, dispositions and maturities of insurance investment securities are as follows: For the years ended December 31 2022 2021 Purchases of investment securities $ (4,046) $ (4,286) Dispositions and maturities of investment securities 3,170 2,997 Net (purchases) dispositions of insurance investment securities $ (876) $ (1,290)
Contractual Maturities of Debt Securities (Excluding Mortgage and Asset-Backed Securities)	Contractual maturities of our debt securities (excluding mortgage and asset-backed securities) at December 31, 2022 are as follows: Amortized cost Estimated fair value Within one year $ 413 $ 409 After one year through five years 4,287 4,247 After five years through ten years 5,910 5,869 After ten years 22,928 20,920

CURRENT AND LONG-TERM RECEIVA_2

CURRENT AND LONG-TERM RECEIVABLES (Tables)	12 Months Ended
	Dec. 31, 2022
Receivables [Abstract]
Schedule of Receivables	CURRENT RECEIVABLES December 31 2022 2021 Customer receivables $ 14,916 $ 13,079 Revenue sharing program receivables(a) 1,326 1,166 Non-income based tax receivables 1,320 1,222 Supplier advances 711 596 Receivables from disposed businesses 115 148 Other sundry receivables 447 483 Allowance for credit losses(b) (859) (1,074) Total current receivables $ 17,976 $ 15,620 (a) Revenue sharing program receivables in Aerospace are amounts due from third parties who participate in engine programs by developing and supplying certain engine components through the life of the program. The participants share in program revenues, receive a share of customer progress payments and share costs related to discounts and warranties. (b) Allowance for credit losses decreased primarily due to write-offs, recoveries and foreign currency impact, partially offset by net new provisions of $48 million. December 31 2022 2021 Aerospace $ 7,784 $ 5,812 Renewable Energy 2,415 2,218 Power 4,229 4,092 HealthCare 3,354 3,255 Corporate 195 244 Total current receivables $ 17,976 $ 15,620 2022 2021 Third Parties WCS Third Parties Balance at January 1 $ 161 $ 3,618 $ 2,992 GE businesses sales to WCS — 13,773 — GE businesses sales to third parties(a) 2,061 — 1,415 WCS sales to third parties — (10,816) 10,816 Collections and other (2,163) (6,676) (15,062) Reclassification from long-term customer receivables 41 100 — Balance at December 31 $ 100 $ — $ 161 (a) The Company sold current customer receivables to third parties related primarily to our participation in customer-sponsored supply chain finance programs. Within these programs, primarily in Renewable Energy and Aerospace, the Company has no continuing involvement, fees associated with the transferred receivables are covered by the customer and cash is received at the original invoice due date. LONG-TERM RECEIVABLES December 31 2022 2021 Long-term customer receivables(a) $ 535 $ 521 Financing receivables 386 592 Supplier advances 277 309 Non-income based tax receivables 241 245 Receivables from disposed businesses 51 150 Sundry receivables 406 440 Allowance for credit losses (223) (160) Total long-term receivables $ 1,672 $ 2,097 (a) The Company sold $86 million and $53 million of long-term customer receivables to third parties for the years ended December 31, 2022 and 2021, respectively, primarily in our Gas Power business for risk mitigation purposes.

INVENTORIES, INCLUDING DEFERR_2

INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS (Tables)	12 Months Ended
	Dec. 31, 2022
Inventory Disclosure [Abstract]
Schedule of Inventories	December 31 2022 2021 Raw materials and work in process $ 10,356 $ 8,710 Finished goods 5,030 4,927 Deferred inventory costs(a) 2,017 2,210 Inventories, including deferred inventory costs $ 17,403 $ 15,847

PROPERTY, PLANT AND EQUIPMENT_2

PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES (Tables)	12 Months Ended
	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	Depreciable lives Original Cost Net Carrying Value December 31 (in years) 2022 2021 2022 2021 Land and improvements 8 $ 542 $ 585 $ 530 $ 576 Buildings, structures and related equipment 8 - 40 7,913 8,311 3,483 3,728 Machinery and equipment 4 - 20 21,119 21,036 6,913 7,356 Leasehold costs and manufacturing plant under construction 1 - 10 2,059 1,971 1,415 1,343 ROU operating lease assets 2,137 2,606 Property, plant and equipment - net $ 31,633 $ 31,904 $ 14,478 $ 15,609
Summary of Operating Lease Expense	OPERATING LEASE EXPENSE 2022 2021 2020 Long-term (fixed) $ 755 $ 770 $ 827 Long-term (variable) 147 119 143 Short-term 153 192 206 Total operating lease expense $ 1,055 $ 1,081 $ 1,176 SUPPLEMENTAL INFORMATION RELATED TO OPERATING LEASES 2022 2021 2020 Operating cash flows used for operating leases $ 790 $ 834 $ 835 Right-of-use assets obtained in exchange for new lease liabilities 526 603 594 Weighted-average remaining lease term 6.2 years 7.2 years 6.7 years Weighted-average discount rate 3.8 % 4.0 % 4.6 %
Schedule of Maturity of Lease Liabilities	MATURITY OF LEASE LIABILITIES 2023 2024 2025 2026 2027 Thereafter Total Undiscounted lease payments $ 687 $ 567 $ 397 $ 291 $ 206 $ 603 $ 2,751 Less: imputed interest (357) Total lease liability as of December 31, 2022 $ 2,393

ACQUISITIONS, GOODWILL AND OT_2

ACQUISITIONS, GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)	12 Months Ended
	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Changes in Goodwill Balances	CHANGES IN GOODWILL BALANCES Balance at December 31, 2020 Acquisitions Currency exchange and other Balance at December 31, 2021 Dispositions Currency exchange and other Balance at December 31, 2022 Aerospace $ 9,247 $ — $ (234) $ 9,013 $ (6) $ (171) $ 8,835 Renewable Energy 3,401 — (169) 3,231 — (30) 3,201 Power 146 — (1) 145 — (1) 144 HealthCare 11,855 1,064 (40) 12,879 — (80) 12,799 Corporate(a) 876 43 (4) 914 — (96) 818 Total $ 25,524 $ 1,106 $ (448) $ 26,182 $ (6) $ (378) $ 25,798
Intangible Assets Subject to Amortization	2022 2021 INTANGIBLE ASSETS SUBJECT TO AMORTIZATION December 31 Useful lives Gross carrying Accumulated Net Gross carrying Accumulated Net Customer-related(a) 3-15 $ 6,063 $ (3,475) $ 2,587 $ 6,400 $ (3,250) $ 3,150 Patents and technology 5-15 8,432 (5,018) 3,415 8,592 (4,361) 4,230 Capitalized software 3-10 5,288 (3,824) 1,464 5,764 (3,999) 1,765 Trademarks & other 2-50 419 (322) 97 449 (313) 136 Total $ 20,202 $ (12,639) $ 7,563 $ 21,205 $ (11,923) $ 9,282 (a) Balance includes payments made to our customers, primarily within our Aerospace business. December 31 2022 2021 Aerospace $ 4,748 $ 5,019 Renewable Energy 183 229 Power 958 1,965 HealthCare 1,520 1,847 Corporate 216 271 Total other intangible assets, net(a) $ 7,625 $ 9,330 (a) Balances include indefinite-lived intangible assets.
Estimated 5 Year Consolidation Amortization	Estimated consolidated annual pre-tax amortization for intangible assets over the next five calendar years are as follows: ESTIMATED 5 YEAR CONSOLIDATED AMORTIZATION 2023 2024 2025 2026 2027 Estimated annual pre-tax amortization $ 1,025 $ 919 $ 848 $ 751 $ 648

CONTRACT AND OTHER DEFERRED A_2

CONTRACT AND OTHER DEFERRED ASSETS & PROGRESS COLLECTIONS AND DEFERRED INCOME (Tables)	12 Months Ended
	Dec. 31, 2022
Contractors [Abstract]
Contract with Customer, Asset and Liability	December 31, 2022 Aerospace Renewable Energy Power HealthCare Corporate Total Revenues in excess of billings $ 2,363 $ — $ 5,403 $ — $ — $ 7,766 Billings in excess of revenues (6,681) — (1,763) — — (8,443) Long-term service agreements $ (4,318) $ — $ 3,640 $ — $ — $ (677) Short-term and other service agreements 391 108 56 174 245 973 Equipment contract revenues 42 955 1,348 447 — 2,792 Current contract assets $ (3,884) $ 1,063 $ 5,044 $ 621 $ 245 $ 3,088 Nonrecurring engineering costs(a) 2,513 17 4 30 — 2,563 Customer advances and other(b) 2,519 — 724 204 — 3,447 Non-current contract and other deferred assets $ 5,032 $ 17 $ 728 $ 234 $ — $ 6,010 Total contract and other deferred assets $ 1,148 $ 1,079 $ 5,772 $ 854 $ 245 $ 9,098 December 31, 2021 Revenues in excess of billings $ 2,478 $ — $ 5,495 $ — $ — $ 7,972 Billings in excess of revenues (5,731) — (1,614) — — (7,346) Long-term service agreements $ (3,253) $ — $ 3,880 $ — $ — $ 627 Short-term and other service agreements 340 87 80 166 256 928 Equipment contract revenues 33 1,297 1,709 287 — 3,326 Current contract assets $ (2,881) $ 1,384 $ 5,669 $ 453 $ 256 $ 4,881 Nonrecurring engineering costs(a) 2,479 28 12 31 — 2,550 Customer advances and other(b) 2,620 — 801 154 — 3,574 Non-current contract and other deferred assets $ 5,099 $ 28 $ 813 $ 184 $ — $ 6,124 Total contract and other deferred assets $ 2,218 $ 1,412 $ 6,482 $ 637 $ 256 $ 11,005 (a) Included costs incurred prior to production (such as requisition engineering) for equipment production contracts, primarily within our Aerospace segment, which are amortized ratably over each unit produced. (b) Included amounts due from customers at Aerospace for the sales of engines, spare parts and services, and at Power, for the sale of services upgrades, which we collect through incremental fixed or usage-based fees from servicing the equipment under long-term service agreements. December 31, 2022 Aerospace Renewable Energy Power HealthCare Corporate Total Progress collections on equipment contracts $ 74 $ 2,464 $ 3,973 $ — $ — $ 6,511 Other progress collections 5,740 2,731 541 511 131 9,654 Current deferred income 233 208 13 1,391 107 1,952 Progress collections and deferred income $ 6,047 $ 5,404 $ 4,527 $ 1,902 $ 238 $ 18,118 Non-current deferred income 1,110 183 104 597 12 2,006 Total Progress collections and deferred income $ 7,157 $ 5,586 $ 4,632 $ 2,499 $ 250 $ 20,124 December 31, 2021 Aerospace Renewable Energy Power HealthCare Corporate Total Progress collections on equipment contracts $ 142 $ 1,843 $ 5,198 $ — $ — $ 7,183 Other progress collections 4,469 2,866 385 522 111 8,354 Current deferred income 170 198 33 1,336 99 1,835 Progress collections and deferred income $ 4,782 $ 4,907 $ 5,615 $ 1,858 $ 210 $ 17,372 Non-current deferred income 1,090 194 110 592 3 1,989 Total Progress collections and deferred income $ 5,871 $ 5,101 $ 5,725 $ 2,450 $ 213 $ 19,361

ALL OTHER ASSETS (Tables)

ALL OTHER ASSETS (Tables)	12 Months Ended
	Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of All Other Assets	December 31 2022 2021 Derivative instruments (Note 22) $ 482 $ 684 Assets held for sale 95 208 Prepaid taxes and deferred charges 395 341 Cash collateral on derivatives — 76 Accrued interest and investment income 457 426 Other 93 199 All other current assets $ 1,521 $ 1,933 Equity method and other investments 8,554 7,840 Long-term receivables (Note 4) 1,672 2,097 Prepaid taxes and deferred charges 670 800 Insurance receivables 2,315 4,705 Insurance cash and cash equivalents(a) 619 353 Pension surplus 2,578 2,784 Other 591 461 All other non-current assets $ 16,998 $ 19,040 Total All other assets $ 18,520 $ 20,973 (a) Cash and cash equivalents in our insurance entities are subject to regulatory restrictions and used for operations of those entities. Therefore, the balance is included in All other assets.
Equity Method Investments	Equity method investment balance Equity method income (loss) December 31 2022 2021 2022 2021 2020 Aerospace $ 1,931 $ 2,000 $ 149 $ 58 $ (41) Renewable Energy 752 739 32 39 13 Power 960 977 89 23 43 HealthCare 182 223 13 27 7 Corporate(a) 3,991 3,451 103 68 23 Total consolidated $ 7,815 $ 7,391 $ 386 $ 215 $ 46 (a) Equity method investments within Corporate include investments held by EFS of $1,975 million and $1,943 million and held by our run-off insurance operations of $1,980 million and $1,480 million as of December 31, 2022 and 2021, respectively.

BORROWINGS (Tables)

BORROWINGS (Tables)	12 Months Ended
	Dec. 31, 2022
Debt Disclosure [Abstract]
Schedule of Borrowings	December 31 2022 2021 Amount Average Rate Amount Average Rate Current portion of long-term borrowings Senior notes issued by GE $ 473 1.04 % $ 1,249 1.39 % Senior and subordinated notes assumed by GE 1,973 1.50 1,645 2.05 Senior notes issued by GE Capital 1,188 1.54 1,370 0.63 Other 124 97 Total short-term borrowings $ 3,757 $ 4,361 Maturities Amount Average Rate Amount Average Rate Senior notes issued by GE 2024-2052 $ 12,927 4.75 % $ 5,373 2.87 % Senior and subordinated notes assumed by GE 2024-2054 8,406 4.71 11,306 3.73 Senior notes issued by GE Capital 2024-2042 6,289 3.95 13,274 4.26 Other 971 870 Total long-term borrowings $ 28,593 $ 30,824 Total borrowings $ 32,350 $ 35,186
Schedule of Maturities of Long-term Debt	Long-term debt maturities over the next five years follow. 2023 2024 2025 2026 2027 Debt issued by GE $ 473 $ 1,217 $ 2,357 $ 49 $ 2,450 Debt assumed by GE 1,973 512 237 1,136 222 Debt issued by GE Capital 1,188 (a) 112 694 149 624

ACCOUNTS PAYABLE AND EQUIPMEN_2

ACCOUNTS PAYABLE AND EQUIPMENT PROJECT PAYABLES (Tables)	12 Months Ended
	Dec. 31, 2022
Payables and Accruals [Abstract]
Schedule of Accounts Payable and Accruals	December 31 2022 2021 Trade payables $ 12,479 $ 10,970 Supply chain finance programs 4,081 3,402 Equipment project payables(a) 1,469 1,341 Non-income based tax payables 616 531 Accounts payable and equipment project payables $ 18,644 $ 16,243 (a) Primarily related to projects in our Power and Renewable Energy segments.

INSURANCE LIABILITIES AND ANN_2

INSURANCE LIABILITIES AND ANNUITY BENEFITS (Tables)	12 Months Ended
	Dec. 31, 2022
Insurance [Abstract]
Schedule of Insurance and Investment Contract Liabilities	A summary of our insurance contracts is presented below: December 31, 2022 Long-term care Structured settlement annuities & life Other contracts Other adjustments(a) Total Future policy benefit reserves $ 17,357 $ 8,678 $ 187 $ — $ 26,223 Claim reserves 4,596 254 307 — 5,156 Investment contracts — 864 907 — 1,771 Unearned premiums and other 18 174 5 — 197 Total $ 21,971 $ 9,970 $ 1,406 $ — $ 33,347 December 31, 2021 Future policy benefit reserves $ 17,097 $ 8,902 $ 188 $ 3,394 $ 29,581 Claim reserves(b) 4,546 258 585 — 5,389 Investment contracts — 955 954 — 1,909 Unearned premiums and other 15 184 89 — 287 Total $ 21,658 $ 10,299 $ 1,815 $ 3,394 $ 37,166 (a) The decrease in Other adjustments of $3,394 million is a result of the decline in unrealized gains on investment securities. (b) Other contracts included claim reserves of $242 million related to short-duration contracts at Electric Insurance Company (EIC), net of eliminations, at December 31, 2021. EIC is a property and casualty insurance company primarily providing insurance to GE and its employees.

POSTRETIREMENT BENEFIT PLANS (T

POSTRETIREMENT BENEFIT PLANS (Tables)	12 Months Ended
	Dec. 31, 2022
Retirement Benefits [Abstract]
Description Postretirement Benefit Plans	DESCRIPTION OF OUR PLANS Plan Category Participants Funding Comments Principal Pension Plans GE Pension Plan Covers U.S. participants ~177,000 retirees and beneficiaries, ~82,500 vested former employees and ~23,000 active employees Our funding policy is to contribute amounts sufficient to meet minimum funding requirements under employee benefit and tax laws. We may decide to contribute additional amounts beyond this level. This plan has been closed to new participants since 2012. Benefits for ~20,000 employees with salaried benefits were frozen effective January 1, 2021, and thereafter these employees receive increased company contributions in the company sponsored defined contribution plan in lieu of participation in a defined benefit plan (announced October 2019). GE Supplementary Pension Plan Provides supplementary benefits to higher-level, longer-service U.S. employees This plan is unfunded. We pay benefits from company cash. The annuity benefit has been closed to new participants since 2011 and has been replaced by an installment benefit (which was closed to new executives after 2020). Benefits for ~700 employees who became executives before 2011 were frozen effective January 1, 2021, and thereafter these employees accrue the installment benefit. Other Pension Plans(a) 41 U.S. and non-U.S. pension plans with pension assets or obligations that have reached $50 million Covers ~58,000 retirees and beneficiaries, ~48,500 vested former employees and ~14,000 active employees Our funding policy is to contribute amounts sufficient to meet minimum funding requirements under employee benefit and tax laws in each country. We may decide to contribute additional amounts beyond this level. We pay benefits for some plans from company cash. In certain countries, benefit accruals have ceased and/or have been closed to new hires as of various dates. Principal Retiree Benefit Plans Provides health and life insurance benefits to certain eligible participants Covers U.S. participants ~151,500 retirees and dependents and ~21,500 active employees We fund retiree health benefits on a pay-as-you-go basis and the retiree life insurance trust at our discretion. Participants share in the cost of the healthcare benefits. (a) Plans that reach $50 million are not removed from the presentation unless part of a disposition or plan termination.
Funded Status	FUNDING STATUS BY PLAN TYPE Benefit Obligation Fair Value of Assets Deficit/(Surplus) 2022 2021 2022 2021 2022 2021 Principal Pension Plans: GE Pension Plan (subject to regulatory funding) $ 48,134 $ 65,073 $ 44,993 $ 60,990 $ 3,141 $ 4,083 GE Supplementary Pension Plan (not subject to regulatory funding) 5,457 7,226 — — 5,457 7,226 53,591 72,299 44,993 60,990 8,598 11,309 Other Pension Plans: Subject to regulatory funding 12,078 19,698 14,512 22,280 (2,434) (2,582) Not subject to regulatory funding 1,838 2,558 151 210 1,687 2,348 Principal retiree benefit plans (not subject to regulatory funding) 3,304 4,308 10 42 3,294 4,266 Total plans subject to regulatory funding 60,212 84,771 59,505 83,270 707 1,501 Total plans not subject to regulatory funding 10,599 14,092 161 252 10,438 13,840 Total plans $ 70,811 $ 98,863 $ 59,666 $ 83,522 $ 11,145 $ 15,341 PLAN FUNDED STATUS AND AMOUNTS RECORDED IN ACCUMULATED OTHER COMPREHENSIVE LOSS (INCOME) 2022 2021 Principal pension Other pension Principal retiree benefit Principal pension Other pension Principal retiree benefit Change in benefit obligations Balance at January 1 $ 72,299 $ 22,256 $ 4,308 $ 76,298 $ 24,658 $ 5,019 Service cost 221 86 39 237 233 44 Interest cost 2,069 398 108 1,951 383 103 Participant contributions 14 19 54 15 24 60 Plan amendments — — — — (1) — Actuarial loss (gain) - net (17,281) (a) (6,282) (a) (778) (a) (2,448) (a) (1,561) (a) (446) Benefits paid (3,731) (920) (438) (3,754) (998) (472) Curtailments — — — — (74) — Dispositions/acquisitions/other - net — — 11 — (188) — Exchange rate adjustments — (1,641) — — (220) — Balance at December 31 $ 53,591 (b) $ 13,916 $ 3,304 (c) $ 72,299 (b) $ 22,256 $ 4,308 (c) Change in plan assets Balance at January 1 $ 60,990 $ 22,490 $ 42 $ 58,843 $ 21,506 $ 134 Actual gain (loss) on plan assets (12,605) (5,334) — 5,559 1,602 41 Employer contributions 325 209 352 327 594 279 Participant contributions 14 19 54 15 24 60 Benefits paid (3,731) (920) (438) (3,754) (998) (472) Dispositions/acquisitions/other - net — — — — (138) — Exchange rate adjustments — (1,801) — — (100) — Balance at December 31 $ 44,993 $ 14,663 $ 10 $ 60,990 $ 22,490 $ 42 Funded status - surplus (deficit) $ (8,598) $ 747 $ (3,294) $ (11,309) $ 234 $ (4,266) Amounts recorded in Non-current assets - other $ — $ 2,591 $ — $ — $ 2,898 $ — Current liabilities - other (351) (101) (355) (337) (107) (362) Non-current liabilities - compensation and benefits (8,247) (1,743) (2,939) (10,972) (2,557) (3,904) Net amount recorded $ (8,598) $ 747 $ (3,294) $ (11,309) $ 234 $ (4,266) Amounts recorded in Accumulated other comprehensive loss (income) Prior service cost (credit) $ (113) $ (42) $ (1,677) $ (109) $ (52) $ (1,912) Net loss (gain) (5,710) 1,787 (1,705) (2,754) 2,012 (1,042) Total recorded in Accumulated other comprehensive loss (income) $ (5,823) $ 1,745 $ (3,382) $ (2,863) $ 1,960 $ (2,954) (a) Principally associated with discount rate changes. (b) The benefit obligation for the GE Supplementary Pension Plan, which is an unfunded plan, was $5,457 million and $7,226 million at December 31, 2022 and 2021, respectively. (c) The benefit obligation for retiree health plans was $1,991 million and $2,548 million at December 31, 2022 and 2021, respectively.
Cost of Benefits Plans and Assumptions	COST OF OUR BENEFITS PLANS 2022 2021 2020 AND ASSUMPTIONS Principal pension Other pension Principal retiree benefit Principal pension Other pension Principal retiree benefit Principal pension Other pension Principal retiree benefit Components of expense (income) Service cost - operating $ 221 $ 86 $ 39 $ 237 $ 233 $ 44 $ 657 $ 243 $ 59 Interest cost 2,069 398 108 1,951 383 103 2,350 422 150 Expected return on plan assets (3,142) (967) — (3,049) (1,194) — (2,993) (1,082) (11) Amortization of net loss (gain) 1,422 101 (115) 3,483 403 (79) 3,399 434 (82) Amortization of prior service cost (credit) 5 (8) (235) 28 (3) (236) 146 1 (234) Curtailment / settlement loss (gain) — (6) — — 76 — — 12 — Non-operating $ 354 $ (482) $ (242) $ 2,413 $ (335) $ (212) $ 2,902 $ (213) $ (177) Net periodic expense (income) $ 575 $ (396) $ (203) $ 2,650 $ (102) $ (168) $ 3,559 $ 30 $ (118) Weighted-average benefit obligations assumptions Discount rate 5.53 % 4.59 % 5.43 % 2.94 % 1.93 % 2.64 % 2.61 % 1.44 % 2.15 % Compensation increases 3.07 2.44 3.12 3.05 2.35 2.63 2.95 3.06 2.82 Initial healthcare trend rate(a) N/A N/A 6.40 N/A N/A 5.70 N/A N/A 5.90 Weighted-average benefit cost assumptions Discount rate 2.94 1.93 2.64 2.61 1.44 2.15 3.36 1.97 3.05 Expected rate of return on plan assets 6.00 4.80 — 6.25 5.69 1.25 6.25 6.10 7.00
Composition of Plan Assets	The fair value of our pension plans' investments is presented below. The inputs and valuation techniques used to measure the fair value of these assets are described in Note 1 and have been applied consistently. 2022 2021 Principal pension Other pension Principal pension Other pension Global equities $ 3,918 $ 1,097 $ 7,778 $ 3,589 Debt securities Fixed income and cash investment funds 4,918 6,506 7,665 10,527 U.S. corporate(a) 8,715 382 10,324 468 Other debt securities(b) 7,853 443 7,331 492 Real estate 1,486 53 2,510 89 Private equities and other investments 1,245 364 1,515 943 Total 28,135 8,845 37,123 16,108 Plan assets measured at net asset value Global equities $ 3,285 $ 1,029 $ 9,517 $ 1,172 Debt securities 3,469 1,024 5,269 1,287 Real estate 1,624 1,976 1,408 2,126 Private equities and other investments 8,480 1,789 7,673 1,797 Total plan assets at fair value $ 44,993 $ 14,663 $ 60,990 $ 22,490 (a) Primarily represented investment-grade bonds of U.S. issuers from diverse industries. (b) Primarily represented investments in residential and commercial mortgage-backed securities, non-U.S. corporate and government bonds and U.S. government, federal agency, state and municipal debt.
Asset Allocation	ASSET ALLOCATION OF PENSION PLANS 2022 Target allocation 2022 Actual allocation Principal Pension Other Pension (weighted average) Principal Pension Other Pension (weighted average) Global equities 14.0 - 34.0 % 17 % 16 % 14 % Debt securities (including cash equivalents) 31.0 - 81.5 60 55 57 Real estate 1.0 - 10.0 8 7 14 Private equities & other investments 6.0 - 30.0 15 22 15
Schedule of Defined Benefit Plan Annual Returns	ANNUALIZED RETURNS 1 year 5 years 10 years 25 years GE Pension Plan (20.5) % 2.7 % 5.4 % 5.8 %
Estimated Future Benefit Payments	EXPECTED FUTURE BENEFIT PAYMENTS OF OUR BENEFIT PLANS(a) Principal pension Other pension Principal retiree benefit 2023 $ 3,830 $ 850 $ 375 2024 3,865 845 360 2025 3,890 855 345 2026 3,910 870 330 2027 3,920 885 325 2028-2032 19,510 4,585 1,375 (a) As of the measurement date of December 31, 2022
Cost of Postretirement Benefit Plans and Changes in Other Comprehensive Income	COST OF POSTRETIREMENT BENEFIT PLANS AND CHANGES IN OTHER COMPREHENSIVE INCOME For the years ended December 31 2022 2021 2020 (Pre-tax) Principal pension Other pension Principal retiree benefit Principal pension Other pension Principal retiree benefit Principal pension Other pension Principal retiree benefit Cost (income) of postretirement benefit plans $ 575 $ (396) $ (203) $ 2,650 $ (102) $ (168) $ 3,559 $ 30 $ (118) Changes in other comprehensive loss (income) Prior service cost (credit) - current year — — — — (1) — — 27 (7) Net loss (gain) - current year (1,533) (128) (778) (4,959) (2,104) (488) 1,124 529 119 Reclassifications out of AOCI Curtailment/settlement gain (loss) — 6 — — (68) — — (3) — Dispositions — — — — (68) — — (166) — Amortization of net gain (loss) (1,422) (101) 115 (3,483) (403) 79 (3,399) (434) 82 Amortization of prior service credit (cost) (5) 8 235 (28) 3 236 (146) (1) 234 Total changes in other comprehensive loss (income) (2,960) (215) (428) (8,470) (2,641) (173) (2,421) (48) 428 Cost (income) of postretirement benefit plans and changes in other comprehensive loss (income) $ (2,385) $ (611) $ (631) $ (5,820) $ (2,743) $ (341) $ 1,138 $ (18) $ 310

ALL OTHER LIABILITIES (Tables)

ALL OTHER LIABILITIES (Tables)	12 Months Ended
	Dec. 31, 2022
Other Liabilities Disclosure [Abstract]
Schedule of Current and All Other Liabilities	December 31 2022 2021 Sales discounts and allowances(a) $ 4,042 $ 4,020 Equipment projects and other commercial liabilities 1,652 1,618 Product warranties (Note 24) 1,268 1,091 Employee compensation and benefit liabilities 4,662 4,677 Interest payable 400 276 Taxes payable 743 500 Environmental, health and safety liabilities (Note 24) 282 386 Derivative instruments (Note 22) 589 212 Other 847 1,196 All other current liabilities $ 14,485 $ 13,977 Equipment projects and other commercial liabilities $ 2,229 $ 2,451 Product warranties (Note 24) 885 800 Operating lease liabilities (Note 6) 2,393 2,848 Uncertain and other income taxes and related liabilities 2,581 3,041 Alstom legacy legal matters (Note 24) 455 567 Environmental, health and safety liabilities (Note 24) 2,404 2,274 Redeemable noncontrolling interests (Note 16) 132 148 Interest payable — 179 Other 1,076 934 All other non-current liabilities $ 12,154 $ 13,240 Total All other liabilities $ 26,639 $ 27,217 (a) Primarily comprise amounts payable to airlines based on future aircraft deliveries by airframers and discounts on spare parts and repair sales at our Aerospace segment.

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
(Benefit) Provision for Income Taxes	EARNINGS (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES 2022 2021 2020 U.S. earnings (loss) $ (238) $ (2,959) $ (4,823) Non-U.S. earnings (loss) 1,650 (724) 10,793 Total $ 1,412 $ (3,683) $ 5,970 PROVISION (BENEFIT) FOR INCOME TAXES 2022 2021 2020 Current U.S. Federal $ 62 $ (1,347) $ 865 Non-U.S. 1,040 1,154 1,276 U.S. State 4 (85) 152 Deferred U.S. Federal (956) (567) (1,898) Non-U.S. 466 608 (810) U.S. State (141) (50) (72) Total $ 476 $ (286) $ (487)
Reconciliation of U.S. Federal Statutory Income Tax Rate to Actual Income Tax Rate	RECONCILIATION OF U.S. FEDERAL STATUTORY INCOME TAX RATE TO ACTUAL INCOME TAX RATE 2022 2021 2020 Amount Rate Amount Rate Amount Rate U.S. federal statutory income tax rate $ 297 21.0 % $ (773) 21.0 % $ 1,254 21.0 % Tax on global activities including exports 342 24.2 155 (4.2) (47) (0.8) U.S. business credits(a) (246) (17.4) (189) 5.1 (169) (2.8) Debt tender and related valuation allowances 30 2.1 940 (25.5) — — Deductible stock and restructuring losses — — (583) 15.8 (203) (3.4) Sale of Biopharma business (13) (0.9) (5) 0.1 (1,447) (24.2) Goodwill impairments — — — — 184 3.1 All other – net(b)(c)(d) 66 4.7 169 (4.5) (59) (1.1) 179 12.7 487 (13.2) (1,741) (29.2) Actual income tax rate $ 476 33.7 % $ (286) 7.8 % $ (487) (8.2) % (a) U.S. general business credits, primarily the credit for energy produced from renewable sources and the credit for research performed in the U.S. (b) For the year ended December 31, 2022, included $134 million for separation income tax costs of which $66 million was due to the repatriation of previously reinvested earnings. (c) For the year ended December 31, 2020, included $(140) million for the resolution of the IRS audit of our consolidated U.S. income tax returns for 2014-2015.
Unrecognized Tax Benefits	The balance of unrecognized tax benefits, the amount of related interest and penalties we have provided and what we believe to be the range of reasonably possible changes in the next 12 months (excluding the expected decrease to the GE balance of $552 million due to the spin-off of GE HealthCare) were: UNRECOGNIZED TAX BENEFITS December 31 2022 2021 2020 Unrecognized tax benefits $ 3,951 $ 4,224 $ 4,191 Portion that, if recognized, would reduce tax expense and effective tax rate(a) 3,072 3,351 2,986 Accrued interest on unrecognized tax benefits 614 597 628 Accrued penalties on unrecognized tax benefits 111 146 179 Reasonably possible reduction to the balance of unrecognized tax benefits in succeeding 12 months 0-650 0-250 0-350 Portion that, if recognized, would reduce tax expense and effective tax rate(a) 0-600 0-200 0-250 (a) Some portion of such reduction may be reported as discontinued operations.
Unrecognized Tax Benefits Reconciliation	UNRECOGNIZED TAX BENEFITS RECONCILIATION 2022 2021 2020 Balance at January 1 $ 4,224 $ 4,191 $ 4,169 Additions for tax positions of the current year 62 396 836 Additions for tax positions of prior years 120 327 326 Reductions for tax positions of prior years (393) (585) (863) Settlements with tax authorities (8) (33) (127) Expiration of the statute of limitations (54) (71) (151) Balance at December 31 $ 3,951 $ 4,224 $ 4,191
Components of Net Deferred Income Tax Asset (Liability)	The following table presents our net deferred tax assets and net deferred tax liabilities attributable to different tax jurisdictions or different tax paying components. DEFERRED INCOME TAXES December 31 2022 2021 Total assets $ 12,325 $ 11,587 Total liabilities (620) (732) Net deferred income tax asset (liability) $ 11,705 $ 10,855 COMPONENTS OF THE NET DEFERRED INCOME TAX ASSET (LIABILITY) December 31 2022 2021 Deferred tax assets Accrued expenses and reserves $ 2,538 $ 2,635 Progress collections, contract assets and deferred items 2,520 2,093 Deferred expenses 1,925 1,597 Principal pension plans 1,806 2,375 Insurance company loss reserves 1,782 1,700 Non-U.S. loss carryforwards(a) 1,240 1,354 Other compensation and benefits 975 1,397 Investment securities 516 (1,278) Principal retiree benefit plans 692 896 Other(b) 703 1,329 Total deferred tax assets $ 14,697 $ 14,098 Deferred tax liabilities Investment in global operations $ (1,011) $ (1,775) Other (1,981) (1,468) Total deferred tax liabilities (2,992) (3,243) Net deferred income tax asset (liability) $ 11,705 $ 10,855 (a) Net of valuation allowances of $7,171 million and $7,081 million as of December 31, 2022 and 2021, respectively. Of the net deferred tax asset as of December 31, 2022 of $1,240 million, $8 million relates to net operating loss carryforwards that expire in various years ending from December 31, 2023 through December 31, 2025; $427 million relates to net operating losses that expire in various years ending from December 31, 2026 through December 31, 2042; and $805 million relates to net operating loss carryforwards that may be carried forward indefinitely. (b) Included valuation allowances related to assets other than non-U.S. loss carryforwards of $3,325 million and $1,653 million as of December 31, 2022 and 2021, respectively. These primarily relate to excess capital loss carryforwards.

SHAREHOLDERS' EQUITY (Tables)

SHAREHOLDERS' EQUITY (Tables)	12 Months Ended
	Dec. 31, 2022
Equity [Abstract]
Schedule of Shareholders' Equity	ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) 2022 2021 2020 Beginning balance $ (4,562) $ (4,386) $ (4,818) AOCI before reclasses – net of taxes of $127, $(91) and $(25) (1,355) (104) (255) Reclasses from AOCI – net of taxes of $—, $87 and $—(a) — (71) 691 AOCI (1,355) (174) 435 Less AOCI attributable to noncontrolling interests (2) 2 2 Currency translation adjustments AOCI $ (5,915) $ (4,562) $ (4,386) Beginning balance $ 3,646 $ (5,395) $ (7,024) AOCI before reclasses – net of taxes of $597, $1,643 and $(283) 2,117 6,225 (1,256) Reclasses from AOCI – net of taxes of $216, $793 and $805(a) 772 2,819 2,888 AOCI 2,889 9,044 1,632 Less AOCI attributable to noncontrolling interests 3 3 4 Benefit plans AOCI $ 6,531 $ 3,646 $ (5,395) Beginning balance $ 2,498 $ 32 $ 109 AOCI before reclasses – net of taxes of $(1,141), $615 and $21(b) (4,461) 2,422 (39) Reclasses from AOCI – net of taxes of $(20), $23 and $(25)(a) 36 44 (39) AOCI (4,425) 2,466 (78) Investment securities and cash flow hedges AOCI $ (1,927) $ 2,498 $ 32 AOCI at December 31 $ (1,311) $ 1,582 $ (9,749) Dividends declared per common share $ 0.32 $ 0.32 $ 0.32 (a) The total reclassification from AOCI included $836 million, including currency translation of $688 million, net of taxes, in 2020, related to the sale of our BioPharma business within our HealthCare segment. (b) Included adjustments of $2,674 million, $3,535 million and $(1,979) million for the years ended December 31, 2022, 2021 and 2020, respectively, related to insurance liabilities and annuity benefits in our run-off insurance operations to reflect the effects that would have been recognized had the related unrealized investment security gains been realized. See Note 12 for further information.

SHARE-BASED COMPENSATION (Table

SHARE-BASED COMPENSATION (Tables)	12 Months Ended
	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Weighted Average Grant Date Fair Value	WEIGHTED AVERAGE GRANT DATE FAIR VALUE 2022 2021 2020 Stock options $ 34.03 $ 40.64 $ 28.64 RSUs 87.68 104.98 63.28 PSUs/Performance shares 95.40 108.51 63.28
Stock-Based Compensation Activity	STOCK-BASED COMPENSATION ACTIVITY Stock options RSUs Shares (in thousands) Weighted average exercise price Weighted average contractual term (in years) Intrinsic value (in millions) Shares (in thousands) Weighted average grant date fair value Weighted average contractual term (in years) Intrinsic value (in millions) Outstanding at January 1, 2022 38,414 $ 144.97 8,057 $ 77.90 Granted 435 92.33 4,110 87.68 Exercised (951) 64.45 (1,630) 89.08 Forfeited (266) 95.12 (850) 81.92 Expired (6,609) 165.67 N/A N/A Outstanding at December 31, 2022 31,023 $ 142.68 3.8 $ 88 9,687 $ 79.82 1.2 $ 812 Exercisable at December 31, 2022 28,723 $ 146.94 3.4 $ 83 N/A N/A N/A N/A Expected to vest 2,151 $ 90.14 7.7 $ 5 8,476 $ 80.03 1.2 $ 710
Schedule of Compensation Expense	2022 2021 2020 Compensation expense (after-tax)(a)(b) $ 305 $ 361 $ 353 Cash received from stock options exercised 62 93 6 Intrinsic value of stock options exercised and RSU/PSUs vested 170 217 81 (a) Unrecognized compensation cost related to unvested equity awards as of December 31, 2022 was $420 million, which will be amortized over a weighted average period of 1.0 year. (b) Income tax benefit recognized in earnings was $17 million, $9 million and $10 million in 2022, 2021, and 2020, respectively.
Schedule of Cash Proceeds and Intrinsic Value	2022 2021 2020 Compensation expense (after-tax)(a)(b) $ 305 $ 361 $ 353 Cash received from stock options exercised 62 93 6 Intrinsic value of stock options exercised and RSU/PSUs vested 170 217 81 (a) Unrecognized compensation cost related to unvested equity awards as of December 31, 2022 was $420 million, which will be amortized over a weighted average period of 1.0 year. (b) Income tax benefit recognized in earnings was $17 million, $9 million and $10 million in 2022, 2021, and 2020, respectively.

EARNINGS PER SHARE INFORMATION

EARNINGS PER SHARE INFORMATION (Tables)	12 Months Ended
	Dec. 31, 2022
Earnings Per Share [Abstract]
Schedule of Earnings Per Share	2022 2021 2020 (Earnings for per-share calculation, shares in millions, per-share amounts in dollars) Diluted Basic Diluted Basic Diluted Basic Earnings (loss) from continuing operations $ 869 $ 869 $ (3,326) $ (3,326) $ 6,601 $ 6,601 Preferred stock dividends (289) (289) (237) (237) (474) (474) Accretion of redeemable noncontrolling interests, net of tax — — (9) (9) (151) (151) Accretion of preferred share repurchase 4 4 — — — — Earnings (loss) from continuing operations attributable to common shareholders 584 584 (3,571) (3,571) 5,975 5,975 Earnings (loss) from discontinued operations (644) (644) (3,195) (3,195) (909) (909) Net earnings (loss) attributable to GE common shareholders (60) (60) (6,766) (6,766) 5,066 5,066 Shares of GE common stock outstanding 1,096 1,096 1,098 1,098 1,094 1,094 Employee compensation-related shares (including stock options) 6 — — — 1 — Total average equivalent shares 1,101 1,096 1,098 1,098 1,095 1,094 Earnings (loss) from continuing operations $ 0.53 $ 0.53 $ (3.25) $ (3.25) $ 5.46 $ 5.46 Earnings (loss) from discontinued operations (0.58) (0.59) (2.91) (2.91) (0.83) (0.83) Net earnings (loss) per share (0.05) (0.06) (6.16) (6.16) 4.63 4.63 Potentially dilutive securities(a) 44 41 56 (a) Outstanding stock awards not included in the computation of diluted earnings (loss) per share because their effect was antidilutive.

OTHER INCOME (LOSS) (Tables)

OTHER INCOME (LOSS) (Tables)	12 Months Ended
	Dec. 31, 2022
Other Income and Expenses [Abstract]
Schedule of Other Income (Loss)	2022 2021 2020 Purchases and sales of business interests(a) $ 66 $ (40) $ 12,468 Licensing and royalty income 203 192 161 Equity method income 233 (96) 7 Investment in Baker Hughes realized and unrealized gain (loss) 912 938 (2,037) Investment in and note with AerCap unrealized gain (loss) (865) 711 — Other net interest and investment income (loss)(b) 456 621 590 Other items 226 497 207 Total other income (loss) $ 1,231 $ 2,823 $ 11,396 (a) Included a pre-tax loss of $170 million related to the sale of our boiler manufacturing business in China in our Power segment in 2021. Included a pre-tax gain of $12,362 million on the sale of our BioPharma business in 2020. See Note 2 for further information. (b) Included interest income associated with customer advances of $162 million, $167 million and $146 million in 2022, 2021 and 2020, respectively. See Note 8 for further information.

RESTRUCTURING CHARGES AND SEP_2

RESTRUCTURING CHARGES AND SEPARATION COSTS (Tables)	12 Months Ended
	Dec. 31, 2022
Restructuring and Related Activities [Abstract]
Schedule of Restructuring and Related Costs	This table is inclusive of all restructuring charges in our segments and at Corporate, and the charges are shown below for the business where they originated. Separately, in our reported segment results, significant, higher-cost restructuring programs are excluded from measurement of segment operating performance for internal and external purposes; those excluded amounts are reported in Restructuring and other charges for Corporate. RESTRUCTURING AND OTHER CHARGES 2022 2021 2020 Workforce reductions $ 348 $ 695 $ 856 Plant closures & associated costs and other asset write-downs 615 145 332 Acquisition/disposition net charges and other 30 (21) 66 Total restructuring and other charges $ 993 $ 819 $ 1,254 Cost of equipment/services $ 250 $ 394 $ 570 Selling, general and administrative expenses 774 499 697 Other (income) loss (31) (75) (13) Total restructuring and other charges $ 993 $ 819 $ 1,254 Aerospace $ 20 $ 70 $ 397 Renewable Energy 177 204 213 Power 155 369 236 HealthCare 148 155 137 Corporate 494 20 270 Total restructuring and other charges $ 993 $ 819 $ 1,254 Restructuring and other charges cash expenditures $ 492 $ 781 $ 1,175 An analysis of changes in the liability for restructuring follows. 2022 2021 2020 Balance at January 1 $ 1,026 $ 1,337 $ 1,746 Additions 578 655 860 Payments (385) (670) (997) Remeasurement (4) (245) (212) Effect of foreign currency and other (31) (52) (60) Balance at December 31 (a) $ 1,183 $ 1,026 $ 1,337 (a) Includes actuarial determined post-employment severance benefits reserve of $475 million, $464 million and $722 million as of December 31, 2022, 2021 and 2020, respectively.

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	12 Months Ended
	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis	ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON A RECURRING BASIS Level 1 Level 2 Level 3(a) Netting Net balance(b) December 31 2022 2021 2022 2021 2022 2021 2022 2021 2022 2021 Investment securities $ 6,754 $ 11,434 $ 30,483 $ 35,849 $ 6,421 $ 7,222 $ — $ — $ 43,657 $ 54,506 Derivatives — — 1,340 1,357 1 17 (859) (691) 482 684 Total assets $ 6,754 $ 11,434 $ 31,823 $ 37,207 $ 6,421 $ 7,239 $ (859) $ (691) $ 44,139 $ 55,189 Derivatives $ — $ — $ 1,444 $ 891 $ 7 $ 1 $ (862) $ (681) $ 589 $ 212 Other(c) — — 627 863 — — — — 627 863 Total liabilities $ — $ — $ 2,071 $ 1,754 $ 7 $ 1 $ (862) $ (681) $ 1,216 $ 1,075 (a) Included $3,548 million of U.S. corporate debt securities, $1,386 million of Mortgage and asset-backed debt securities, and the $900 million AerCap note at December 31, 2022. Included $4,228 million of U.S. corporate debt securities, $1,427 million of Mortgage and asset-backed debt securities, and the $993 million AerCap note at December 31, 2021. (b) See Notes 3 and 22 for further information on the composition of our investment securities and derivative portfolios. (c) Primarily represents the liabilities associated with certain of our deferred incentive compensation plans.
Schedule of Changes in Level 3 Investment Securities	Balance at Net realized/unrealized gains(losses)(a) Purchases(b) Sales & Settlements Transfers Transfers Balance at 2022 Investment securities $ 7,222 $ (1,002) $ 973 $ (628) $ 57 $ (201) $ 6,421 2021 Investment securities $ 5,866 $ (261) $ 2,589 $ (943) $ 6 $ (35) $ 7,222 (a) Primarily included net unrealized gains (losses) of $(994) million and $(288) million in Other comprehensive income for the years ended December 31, 2022 and 2021, respectively. (b) Included $508 million of U.S. corporate debt securities and $302 million of Mortgage and asset-backed debt securities for the year ended December 31, 2022. Included $1,084 million of Mortgage and asset-backed debt securities and $1,000 million AerCap senior note received as partial consideration on the completion of the GECAS transaction for the year ended December 31, 2021.

FINANCIAL INSTRUMENTS (Tables)

FINANCIAL INSTRUMENTS (Tables)	12 Months Ended
	Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Estimated Fair Value of Assets and Liabilities	The following table provides information about assets and liabilities not carried at fair value and excludes finance leases, equity securities without readily determinable fair value and non-financial assets and liabilities. Substantially all of these assets are considered to be Level 3 and the vast majority of our liabilities’ fair value are considered Level 2. December 31, 2022 December 31, 2021 Carrying Estimated Carrying Estimated Assets Loans and other receivables $ 2,695 $ 2,560 $ 2,706 $ 2,853 Liabilities Borrowings (Note 10) $ 32,350 $ 31,410 $ 35,186 $ 41,207 Investment contracts (Note 12) 1,771 1,822 1,909 2,282
Fair Value of Derivative Assets	FAIR VALUE OF DERIVATIVES December 31, 2022 December 31, 2021 Gross Notional All other assets All other liabilities Gross Notional All other assets All other liabilities Currency exchange contracts $ 8,484 $ 164 $ 312 $ 7,214 $ 114 $ 122 Interest rate contracts 2,071 75 4 Derivatives accounted for as hedges $ 8,484 $ 164 $ 312 $ 9,285 $ 188 $ 126 Currency exchange contracts $ 56,950 $ 977 $ 1,118 $ 64,097 $ 794 $ 756 Interest rate contracts 43 — 1 1,369 5 1 Other contracts 914 200 20 1,674 387 10 Derivatives not accounted for as hedges $ 57,907 $ 1,178 $ 1,139 $ 67,140 $ 1,186 $ 767 Gross derivatives $ 66,392 $ 1,341 $ 1,451 $ 76,425 $ 1,374 $ 893 Netting and credit adjustments $ (859) $ (862) $ (637) $ (639) Cash collateral adjustments — — (54) (42) Net derivatives recognized in statement of financial position $ 482 $ 589 $ 684 $ 212 Net accrued interest $ — $ (4) $ 10 $ 5 Securities held as collateral — — (2) — Net amount $ 482 $ 585 $ 691 $ 217
Fair Value of Derivative Liabilities	FAIR VALUE OF DERIVATIVES December 31, 2022 December 31, 2021 Gross Notional All other assets All other liabilities Gross Notional All other assets All other liabilities Currency exchange contracts $ 8,484 $ 164 $ 312 $ 7,214 $ 114 $ 122 Interest rate contracts 2,071 75 4 Derivatives accounted for as hedges $ 8,484 $ 164 $ 312 $ 9,285 $ 188 $ 126 Currency exchange contracts $ 56,950 $ 977 $ 1,118 $ 64,097 $ 794 $ 756 Interest rate contracts 43 — 1 1,369 5 1 Other contracts 914 200 20 1,674 387 10 Derivatives not accounted for as hedges $ 57,907 $ 1,178 $ 1,139 $ 67,140 $ 1,186 $ 767 Gross derivatives $ 66,392 $ 1,341 $ 1,451 $ 76,425 $ 1,374 $ 893 Netting and credit adjustments $ (859) $ (862) $ (637) $ (639) Cash collateral adjustments — — (54) (42) Net derivatives recognized in statement of financial position $ 482 $ 589 $ 684 $ 212 Net accrued interest $ — $ (4) $ 10 $ 5 Securities held as collateral — — (2) — Net amount $ 482 $ 585 $ 691 $ 217
Effects of Derivatives on AOCI	Gain (loss) recognized in AOCI for the year ended December 31 2022 2021 2020 Cash flow hedges(a) $ (206) $ (86) $ (61) Net investment hedges(b) 230 487 (675) (a) Primarily related to currency exchange contracts. (b) The carrying value of foreign currency debt designated as net investment hedges was $3,329 million and $4,061 million at December 31, 2022 and 2021, respectively. The total reclassified from AOCI into earnings was zero, $(87) million and zero for the years ended December 31, 2022, 2021 and 2020, respectively.
Effects of Derivatives on Earnings	The table below presents the gains (losses) of our derivative financial instruments in the Statement of Earnings (Loss): 2022 2021 Revenues Debt Extinguishment Costs Interest Expense SG&A Other(a) Revenues Debt Extinguishment Costs Interest Expense SG&A Other(a) $ 76,555 $ 465 $ 1,607 $ 12,781 $ 56,766 $ 74,196 $ 6,524 $ 1,876 $ 11,716 $ 56,719 Effect of cash flow hedges $ (23) $ — $ (20) $ (2) $ (34) $ 27 $ — $ (40) $ 1 $ (67) Hedged items 127 70 1,413 Derivatives designated as hedging instruments (143) (66) (1,549) Effect of fair value hedges $ (16) $ 3 $ (135) Currency exchange contracts $ 5 $ — $ — $ (133) $ (737) $ (6) $ (16) $ (18) $ (127) $ 44 Interest rate, commodity 1 159 (4) (135) 161 1 52 (3) 183 191 Effect of derivatives not designated as hedges $ 7 $ 159 $ (4) $ (269) $ (575) $ (5) $ 35 $ (22) $ 56 $ 235 (a) Amounts are inclusive of cost of sales and other income (loss).

COMMITMENTS, GUARANTEES, PROD_2

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES (Tables)	12 Months Ended
	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Schedule of Product Warranty Liability	An analysis of changes in the liability for product warranties follows. 2022 2021 2020 Balance at January 1 $ 1,891 $ 2,054 $ 2,165 Current-year provisions(a) 1,319 862 788 Expenditures (967) (945) (913) Other changes (90) (81) 14 Balance at December 31 $ 2,153 $ 1,891 $ 2,054 (a) The increase in current-year provisions is primarily related to Renewable Energy, which was substantially all due to changes in estimates on pre-existing warranties and related to the deployment of repairs and other corrective measures.

OPERATING SEGMENTS (Tables)

OPERATING SEGMENTS (Tables)	12 Months Ended
	Dec. 31, 2022
Segment Reporting [Abstract]
Reconciliation of Revenue from Segments to Consolidated	REVENUES Total revenues Intersegment revenues External revenues Years ended December 31 2022 2021 2020 2022 2021 2020 2022 2021 2020 Aerospace $ 26,050 $ 21,310 $ 22,042 $ 660 $ 1,036 $ 1,445 $ 25,390 $ 20,274 $ 20,597 Renewable Energy 12,977 15,697 15,666 80 138 142 12,896 15,559 15,523 Power 16,262 16,903 17,589 267 345 352 15,995 16,558 17,237 HealthCare 18,461 17,725 18,009 — 1 1 18,461 17,724 18,008 Corporate 2,806 2,561 2,528 (1,008) (1,520) (1,941) 3,814 4,081 4,468 Total $ 76,555 $ 74,196 $ 75,833 $ — $ — $ — $ 76,555 $ 74,196 $ 75,833
Classification of Equipment and Services Revenues	Years ended December 31 2022 2021 2020 Equipment Services Total Equipment Services Total Equipment Services Total Aerospace $ 7,842 $ 18,207 $ 26,050 $ 7,531 $ 13,780 $ 21,310 $ 8,582 $ 13,460 $ 22,042 Renewable Energy 10,191 2,785 12,977 13,224 2,473 15,697 12,859 2,807 15,666 Power 4,737 11,526 16,262 5,035 11,868 16,903 6,707 10,883 17,589 HealthCare 9,643 8,818 18,461 9,104 8,620 17,725 9,992 8,017 18,009 Total segment revenues $ 32,413 $ 41,336 $ 73,749 $ 34,894 $ 36,741 $ 71,635 $ 38,140 $ 35,166 $ 73,306 SEGMENT REVENUES Years ended December 31 2022 2021 2020 Commercial Engines & Services $ 18,665 $ 14,360 $ 14,479 Military 4,410 4,136 4,572 Systems & Other 2,975 2,814 2,991 Aerospace $ 26,050 $ 21,310 $ 22,042 Onshore Wind $ 8,373 $ 11,026 $ 10,881 Grid Solutions equipment and services 3,086 3,207 3,585 Hydro, Offshore Wind and Hybrid Solutions 1,518 1,464 1,200 Renewable Energy $ 12,977 $ 15,697 $ 15,666 Gas Power $ 12,072 $ 12,080 $ 12,655 Steam Power 2,643 3,241 3,557 Power Conversion, Nuclear and other 1,547 1,582 1,378 Power $ 16,262 $ 16,903 $ 17,589 Healthcare Systems $ 16,489 $ 15,694 $ 15,387 Pharmaceutical Diagnostics 1,972 2,031 1,792 BioPharma — — 830 HealthCare $ 18,461 $ 17,725 $ 18,009 Total segment revenues $ 73,749 $ 71,635 $ 73,306 Corporate $ 2,806 $ 2,561 $ 2,528 Total revenues $ 76,555 $ 74,196 $ 75,833 Revenues are classified according to the region to which equipment and services are sold. For purposes of this analysis, the U.S. is presented separately from the remainder of the Americas. Year ended December 31, 2022 Aerospace Renewable Energy Power HealthCare Corporate Total U.S. $ 10,722 $ 6,265 $ 5,121 $ 8,078 $ 2,850 $ 33,036 Non-U.S. Europe 6,013 3,023 3,484 3,697 68 16,284 China region 2,154 216 1,173 2,525 (5) 6,062 Asia (excluding China region) 2,731 1,396 2,101 2,225 (129) 8,324 Americas 1,713 1,120 1,931 1,038 (14) 5,788 Middle East and Africa 2,719 956 2,453 897 36 7,060 Total Non-U.S. $ 15,328 $ 6,711 $ 11,142 $ 10,383 $ (44) $ 43,519 Total geographic revenues $ 26,050 $ 12,977 $ 16,262 $ 18,461 $ 2,806 $ 76,555 Non-U.S. revenues as a % of total revenues 59 % 52 % 69 % 56 % 57 % Year ended December 31, 2021 Aerospace Renewable Energy Power HealthCare Corporate Total U.S. $ 9,675 $ 7,275 $ 6,186 $ 7,229 $ 2,473 $ 32,838 Non-U.S. Europe 3,920 3,651 3,621 3,702 52 14,946 China region 2,419 464 1,145 2,700 16 6,744 Asia (excluding China region) 1,758 1,959 2,090 2,345 (45) 8,107 Americas 1,310 1,009 1,239 923 (4) 4,476 Middle East and Africa 2,228 1,340 2,622 826 69 7,085 Total Non-U.S. $ 11,635 $ 8,422 $ 10,717 $ 10,496 $ 88 $ 41,358 Total geographic revenues $ 21,310 $ 15,697 $ 16,903 $ 17,725 $ 2,561 $ 74,196 Non-U.S. revenues as a % of total revenues 55 % 54 % 63 % 59 % 56 % Year ended December 31, 2020 U.S. $ 11,239 $ 7,846 $ 6,186 $ 7,611 $ 2,336 $ 35,217 Non-U.S. Europe 4,288 3,047 2,895 3,952 159 14,342 China region 2,078 1,156 1,253 2,455 35 6,978 Asia (excluding China region) 1,842 1,484 2,707 2,264 (55) 8,241 Americas 882 819 1,483 879 1 4,064 Middle East and Africa 1,713 1,314 3,064 848 52 6,991 Total Non-U.S. $ 10,803 $ 7,820 $ 11,403 $ 10,398 $ 192 $ 40,616 Total geographic revenues $ 22,042 $ 15,666 $ 17,589 $ 18,009 $ 2,528 $ 75,833 Non-U.S. revenues as a % of total revenues 49 % 50 % 65 % 58 % 54 %
Reconciliation of Profit and Earnings	PROFIT AND EARNINGS For the years ended December 31 2022 2021 2020 Aerospace $ 4,775 $ 2,882 $ 1,229 Renewable Energy (2,240) (795) (715) Power 1,217 726 274 HealthCare 2,705 2,966 3,060 Total segment profit (loss) 6,456 5,778 3,848 Corporate(a) (3,413) 892 8,061 Interest and other financial charges (1,552) (1,813) (2,018) Debt extinguishment costs (465) (6,524) (301) Non-operating benefit income (cost) 532 (1,782) (2,430) Goodwill impairments — — (877) Benefit (provision) for income taxes (689) 124 333 Preferred stock dividends (289) (237) (474) Earnings (loss) from continuing operations attributable to GE common shareholders 581 (3,562) 6,141 Earnings (loss) from discontinued operations attributable to GE common shareholders (644) (3,195) (911) Net earnings (loss) attributable to GE common shareholders $ (64) $ (6,757) $ 5,230 (a) Includes interest and other financial charges of $54 million, $63 million and $50 million and benefit for income taxes of $213 million, $162 million and $154 million related to EFS within Corporate for the years ended December 31, 2022, 2021, and 2020, respectively.
Assets, PPE Additions, and Depreciation and Amortization	Assets Property, plant and Depreciation and amortization At December 31 For the years ended December 31 For the years ended December 31 2022 2021 2020 2022 2021 2020 2022 2021 2020 Aerospace $ 39,243 $ 38,298 $ 38,634 $ 543 $ 445 $ 737 $ 1,037 $ 1,074 $ 1,142 Renewable Energy 15,719 14,804 15,927 275 349 302 412 432 413 Power 22,173 23,569 24,453 210 189 245 506 692 749 HealthCare 26,070 24,770 22,229 310 278 256 640 641 628 Corporate(b)(c) 81,692 94,256 114,220 34 25 40 948 168 531 Total continuing $ 184,896 $ 195,697 $ 215,463 $ 1,371 $ 1,286 $ 1,579 $ 3,543 $ 3,009 $ 3,464 (a) Additions to property, plant and equipment include amounts relating to principal businesses purchased. (b) Depreciation and amortization included the Steam asset sale impairment in the first quarter of 2022. (c) Included deferred income taxes that are presented as assets for purposes of our Statement of Financial Position presentation.
Assets by Geographic Areas	We classify certain assets that cannot meaningfully be associated with specific geographic areas as “Other Global” for this purpose. December 31 2022 2021 U.S. $ 126,005 $ 130,956 Non-U.S. Europe 36,603 42,213 Asia 11,317 11,534 Americas 6,405 6,406 Other Global 4,566 4,588 Total Non-U.S. $ 58,892 $ 64,741 Total assets (Continuing operations) $ 184,896 $ 195,697

SUMMARIZED FINANCIAL INFORMAT_2

SUMMARIZED FINANCIAL INFORMATION (Tables)	12 Months Ended
	Dec. 31, 2022
Equity Method Investments and Joint Ventures [Abstract]
Associated Companies Summarized Financial Information	Summarized financial information of Baker Hughes is as follows. For the years ended December 31 2022(a) 2021(b) 2020 Revenues $ — $ 16,997 $ 20,705 Gross Profit — 3,276 3,199 Net income (loss) — (546) (15,761) Net income (loss) attributable to the entity — (407) (9,940) (a) As of November 3, 2021, our investment in BKR reduced below 20%, and as a result, we no longer have significant influence. (b) Financial information is from January 1, 2021 to November 3, 2021 (date investment in BKR reduced below 20%). For the year ended December 31 2022(a) Revenues $ 6,627 Net income (loss) (1,128) Net income (loss) attributable to the entity (1,132) (a) As we are unable to obtain monthly financial data for AerCap to match the exact period of ownership, we reported summarized financial information for AerCap starting October 1, 2021 instead of November 1, 2021. As of December 31 2022(a) Flight equipment held for operating leases, net $ 54,611 Other 15,200 Total assets $ 69,811 Debt $ 47,350 Other 6,817 Total liabilities $ 54,167 Noncontrolling interests $ 77 (a) Financial information is from September 30, 2022. For the years ended December 31 2022 2021 2020 Revenues $ 23,317 $ 17,118 $ 15,931 Gross Profit 312 284 359 Net income (loss) 249 (123) 327 Net income (loss) attributable to the entity 237 (140) 312 As of December 31 2022 2021 Current assets $ 13,328 $ 8,845 Total assets $ 14,327 $ 9,941 Current liabilities $ 12,828 $ 8,435 Total liabilities $ 12,887 $ 8,470 Noncontrolling interests $ 153 $ 147

QUARTERLY INFORMATION (UNAUDI_2

QUARTERLY INFORMATION (UNAUDITED) (Tables)	12 Months Ended
	Dec. 31, 2022
Quarterly Financial Information Disclosure [Abstract]
Quarterly Information	First quarter Second quarter Third quarter Fourth quarter (Per-share amounts in dollars) 2022 2021 2022 2021 2022 2021 2022 2021 Total revenues $ 17,040 $ 17,071 $ 18,646 $ 18,253 $ 19,084 $ 18,569 $ 21,786 $ 20,303 Sales of equipment and services 16,272 16,316 17,880 17,470 18,438 17,813 21,011 19,492 Cost of equipment and services sold 12,453 12,538 13,244 13,618 14,371 13,401 15,467 14,338 Earnings (loss) from continuing operations (729) 97 (561) (571) (76) 582 2,302 (3,504) Earnings (loss) from discontinued operations (286) (2,894) (210) (564) (85) 602 (64) (339) Net earnings (loss) (1,014) (2,798) (771) (1,135) (160) 1,184 2,238 (3,843) Less net earnings (loss) attributable to noncontrolling interests 28 5 19 (3) 4 (73) 16 1 Net earnings (loss) attributable to the Company $ (1,042) $ (2,802) $ (790) $ (1,131) $ (165) $ 1,257 $ 2,222 $ (3,843) Per-share amounts – earnings (loss) from continuing operations Diluted earnings (loss) per share $ (0.74) $ 0.02 $ (0.59) $ (0.57) $ (0.14) $ 0.54 $ 1.99 $ (3.24) Basic earnings (loss) per share (0.74) 0.02 (0.59) (0.57) (0.14) 0.54 2.01 (3.24) Per-share amounts – earnings (loss) from discontinued operations Diluted earnings (loss) per share (0.26) (2.63) (0.19) (0.51) (0.08) 0.54 (0.06) (0.31) Basic earnings (loss) per share (0.26) (2.64) (0.19) (0.51) (0.08) 0.55 (0.06) (0.31) Per-share amounts – net earnings (loss) Diluted earnings (loss) per share (0.99) (2.61) (0.78) (1.08) (0.21) 1.08 1.93 (3.55) Basic earnings (loss) per share (0.99) (2.62) (0.78) (1.08) (0.21) 1.09 1.95 (3.55) Dividends declared 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08

BASIS OF PRESENTATION AND SUM_3

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenues from Sale of Services (Details)	12 Months Ended
	Dec. 31, 2022
Minimum | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01
Revenue from External Customer [Line Items]
Performance obligations expected to be satisfied, expected timing	5 years
Maximum | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01
Revenue from External Customer [Line Items]
Performance obligations expected to be satisfied, expected timing	25 years
Satisfied Over Time
Revenue from External Customer [Line Items]
Performance obligation, description of timing	5 to 25 years

BASIS OF PRESENTATION AND SUM_4

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Collaborative Arrangements (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenue from External Customer [Line Items]
Cost of sales	$ 15,467	$ 14,371	$ 13,244	$ 12,453	$ 14,338	$ 13,401	$ 13,618	$ 12,538
Services
Revenue from External Customer [Line Items]
Cost of sales									$ 25,109	$ 22,497	$ 22,629
Equipment
Revenue from External Customer [Line Items]
Cost of sales									30,426	31,399	35,242
Collaborative Arrangement | Services
Revenue from External Customer [Line Items]
Cost of sales									2,898	2,125	2,407
Collaborative Arrangement | Equipment
Revenue from External Customer [Line Items]
Cost of sales									$ 658	$ 751	$ 1,093

BASIS OF PRESENTATION AND SUM_5

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Cash, Cash Equivalents and Restricted Cash (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Accounting Policies [Abstract]
Restricted cash	$ 745	$ 317

BASIS OF PRESENTATION AND SUM_6

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounting Changes (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Jan. 01, 2021	Dec. 31, 2020	Dec. 31, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Shareholders' equity decrease	$ (37,582)	$ (41,612)		$ (37,073)
Accumulated other comprehensive income (loss)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Shareholders' equity decrease	1,311	(1,582)		9,749	$ 11,732
Retained earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Shareholders' equity decrease	(84,693)	(85,110)		(92,247)	(87,732)
Cumulative effect adjustment | Retained earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Shareholders' equity decrease		$ 0		$ 0	$ 175
Cumulative effect adjustment | Pro forma | Minimum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Shareholders' equity decrease	3,000		$ 7,000
Cumulative effect adjustment | Pro forma | Minimum | Accumulated other comprehensive income (loss)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Shareholders' equity decrease			5,500
Cumulative effect adjustment | Pro forma | Minimum | Retained earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Shareholders' equity decrease			1,500
Cumulative effect adjustment | Pro forma | Maximum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Shareholders' equity decrease	$ 4,000		8,000
Cumulative effect adjustment | Pro forma | Maximum | Accumulated other comprehensive income (loss)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Shareholders' equity decrease			6,000
Cumulative effect adjustment | Pro forma | Maximum | Retained earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Shareholders' equity decrease			$ 2,000

BUSINESSES HELD FOR SALE AND _3

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS - Assets Held for Sale Narrative (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2021	Dec. 31, 2020	Mar. 31, 2020
Held for sale, not discontinued operation
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Assets of businesses held for sale	$ 1,374	$ 0	$ 0
Liabilities of businesses held for sale	1,944	0	0
Held for sale, not discontinued operation | Captive industrial insurance subsidiary
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Assets of businesses held for sale	638
Liabilities of businesses held for sale	372
Pre-tax gain (loss) on sale	$ (17)
Disposed of by sale, not discontinued operations | Boiler manufacturing business
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Pre-tax gain (loss) on sale		$ (170)	$ (170)
Disposed of by sale, not discontinued operations | BioPharma
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Pre-tax gain (loss) on sale				$ 12,362
Consideration					$ 21,112
Cash payments associated with transaction				185
Gain (loss) on sale, after tax				$ 11,213

BUSINESSES HELD FOR SALE AND _4

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS - Financial Information for Assets and Liabilities of Businesses Held for Sale (Details) - Held for sale, not discontinued operation - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Assets
Current receivables, inventories and contract assets	$ 495	$ 0
Non-current captive insurance investment securities	554	0
Property, plant and equipment and intangible assets - net	232	0
All other assets	94	0
Assets of businesses held for sale	1,374	0
Liabilities
Progress collections and deferred income	1,127	0
Insurance liabilities and annuity benefits	358	0
Accounts payable, equipment project payables and all other liabilities	458	0
Liabilities of businesses held for sale	$ 1,944	$ 0

BUSINESSES HELD FOR SALE AND _5

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS - Discontinued Operations Narrative (Details) - Discontinued operations - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gain (loss) on disposal, net of taxes			$ 196	$ (3,855)	$ (32)
Financing receivables held for sale (Polish mortgage portfolio)		$ 1,799	$ 1,199	1,799
Bank BPH
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Percentage indexed to or denominated in foreign currencies			85%
Financing receivables held for sale (Polish mortgage portfolio)			$ 1,199
Pre-tax non-cash charges			720	509	121
Capital contribution	$ 530	$ 360
GECAS
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gain (loss) on disposal, net of taxes			121	$ (3,882)	$ 0
Discontinued operations after disposal, cash paid			48
GECAS | AerCap
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Discontinued operations after disposal, sales of product and services			162
Discontinued operations after disposal, purchases of products and services			$ 174

BUSINESSES HELD FOR SALE AND _6

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS - Financial Information for Discontinued Operations (Details) - USD ($)	3 Months Ended								12 Months Ended
	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
RESULTS OF DISCONTINUED OPERATIONS
Earnings (loss) from discontinued operations, net of taxes	$ (64,000,000)	$ (85,000,000)	$ (210,000,000)	$ (286,000,000)	$ (339,000,000)	$ 602,000,000	$ (564,000,000)	$ (2,894,000,000)	$ (644,000,000)	$ (3,195,000,000)	$ (911,000,000)
Discontinued operations
RESULTS OF DISCONTINUED OPERATIONS
Total revenues									0	0	0
Cost of equipment and services sold									0	(398,000,000)	(2,555,000,000)
Other income, costs and expenses									(808,000,000)	1,393,000,000	1,586,000,000
Earnings (loss) of discontinued operations before income taxes									(808,000,000)	995,000,000	(968,000,000)
Benefit (provision) for income taxes									(32,000,000)	(335,000,000)	89,000,000
Earnings (loss) of discontinued operations, net of taxes									(841,000,000)	660,000,000	(879,000,000)
Gain (loss) on disposal before income taxes									58,000,000	(3,246,000,000)	(31,000,000)
Benefit (provision) for income taxes									139,000,000	(608,000,000)	(1,000,000)
Gain (loss) on disposal, net of taxes									196,000,000	(3,855,000,000)	(32,000,000)
Earnings (loss) from discontinued operations, net of taxes									(644,000,000)	(3,195,000,000)	(911,000,000)
Assets
Cash, cash equivalents and restricted cash	1,176,000,000				736,000,000				1,176,000,000	736,000,000
Financing receivables held for sale (Polish mortgage portfolio)	1,199,000,000				1,799,000,000				1,199,000,000	1,799,000,000
Property, plant, and equipment - net	73,000,000				88,000,000				73,000,000	88,000,000
All other assets	444,000,000				554,000,000				444,000,000	554,000,000
Assets of businesses held for sale	2,892,000,000				3,177,000,000				2,892,000,000	3,177,000,000
Liabilities
Accounts payable, equipment project payables and all other liabilities	1,137,000,000				887,000,000				1,137,000,000	887,000,000
Liabilities of businesses held for sale	$ 1,137,000,000				$ 887,000,000				1,137,000,000	887,000,000
Discontinued operations | GECAS
RESULTS OF DISCONTINUED OPERATIONS
Total revenues									0	0	0
Cost of equipment and services sold									0	(398,000,000)	(2,555,000,000)
Other income, costs and expenses									0	1,992,000,000	1,781,000,000
Earnings (loss) of discontinued operations before income taxes									0	1,594,000,000	(773,000,000)
Benefit (provision) for income taxes									0	(258,000,000)	(13,000,000)
Earnings (loss) of discontinued operations, net of taxes									0	1,336,000,000	(786,000,000)
Gain (loss) on disposal before income taxes									(18,000,000)	(3,312,000,000)	0
Benefit (provision) for income taxes									139,000,000	(570,000,000)	0
Gain (loss) on disposal, net of taxes									121,000,000	(3,882,000,000)	0
Earnings (loss) from discontinued operations, net of taxes									121,000,000	(2,546,000,000)	(786,000,000)
Depreciation and amortization									0	359,000,000	2,545,000,000
Discontinued operations | Bank BPH & Other
RESULTS OF DISCONTINUED OPERATIONS
Total revenues									0	0	0
Cost of equipment and services sold									0	0	0
Other income, costs and expenses									(808,000,000)	(599,000,000)	(195,000,000)
Earnings (loss) of discontinued operations before income taxes									(808,000,000)	(599,000,000)	(195,000,000)
Benefit (provision) for income taxes									(32,000,000)	(77,000,000)	101,000,000
Earnings (loss) of discontinued operations, net of taxes									(841,000,000)	(676,000,000)	(93,000,000)
Gain (loss) on disposal before income taxes									75,000,000	65,000,000	(31,000,000)
Benefit (provision) for income taxes									0	(38,000,000)	(1,000,000)
Gain (loss) on disposal, net of taxes									75,000,000	27,000,000	(32,000,000)
Earnings (loss) from discontinued operations, net of taxes									$ (765,000,000)	$ (648,000,000)	$ (125,000,000)

INVESTMENT SECURITIES - Narrati

INVESTMENT SECURITIES - Narrative (Details) - USD ($) shares in Millions, $ in Millions		3 Months Ended	12 Months Ended
	Nov. 01, 2021	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Accrued interest, current			$ 457	$ 415
Accrued interest, current, statement of financial position			All other current assets (Note 9)	All other current assets (Note 9)
Debt securities in unrealized loss position, total			$ 21,482	$ 3,446
Debt securities in unrealized loss position, 12 months or more			3,275	644
Gross unrealized losses, 12 months or more			(835)	(42)
Gross unrealized losses			(3,143)	(92)
Net unrealized gains (losses) recorded to earnings			(65)	1,656	$ (1,670)
Proceeds from investment securities sales and early redemptions by issuers			7,268	6,666	5,060
Debt securities, realized gain			34	69	173
Debt securities, realized losses and impairments			(42)	(11)	(68)
Equity securities without readily determinable fair values			731	441
Fair value adjustments, including impairment			(11)	46	(141)
Assets held by insurance regulators			800
Assets held in trust accounts, reinsurance agreements			29,700
Subsequent event | Forecast
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Increase in funds held in trust accounts		$ 2,300
AerCap
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Net unrealized gains (losses) recorded to earnings			$ (865)	711	$ 0
Baker Hughes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities, ownership percentage			1%
Equity securities, remaining interest (in shares)			7
Discontinued operations | GECAS | AerCap
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Consideration, stock transaction (in shares)	111.5
Equity securities, ownership percentage	46%
U.S. corporate
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Gross unrealized losses			$ (2,164)	$ (33)
CMBS
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Gross unrealized losses			(182)
Asset-backed securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Gross unrealized losses			$ (106)

INVESTMENT SECURITIES - Schedul

INVESTMENT SECURITIES - Schedule of Investment Securities (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Debt and Equity Securities, FV-NI [Line Items]
Current equity, amortized cost	$ 0	$ 0
Current equity, estimated fair value	7,609	12,297
Gross unrealized gains	781	6,639
Gross unrealized losses	(3,143)	(92)
Other equity	429	443
Non-current investment securities, amortized cost	38,410	35,662
Non-current investment securities, estimated fair value	36,048	42,209
AerCap
Debt and Equity Securities, FV-NI [Line Items]
Current equity, amortized cost	0	0
Current equity, estimated fair value	7,403	8,287
Baker Hughes
Debt and Equity Securities, FV-NI [Line Items]
Current equity, amortized cost	0	0
Current equity, estimated fair value	207	4,010
U.S. corporate
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost, excluding accrued interest	26,921	25,182
Gross unrealized gains	675	5,502
Gross unrealized losses	(2,164)	(33)
Estimated fair value	25,432	30,652
Non-U.S. corporate
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost, excluding accrued interest	2,548	2,361
Gross unrealized gains	18	343
Gross unrealized losses	(300)	(4)
Estimated fair value	2,266	2,701
State and municipal
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost, excluding accrued interest	2,898	2,639
Gross unrealized gains	66	573
Gross unrealized losses	(241)	(6)
Estimated fair value	2,722	3,205
Mortgage and asset-backed
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost, excluding accrued interest	4,442	3,950
Gross unrealized gains	21	117
Gross unrealized losses	(290)	(47)
Estimated fair value	4,173	4,019
Government and agencies
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost, excluding accrued interest	1,172	1,086
Gross unrealized gains	2	104
Gross unrealized losses	(147)	(2)
Estimated fair value	$ 1,026	$ 1,188

INVESTMENT SECURITIES - Net (Pu

INVESTMENT SECURITIES - Net (Purchases) Dispositions of Investment Securities (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Investments, Debt and Equity Securities [Abstract]
Purchases of investment securities	$ (4,046)	$ (4,286)
Dispositions and maturities of investment securities	3,170	2,997
Net (purchases) dispositions of insurance investment securities	$ (876)	$ (1,290)	$ (1,352)

INVESTMENT SECURITIES - Contrac

INVESTMENT SECURITIES - Contractual Maturities (Details) $ in Millions	Dec. 31, 2022 USD ($)
Amortized cost
Within one year	$ 413
After one year through five years	4,287
After five years through ten years	5,910
After ten years	22,928
Estimated fair value
Within one year	409
After one year through five years	4,247
After five years through ten years	5,869
After ten years	$ 20,920

CURRENT AND LONG-TERM RECEIVA_3

CURRENT AND LONG-TERM RECEIVABLES - Schedule of Current Receivables (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Customer receivables	$ 14,916	$ 13,079
Revenue sharing program receivables	1,326	1,166
Non-income based tax receivables	1,320	1,222
Supplier advances	711	596
Receivables from disposed businesses	115	148
Other sundry receivables	447	483
Allowance for credit losses	(859)	(1,074)
Total current receivables	17,976	15,620
Increase in allowance for credit losses	48
Operating segments | Aerospace
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total current receivables	7,784	5,812
Operating segments | Renewable Energy
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total current receivables	2,415	2,218
Operating segments | Power
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total current receivables	4,229	4,092
Operating segments | HealthCare
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total current receivables	3,354	3,255
Corporate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total current receivables	$ 195	$ 244

CURRENT AND LONG-TERM RECEIVA_4

CURRENT AND LONG-TERM RECEIVABLES - Sales of Current Customer Receivables (Details) - Current receivables - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Third Parties
Movement in Accounts Receivable from Securitization [Roll Forward]
Balance at beginning of period	$ 161	$ 2,992
GE business sales	2,061	1,415
WCS sales to third parties	0	10,816
Collections and other	(2,163)	(15,062)
Reclassification from long-term customer receivables	41	0
Balance at end of period	100	161
WCS
Movement in Accounts Receivable from Securitization [Roll Forward]
Balance at beginning of period	$ 0	3,618
GE business sales		13,773
WCS sales to third parties		(10,816)
Collections and other		(6,676)
Reclassification from long-term customer receivables		100
Balance at end of period		$ 0

CURRENT AND LONG-TERM RECEIVA_5

CURRENT AND LONG-TERM RECEIVABLES - Schedule of Long-term Receivables (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Long-term customer receivables	$ 535	$ 521
Financing receivables	386	592
Supplier advances	277	309
Non-income based tax receivables	241	245
Receivables from disposed businesses	51	150
Sundry receivables	406	440
Allowance for credit losses	(223)	(160)
Total long-term receivables	1,672	2,097
Third Parties
Accounts, Notes, Loans and Financing Receivable [Line Items]
Sale of long term customer receivables	$ 86	$ 53

INVENTORIES, INCLUDING DEFERR_3

INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Inventory Disclosure [Abstract]
Raw materials and work in process	$ 10,356	$ 8,710
Finished goods	5,030	4,927
Deferred inventory costs	2,017	2,210
Inventories, including deferred inventory costs	$ 17,403	$ 15,847

PROPERTY, PLANT AND EQUIPMENT_3

PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES - Schedule of Property, Plant and Equipment and Depreciable Lives (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Original Cost	$ 31,633	$ 31,904
Right-of-use operating lease assets	2,137	2,606
Property, plant and equipment – net	$ 14,478	$ 15,609
Operating Lease, Right-of-Use Asset, Statement of Financial Position	Property, plant and equipment – net	Property, plant and equipment – net
Land and improvements
Property, Plant and Equipment [Line Items]
Depreciable lives	8 years
Original Cost	$ 542	$ 585
Net Carrying Value	530	576
Buildings, structures and related equipment
Property, Plant and Equipment [Line Items]
Original Cost	7,913	8,311
Net Carrying Value	$ 3,483	3,728
Buildings, structures and related equipment | Minimum
Property, Plant and Equipment [Line Items]
Depreciable lives	8 years
Buildings, structures and related equipment | Maximum
Property, Plant and Equipment [Line Items]
Depreciable lives	40 years
Machinery and equipment
Property, Plant and Equipment [Line Items]
Original Cost	$ 21,119	21,036
Net Carrying Value	$ 6,913	7,356
Machinery and equipment | Minimum
Property, Plant and Equipment [Line Items]
Depreciable lives	4 years
Machinery and equipment | Maximum
Property, Plant and Equipment [Line Items]
Depreciable lives	20 years
Leasehold costs and manufacturing plant under construction
Property, Plant and Equipment [Line Items]
Original Cost	$ 2,059	1,971
Net Carrying Value	$ 1,415	$ 1,343
Leasehold costs and manufacturing plant under construction | Minimum
Property, Plant and Equipment [Line Items]
Depreciable lives	1 year
Leasehold costs and manufacturing plant under construction | Maximum
Property, Plant and Equipment [Line Items]
Depreciable lives	10 years

PROPERTY, PLANT AND EQUIPMENT_4

PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	All other liabilities (Note 14)	All other liabilities (Note 14)
Operating lease liabilities	$ 2,393	$ 2,848
Remaining lease terms	11 years
Power
Property, Plant and Equipment [Line Items]
Pre-tax impairment charges	$ 59

PROPERTY, PLANT AND EQUIPMENT_5

PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES - Operating Lease Expense (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Abstract]
Long-term (fixed)	$ 755	$ 770	$ 827
Long-term (variable)	147	119	143
Short-term	153	192	206
Total operating lease expense	$ 1,055	$ 1,081	$ 1,176

PROPERTY, PLANT AND EQUIPMENT_6

PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES - Maturity of Lease Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
2023	$ 687
2024	567
2025	397
2026	291
2027	206
Thereafter	603
Total undiscounted lease payments	2,751
Less: imputed interest	(357)
Operating lease liabilities	$ 2,393	$ 2,848

PROPERTY, PLANT AND EQUIPMENT_7

PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES - Supplemental Information Related to Operating Leases (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Abstract]
Operating cash flows used for operating leases	$ 790	$ 834	$ 835
Right-of-use assets obtained in exchange for new lease liabilities	$ 526	$ 603	$ 594
Weighted-average remaining lease term	6 years 2 months 12 days	7 years 2 months 12 days	6 years 8 months 12 days
Weighted-average discount rate	3.80%	4%	4.60%

ACQUISITIONS, GOODWILL AND OT_3

ACQUISITIONS, GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details) $ in Millions		12 Months Ended
	Dec. 21, 2021 USD ($)	Dec. 31, 2022 USD ($) reporting_unit	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Goodwill [Line Items]
Goodwill		$ 25,798	$ 26,182	$ 25,524
Number of reporting units impaired | reporting_unit		2
Increase (decrease) in intangible assets		$ (1,705)
Addition of intangible assets		214
Amortization of intangible assets		$ 1,742	1,138	1,336
Impairment, intangible asset, statement of income location		Selling, general and administrative expenses
Weighted-average amortizable period (in years)		7 years 1 month 6 days
Capitalized software and patents and technology
Goodwill [Line Items]
Addition of intangible assets		$ 209
Capitalized software
Goodwill [Line Items]
Addition of intangible assets		$ 172
Weighted-average amortizable period (in years)		5 years 10 months 24 days
Corporate
Goodwill [Line Items]
Goodwill		$ 818	914	876
Corporate | Digital
Goodwill [Line Items]
Goodwill		$ 818
Percentage of fair value in excess of carrying amount		16%
Operating segments | Healthcare Segment | BK Medical
Goodwill [Line Items]
Business acquisition, consideration	$ 1,455
Goodwill	997
Amortizable intangible assets acquired	398
Indefinite lived intangible assets	$ 23
Operating segments | Aerospace
Goodwill [Line Items]
Goodwill		$ 8,835	9,013	9,247
Operating segments | Aerospace | Additive
Goodwill [Line Items]
Goodwill		$ 239
Percentage of fair value in excess of carrying amount		21%
Operating segments | Power
Goodwill [Line Items]
Goodwill		$ 144	$ 145	$ 146
Non-cash pre-tax impairment charge		$ 765

ACQUISITIONS, GOODWILL AND OT_4

ACQUISITIONS, GOODWILL AND OTHER INTANGIBLE ASSETS - Changes in Goodwill Balances (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Goodwill
Balance at beginning of period	$ 26,182	$ 25,524
Acquisitions		1,106
Dispositions	(6)
Currency exchange and other	(378)	(448)
Balance at end of period	25,798	26,182
Operating segments | Aerospace
Goodwill
Balance at beginning of period	9,013	9,247
Acquisitions		0
Dispositions	(6)
Currency exchange and other	(171)	(234)
Balance at end of period	8,835	9,013
Operating segments | Renewable Energy
Goodwill
Balance at beginning of period	3,231	3,401
Acquisitions		0
Dispositions	0
Currency exchange and other	(30)	(169)
Balance at end of period	3,201	3,231
Operating segments | Power
Goodwill
Balance at beginning of period	145	146
Acquisitions		0
Dispositions	0
Currency exchange and other	(1)	(1)
Balance at end of period	144	145
Operating segments | HealthCare
Goodwill
Balance at beginning of period	12,879	11,855
Acquisitions		1,064
Dispositions	0
Currency exchange and other	(80)	(40)
Balance at end of period	12,799	12,879
Corporate
Goodwill
Balance at beginning of period	914	876
Acquisitions		43
Dispositions	0
Currency exchange and other	(96)	(4)
Balance at end of period	$ 818	$ 914

ACQUISITIONS, GOODWILL AND OT_5

ACQUISITIONS, GOODWILL AND OTHER INTANGIBLE ASSETS - Intangible Assets Subject to Amortization (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 20,202	$ 21,205
Accumulated amortization	(12,639)	(11,923)
Total finite intangible assets, net	7,563	9,282
Total other intangible assets, net	7,625	9,330
Operating segments | Aerospace
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Total other intangible assets, net	4,748	5,019
Operating segments | Renewable Energy
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Total other intangible assets, net	183	229
Operating segments | Power
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Total other intangible assets, net	958	1,965
Operating segments | HealthCare
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Total other intangible assets, net	1,520	1,847
Corporate
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Total other intangible assets, net	216	271
Customer-related
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Gross carrying amount	6,063	6,400
Accumulated amortization	(3,475)	(3,250)
Total finite intangible assets, net	$ 2,587	3,150
Customer-related | Minimum
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Useful lives (in years)	3 years
Customer-related | Maximum
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Useful lives (in years)	15 years
Patents and technology
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 8,432	8,592
Accumulated amortization	(5,018)	(4,361)
Total finite intangible assets, net	$ 3,415	4,230
Patents and technology | Minimum
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Useful lives (in years)	5 years
Patents and technology | Maximum
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Useful lives (in years)	15 years
Capitalized software
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 5,288	5,764
Accumulated amortization	(3,824)	(3,999)
Total finite intangible assets, net	$ 1,464	1,765
Capitalized software | Minimum
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Useful lives (in years)	3 years
Capitalized software | Maximum
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Useful lives (in years)	10 years
Trademarks & other
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 419	449
Accumulated amortization	(322)	(313)
Total finite intangible assets, net	$ 97	$ 136
Trademarks & other | Minimum
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Useful lives (in years)	2 years
Trademarks & other | Maximum
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Useful lives (in years)	50 years

ACQUISITIONS, GOODWILL AND OT_6

ACQUISITIONS, GOODWILL AND OTHER INTANGIBLE ASSETS - Estimated 5 Year Amortization (Details) $ in Millions	Dec. 31, 2022 USD ($)
Estimated annual pre-tax amortization
2023	$ 1,025
2024	919
2025	848
2026	751
2027	$ 648

CONTRACT AND OTHER DEFERRED A_3

CONTRACT AND OTHER DEFERRED ASSETS & PROGRESS COLLECTIONS AND DEFERRED INCOME - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Capitalized Contract Cost [Line Items]
Increase (decrease) in contract and other deferred assets	$ (1,907)
Increase (decrease) in progress collections and deferred income due to timing of revenue recognition	763
Revenue recognized included in contract liability	13,863	$ 14,884
Long-term | Services
Capitalized Contract Cost [Line Items]
Increase (decrease) due to billings	(11,665)
Revenues recognized	9,680
Long-term | Services | Aerospace
Capitalized Contract Cost [Line Items]
Net favorable (unfavorable) change in estimated profitability	85
Long-term | Services | Power
Capitalized Contract Cost [Line Items]
Net favorable (unfavorable) change in estimated profitability	$ 303

CONTRACT AND OTHER DEFERRED A_4

CONTRACT AND OTHER DEFERRED ASSETS & PROGRESS COLLECTIONS AND DEFERRED INCOME - Schedule of Contract Assets (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current contract assets	$ 3,088	$ 4,881
Nonrecurring engineering costs	2,563	2,550
Customer advances and other	3,447	3,574
Non-current contract and other deferred assets	6,010	6,124
Total contract and other deferred assets	9,098	11,005
Services | Long-term
Accounts, Notes, Loans and Financing Receivable [Line Items]
Revenues in excess of billings	7,766	7,972
Billings in excess of revenues	(8,443)	(7,346)
Long-term service agreements	(677)	627
Services | Short-term
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current contract assets	973	928
Equipment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current contract assets	2,792	3,326
Operating segments | Aerospace
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current contract assets	(3,884)	(2,881)
Nonrecurring engineering costs	2,513	2,479
Customer advances and other	2,519	2,620
Non-current contract and other deferred assets	5,032	5,099
Total contract and other deferred assets	1,148	2,218
Operating segments | Aerospace | Services | Long-term
Accounts, Notes, Loans and Financing Receivable [Line Items]
Revenues in excess of billings	2,363	2,478
Billings in excess of revenues	(6,681)	(5,731)
Long-term service agreements	(4,318)	(3,253)
Operating segments | Aerospace | Services | Short-term
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current contract assets	391	340
Operating segments | Aerospace | Equipment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current contract assets	42	33
Operating segments | Renewable Energy
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current contract assets	1,063	1,384
Nonrecurring engineering costs	17	28
Customer advances and other	0	0
Non-current contract and other deferred assets	17	28
Total contract and other deferred assets	1,079	1,412
Operating segments | Renewable Energy | Services | Long-term
Accounts, Notes, Loans and Financing Receivable [Line Items]
Revenues in excess of billings	0	0
Billings in excess of revenues	0	0
Long-term service agreements	0	0
Operating segments | Renewable Energy | Services | Short-term
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current contract assets	108	87
Operating segments | Renewable Energy | Equipment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current contract assets	955	1,297
Operating segments | Power
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current contract assets	5,044	5,669
Nonrecurring engineering costs	4	12
Customer advances and other	724	801
Non-current contract and other deferred assets	728	813
Total contract and other deferred assets	5,772	6,482
Operating segments | Power | Services | Long-term
Accounts, Notes, Loans and Financing Receivable [Line Items]
Revenues in excess of billings	5,403	5,495
Billings in excess of revenues	(1,763)	(1,614)
Long-term service agreements	3,640	3,880
Operating segments | Power | Services | Short-term
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current contract assets	56	80
Operating segments | Power | Equipment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current contract assets	1,348	1,709
Operating segments | HealthCare
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current contract assets	621	453
Nonrecurring engineering costs	30	31
Customer advances and other	204	154
Non-current contract and other deferred assets	234	184
Total contract and other deferred assets	854	637
Operating segments | HealthCare | Services | Long-term
Accounts, Notes, Loans and Financing Receivable [Line Items]
Revenues in excess of billings	0	0
Billings in excess of revenues	0	0
Long-term service agreements	0	0
Operating segments | HealthCare | Services | Short-term
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current contract assets	174	166
Operating segments | HealthCare | Equipment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current contract assets	447	287
Corporate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current contract assets	245	256
Nonrecurring engineering costs	0	0
Customer advances and other	0	0
Non-current contract and other deferred assets	0	0
Total contract and other deferred assets	245	256
Corporate | Services | Long-term
Accounts, Notes, Loans and Financing Receivable [Line Items]
Revenues in excess of billings	0	0
Billings in excess of revenues	0	0
Long-term service agreements	0	0
Corporate | Services | Short-term
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current contract assets	245	256
Corporate | Equipment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current contract assets	$ 0	$ 0

CONTRACT AND OTHER DEFERRED A_5

CONTRACT AND OTHER DEFERRED ASSETS & PROGRESS COLLECTIONS AND DEFERRED INCOME - Progress Collections and Deferred Income (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Capitalized Contract Cost [Line Items]
Current deferred income	$ 1,952	$ 1,835
Progress collections and deferred income	18,118	17,372
Non-current deferred income	2,006	1,989
Total Progress collections and deferred income	20,124	19,361
Equipment
Capitalized Contract Cost [Line Items]
Progress collections	6,511	7,183
Other
Capitalized Contract Cost [Line Items]
Progress collections	9,654	8,354
Operating segments | Aerospace
Capitalized Contract Cost [Line Items]
Current deferred income	233	170
Progress collections and deferred income	6,047	4,782
Non-current deferred income	1,110	1,090
Total Progress collections and deferred income	7,157	5,871
Operating segments | Aerospace | Equipment
Capitalized Contract Cost [Line Items]
Progress collections	74	142
Operating segments | Aerospace | Other
Capitalized Contract Cost [Line Items]
Progress collections	5,740	4,469
Operating segments | Renewable Energy
Capitalized Contract Cost [Line Items]
Current deferred income	208	198
Progress collections and deferred income	5,404	4,907
Non-current deferred income	183	194
Total Progress collections and deferred income	5,586	5,101
Operating segments | Renewable Energy | Equipment
Capitalized Contract Cost [Line Items]
Progress collections	2,464	1,843
Operating segments | Renewable Energy | Other
Capitalized Contract Cost [Line Items]
Progress collections	2,731	2,866
Operating segments | Power
Capitalized Contract Cost [Line Items]
Current deferred income	13	33
Progress collections and deferred income	4,527	5,615
Non-current deferred income	104	110
Total Progress collections and deferred income	4,632	5,725
Operating segments | Power | Equipment
Capitalized Contract Cost [Line Items]
Progress collections	3,973	5,198
Operating segments | Power | Other
Capitalized Contract Cost [Line Items]
Progress collections	541	385
Operating segments | HealthCare
Capitalized Contract Cost [Line Items]
Current deferred income	1,391	1,336
Progress collections and deferred income	1,902	1,858
Non-current deferred income	597	592
Total Progress collections and deferred income	2,499	2,450
Operating segments | HealthCare | Equipment
Capitalized Contract Cost [Line Items]
Progress collections	0	0
Operating segments | HealthCare | Other
Capitalized Contract Cost [Line Items]
Progress collections	511	522
Corporate
Capitalized Contract Cost [Line Items]
Current deferred income	107	99
Progress collections and deferred income	238	210
Non-current deferred income	12	3
Total Progress collections and deferred income	250	213
Corporate | Equipment
Capitalized Contract Cost [Line Items]
Progress collections	0	0
Corporate | Other
Capitalized Contract Cost [Line Items]
Progress collections	$ 131	$ 111

ALL OTHER ASSETS - Schedule of

ALL OTHER ASSETS - Schedule of All Other Assets (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Derivative instruments (Note 22)	$ 482	$ 684
Assets held for sale	95	208
Prepaid taxes and deferred charges	395	341
Cash collateral on derivatives	0	76
Accrued interest and investment income	457	426
Other	93	199
All other current assets	1,521	1,933
Equity method and other investments	8,554	7,840
Long-term receivables (Note 4)	1,672	2,097
Prepaid taxes and deferred charges	670	800
Insurance receivables	2,315	4,705
Insurance cash and cash equivalents	619	353
Pension surplus	2,578	2,784
Other	591	461
All other non-current assets	16,998	19,040
Other assets, total	$ 18,520	$ 20,973

ALL OTHER ASSETS - Equity Metho

ALL OTHER ASSETS - Equity Method Investments (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Entity Information [Line Items]
Equity method investment balance	$ 7,815	$ 7,391
Equity method income (loss)	386	215	$ 46
Operating segments | Aerospace
Entity Information [Line Items]
Equity method investment balance	1,931	2,000
Equity method income (loss)	149	58	(41)
Operating segments | Renewable Energy
Entity Information [Line Items]
Equity method investment balance	752	739
Equity method income (loss)	32	39	13
Operating segments | Power
Entity Information [Line Items]
Equity method investment balance	960	977
Equity method income (loss)	89	23	43
Operating segments | HealthCare
Entity Information [Line Items]
Equity method investment balance	182	223
Equity method income (loss)	13	27	7
Corporate
Entity Information [Line Items]
Equity method investment balance	3,991	3,451
Equity method income (loss)	103	68	$ 23
Corporate | Energy Financial Services
Entity Information [Line Items]
Equity method investment balance	1,975	1,943
Corporate | Insurance
Entity Information [Line Items]
Equity method investment balance	$ 1,980	$ 1,480

BORROWINGS - Schedule of Borrow

BORROWINGS - Schedule of Borrowings (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Short-term borrowings
Total short-term borrowings	$ 3,757	$ 4,361
Long-term borrowings
Long-term borrowings and lease obligation	28,593	30,824
Total borrowings	32,350	35,186
Other
Long-term borrowings
Long-term borrowings and lease obligation	971	870
Debt issued by GE | Senior notes
Long-term borrowings
Long-term borrowings	$ 12,927	$ 5,373
Average Rate	4.75%	2.87%
Debt assumed by GE | Senior and subordinated notes
Long-term borrowings
Long-term borrowings	$ 8,406	$ 11,306
Average Rate	4.71%	3.73%
Debt issued by GE Capital | Senior notes
Long-term borrowings
Long-term borrowings	$ 6,289	$ 13,274
Average Rate	3.95%	4.26%
Senior notes | Debt issued by GE
Short-term borrowings
Current portion of long-term borrowings	$ 473	$ 1,249
Long-term borrowings
Average Rate	1.04%	1.39%
Senior notes | Debt issued by GE Capital
Short-term borrowings
Current portion of long-term borrowings	$ 1,188	$ 1,370
Long-term borrowings
Average Rate	1.54%	0.63%
Senior and subordinated notes | Debt assumed by GE
Short-term borrowings
Current portion of long-term borrowings	$ 1,973	$ 1,645
Long-term borrowings
Average Rate	1.50%	2.05%
Other
Short-term borrowings
Other	$ 124	$ 97

BORROWINGS - Narrative (Details

BORROWINGS - Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Guarantor Obligations [Line Items]
Total interest payments on consolidated borrowings, 2023	$ 1,367
Total interest payments on consolidated borrowings, 2024	1,289
Total interest payments on consolidated borrowings, 2025	1,195
Total interest payments on consolidated borrowings, 2026	1,052
Total interest payments on consolidated borrowings, 2027	988
Unsecured debt
Guarantor Obligations [Line Items]
Aggregate principal amount	8,250
Purchased notes	7,234
Non-recourse borrowings of consolidated securitization entities
Guarantor Obligations [Line Items]
Debt assumed by GE upon merger	5,258	$ 13,719
Debt issued by GE Capital | Unsecured debt
Guarantor Obligations [Line Items]
Purchased notes	6,106
Debt assumed by GE | Unsecured debt
Guarantor Obligations [Line Items]
Purchased notes	$ 1,128
5.55% Notes Due 2024
Guarantor Obligations [Line Items]
Debt interest rate	5.55%
5.55% Notes Due 2024 | Unsecured debt
Guarantor Obligations [Line Items]
Aggregate principal amount	$ 1,000
5.60% Notes Due 2025
Guarantor Obligations [Line Items]
Debt interest rate	5.60%
5.60% Notes Due 2025 | Unsecured debt
Guarantor Obligations [Line Items]
Aggregate principal amount	$ 1,500
5.65% Notes Due 2027
Guarantor Obligations [Line Items]
Debt interest rate	5.65%
5.65% Notes Due 2027 | Unsecured debt
Guarantor Obligations [Line Items]
Aggregate principal amount	$ 1,750
5.857% Notes Due 2030
Guarantor Obligations [Line Items]
Debt interest rate	5.857%
5.857% Notes Due 2030 | Unsecured debt
Guarantor Obligations [Line Items]
Aggregate principal amount	$ 1,250
5.905% Notes Due 2032
Guarantor Obligations [Line Items]
Debt interest rate	5.905%
5.905% Notes Due 2032 | Unsecured debt
Guarantor Obligations [Line Items]
Aggregate principal amount	$ 1,750
6.377% Notes Due 2052
Guarantor Obligations [Line Items]
Debt interest rate	6.377%
6.377% Notes Due 2052 | Unsecured debt
Guarantor Obligations [Line Items]
Aggregate principal amount	$ 1,000

BORROWINGS - Maturities of Borr

BORROWINGS - Maturities of Borrowings (Details) $ in Millions	Dec. 31, 2022 USD ($)
Senior notes | Debt issued by GE
Debt Instrument [Line Items]
2023	$ 473
2024	1,217
2025	2,357
2026	49
2027	2,450
Senior notes | Debt issued by GE Capital
Debt Instrument [Line Items]
2023	1,188
2024	112
2025	694
2026	149
2027	624
Fixed and floating rate notes	363
Senior and subordinated notes | Debt assumed by GE
Debt Instrument [Line Items]
2023	1,973
2024	512
2025	237
2026	1,136
2027	$ 222

ACCOUNTS PAYABLE AND EQUIPMEN_3

ACCOUNTS PAYABLE AND EQUIPMENT PROJECT PAYABLES (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Payables and Accruals [Abstract]
Trade payables	$ 12,479	$ 10,970
Supply chain finance programs	4,081	3,402
Equipment project accruals	1,469	1,341
Non-income based tax payables	616	531
Accounts payable and equipment project payables	$ 18,644	$ 16,243

INSURANCE LIABILITIES AND ANN_3

INSURANCE LIABILITIES AND ANNUITY BENEFITS - Narrative (Details) - USD ($) $ in Millions	3 Months Ended									12 Months Ended			24 Months Ended	48 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2024	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Insurance revenues										$ 2,954	$ 3,106	$ 2,865
Net earnings (loss)		$ 2,238	$ (160)	$ (771)	$ (1,014)	$ (3,843)	$ 1,184	$ (1,135)	$ (2,798)	292	(6,591)	5,546
Assets		187,788				198,874				187,788	198,874			$ 187,788
Claims incurred										1,481	1,699	1,801
Paid claims										1,518	1,709	1,728
Reinsurance recoveries										321	351	350
Reinsurance recoverables, allowances						1,654					1,654
Reinsurance recoverables, net		132				2,651				132	2,651			132
Reinsurance recoverable, credit loss increase, expense, pre-tax			415
Reinsurance recoverable, credit loss increase, expense, after-tax			$ 328
Reinsurance recoverable, incurred but not yet reported claims		2,396								$ 2,396				$ 2,396
Reinsurance incremental loss (pre-tax)		56
Reinsurance incremental loss (after-tax)		$ 44
Margin percentage (less than)		10%								10%				10%
Capital contributions to insurance subsidiaries														$ 11,400
Statutory capital level requirement		300%								300%				300%
Forecast
Disaggregation of Revenue [Line Items]
Capital contributions to insurance subsidiaries	$ 1,800												$ 3,600
Run-off Insurance Operations
Disaggregation of Revenue [Line Items]
Insurance revenues										$ 2,954	3,106	2,865
Gross profit (loss)										60	566	197
Net earnings (loss)										44	444	$ 143
Assets		$ 44,197				$ 49,894				$ 44,197	$ 49,894			$ 44,197

INSURANCE LIABILITIES AND ANN_4

INSURANCE LIABILITIES AND ANNUITY BENEFITS - Schedule of Investment Contracts, Insurance Liabilities and Insurance Annuity Benefits (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Liability for Claims and Claims Adjustment Expense [Line Items]
Future policy benefit reserves	$ 26,223	$ 29,581
Claim reserves	5,156	5,389
Investment contracts	1,771	1,909
Unearned premiums and other	197	287
Total	33,347	37,166
Other adjustments	0	3,394
Decrease in other adjustment of insurance liabilities and annuity benefits	3,394
Long-term care
Liability for Claims and Claims Adjustment Expense [Line Items]
Future policy benefit reserves	17,357	17,097
Claim reserves	4,596	4,546
Investment contracts	0	0
Unearned premiums and other	18	15
Total	21,971	21,658
Structured settlement annuities & life
Liability for Claims and Claims Adjustment Expense [Line Items]
Future policy benefit reserves	8,678	8,902
Claim reserves	254	258
Investment contracts	864	955
Unearned premiums and other	174	184
Total	9,970	10,299
Other contracts
Liability for Claims and Claims Adjustment Expense [Line Items]
Future policy benefit reserves	187	188
Claim reserves	307	585
Investment contracts	907	954
Unearned premiums and other	5	89
Total	$ 1,406	1,815
Claim reserves, short-duration insurance contracts		$ 242

POSTRETIREMENT BENEFIT PLANS -

POSTRETIREMENT BENEFIT PLANS - Pension Benefits and Retiree Health and Life Benefits - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($) category
Defined Benefit Plan Disclosure [Line Items]
Number of categories | category	3
Other pension plans
Defined Benefit Plan Disclosure [Line Items]
Assets or obligations of U.S. and non-U.S. pension plans, threshold | $	$ 50

POSTRETIREMENT BENEFIT PLANS _2

POSTRETIREMENT BENEFIT PLANS - Description of Postretirement Benefit Plans (Details) $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($) employee plan
Principal pension plans | GE Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Number of retirees and beneficiaries covered	177,000
Number of vested former employees	82,500
Number of active employees	23,000
Frozen benefit plan, number of salaried employees | plan	20,000
Principal pension plans | GE Supplementary Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Frozen benefit plan, number of executive employees	700
Other pension plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Number of retirees and beneficiaries covered	58,000
Number of vested former employees	48,500
Number of active employees	14,000
Number of U.S. and non-U.S. pension plans | plan	41
Assets or obligations of U.S. and non-U.S. pension plans, threshold | $	$ 50
Principal retiree benefit plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Number of retirees and beneficiaries covered	151,500
Number of active employees	21,500

POSTRETIREMENT BENEFIT PLANS _3

POSTRETIREMENT BENEFIT PLANS - Funding Status by Plan Type (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Benefit Obligation	$ 70,811	$ 98,863
Fair Value of Assets	59,666	83,522
Deficit/(Surplus)	11,145	15,341
Subject to regulatory funding
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Benefit Obligation	60,212	84,771
Fair Value of Assets	59,505	83,270
Deficit/(Surplus)	707	1,501
Not subject to regulatory funding
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Benefit Obligation	10,599	14,092
Fair Value of Assets	161	252
Deficit/(Surplus)	10,438	13,840
Principal pension plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Benefit Obligation	53,591	72,299	$ 76,298
Fair Value of Assets	44,993	60,990	58,843
Deficit/(Surplus)	8,598	11,309
Principal pension plans | GE Pension Plan | Subject to regulatory funding
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Benefit Obligation	48,134	65,073
Fair Value of Assets	44,993	60,990
Deficit/(Surplus)	3,141	4,083
Principal pension plans | GE Supplementary Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Benefit Obligation	5,457	7,226
Principal pension plans | GE Supplementary Pension Plan | Not subject to regulatory funding
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Benefit Obligation	5,457	7,226
Fair Value of Assets	0	0
Deficit/(Surplus)	5,457	7,226
Other pension plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Benefit Obligation	13,916	22,256	24,658
Fair Value of Assets	14,663	22,490	21,506
Deficit/(Surplus)	(747)	(234)
Other pension plans | Subject to regulatory funding
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Benefit Obligation	12,078	19,698
Fair Value of Assets	14,512	22,280
Deficit/(Surplus)	(2,434)	(2,582)
Other pension plans | Not subject to regulatory funding
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Benefit Obligation	1,838	2,558
Fair Value of Assets	151	210
Deficit/(Surplus)	1,687	2,348
Principal retiree benefit plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Benefit Obligation	3,304	4,308	5,019
Fair Value of Assets	10	42	$ 134
Deficit/(Surplus)	3,294	4,266
Principal retiree benefit plans | Not subject to regulatory funding
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Benefit Obligation	3,304	4,308
Fair Value of Assets	10	42
Deficit/(Surplus)	$ 3,294	$ 4,266

POSTRETIREMENT BENEFIT PLANS _4

POSTRETIREMENT BENEFIT PLANS - Funding (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Other pension plans
Defined Benefit Plan Disclosure [Line Items]
Expected employer contributions	$ 170
Retiree health benefits and life insurance
Defined Benefit Plan Disclosure [Line Items]
Expected employer contributions	$ 365
GE Pension Plan | Principal pension plans
Defined Benefit Plan Disclosure [Line Items]
Funded percentage, ERISA	92.80%	107.30%
Funded percentage	93.50%	93.70%
GE Supplementary Pension Plan | Principal pension plans
Defined Benefit Plan Disclosure [Line Items]
Expected employer contributions	$ 370

POSTRETIREMENT BENEFIT PLANS _5

POSTRETIREMENT BENEFIT PLANS - Actions (Details) - Other pension plans - employee	Dec. 31, 2023	Jan. 01, 2022
United Kingdom
Defined Benefit Plan Disclosure [Line Items]
Frozen benefit plan, number of salaried employees		2,700
Canada | Subsequent event | Forecast
Defined Benefit Plan Disclosure [Line Items]
Frozen benefit plan, number of salaried employees	800

POSTRETIREMENT BENEFIT PLANS _6

POSTRETIREMENT BENEFIT PLANS - Cost of Benefits Plans and Assumptions (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Forecast | Subsequent event
Components of expense (income)
Benefit plans cost	$ (2,010)
Weighted-average benefit cost assumptions
Decrease in net periodic benefit cost	$ 1,985
Principal pension plans
Components of expense (income)
Service cost for benefits earned		$ 221	$ 237	$ 657
Interest cost on benefit obligations		2,069	1,951	2,350
Expected return on plan assets		(3,142)	(3,049)	(2,993)
Net actuarial loss amortization		1,422	3,483	3,399
Prior service cost amortization		5	28	146
Curtailment loss		0	0	0
Non-operating		354	2,413	2,902
Benefit plans cost		575	2,650	3,559
Principal pension plans | GE Pension Plan
Weighted-average benefit cost assumptions
Increase (decrease) in mortality assumptions decreased benefit plan obligations			278
Increase in principal pension plan cost assuming 25 basis point decrease in discount rate		130
Increase in principal pension benefit obligation assuming 25 basis point decrease in discount rate		1,300
Increase in principal pension plan cost assuming 50 basis point decrease in expected return on assets		260
Other pension plans
Components of expense (income)
Service cost for benefits earned		86	233	243
Interest cost on benefit obligations		398	383	422
Expected return on plan assets		(967)	(1,194)	(1,082)
Net actuarial loss amortization		101	403	434
Prior service cost amortization		(8)	(3)	1
Curtailment loss		(6)	76	12
Non-operating		(482)	(335)	(213)
Benefit plans cost		(396)	(102)	30
Principal retiree benefit plans
Components of expense (income)
Service cost for benefits earned		39	44	59
Interest cost on benefit obligations		108	103	150
Expected return on plan assets		0	0	(11)
Net actuarial loss amortization		(115)	(79)	(82)
Prior service cost amortization		(235)	(236)	(234)
Curtailment loss		0	0	0
Non-operating		(242)	(212)	(177)
Benefit plans cost		$ (203)	$ (168)	$ (118)
Weighted-average benefit cost assumptions
Ultimate health care cost trend rate		5%
Weighted average | Principal pension plans
Weighted-average benefit obligations assumptions
Discount rate		5.53%	2.94%	2.61%
Compensation increases		3.07%	3.05%	2.95%
Weighted-average benefit cost assumptions
Discount rate		2.94%	2.61%	3.36%
Expected rate of return on plan assets		6%	6.25%
Weighted average | Principal pension plans | Forecast | Subsequent event
Weighted-average benefit cost assumptions
Expected rate of return on plan assets	7%
Weighted average | Other pension plans
Weighted-average benefit obligations assumptions
Discount rate		4.59%	1.93%	1.44%
Compensation increases		2.44%	2.35%	3.06%
Weighted-average benefit cost assumptions
Discount rate		1.93%	1.44%	1.97%
Expected rate of return on plan assets		4.80%	5.69%	6.10%
Weighted average | Principal retiree benefit plans
Weighted-average benefit obligations assumptions
Discount rate		5.43%	2.64%	2.15%
Compensation increases		3.12%	2.63%	2.82%
Initial healthcare trend rate		6.40%	5.70%	5.90%
Weighted-average benefit cost assumptions
Discount rate		2.64%	2.15%	3.05%
Expected rate of return on plan assets		0%	1.25%	7%

POSTRETIREMENT BENEFIT PLANS _7

POSTRETIREMENT BENEFIT PLANS - Plan Funded Status and Amounts Recorded in Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Change in benefit obligations
Balance at January 1	$ 98,863
Balance at December 31	70,811	$ 98,863
Change in plan assets
Balance at January 1	83,522
Balance at December 31	59,666	83,522
Funded status - surplus (deficit)	(11,145)	(15,341)
Amounts recorded in Statement of Financial Position
Non-current assets - other	2,578	2,784
Principal pension plans
Change in benefit obligations
Balance at January 1	72,299	76,298
Service cost for benefits earned	221	237	$ 657
Interest cost on benefit obligations	2,069	1,951	2,350
Participant contributions	14	15
Plan amendments	0	0
Actuarial loss (gain) - net	(17,281)	(2,448)
Benefits paid	(3,731)	(3,754)
Curtailments	0	0
Dispositions/acquisitions/other - net	0	0
Exchange rate adjustments	0	0
Balance at December 31	53,591	72,299	76,298
Change in plan assets
Balance at January 1	60,990	58,843
Actual gain (loss) on plan assets	(12,605)	5,559
Employer contributions	325	327
Participant contributions	14	15
Benefits paid	(3,731)	(3,754)
Dispositions/acquisitions/other - net	0	0
Exchange rate adjustments	0	0
Balance at December 31	44,993	60,990	58,843
Funded status - surplus (deficit)	(8,598)	(11,309)
Amounts recorded in Statement of Financial Position
Non-current assets - other	0	0
Current liabilities - other	(351)	(337)
Non-current liabilities - compensation and benefits	(8,247)	(10,972)
Net amount recorded	(8,598)	(11,309)
Prior service cost (credit)	(113)	(109)
Net loss (gain)	(5,710)	(2,754)
Total recorded in Accumulated other comprehensive loss (income)	(5,823)	(2,863)
Principal pension plans | GE Supplementary Pension Plan
Change in benefit obligations
Balance at January 1	7,226
Balance at December 31	5,457	7,226
Other pension plans
Change in benefit obligations
Balance at January 1	22,256	24,658
Service cost for benefits earned	86	233	243
Interest cost on benefit obligations	398	383	422
Participant contributions	19	24
Plan amendments	0	(1)
Actuarial loss (gain) - net	(6,282)	(1,561)
Benefits paid	(920)	(998)
Curtailments	0	(74)
Dispositions/acquisitions/other - net	0	(188)
Exchange rate adjustments	(1,641)	(220)
Balance at December 31	13,916	22,256	24,658
Change in plan assets
Balance at January 1	22,490	21,506
Actual gain (loss) on plan assets	(5,334)	1,602
Employer contributions	209	594
Participant contributions	19	24
Benefits paid	(920)	(998)
Dispositions/acquisitions/other - net	0	(138)
Exchange rate adjustments	(1,801)	(100)
Balance at December 31	14,663	22,490	21,506
Funded status - surplus (deficit)	747	234
Amounts recorded in Statement of Financial Position
Non-current assets - other	2,591	2,898
Current liabilities - other	(101)	(107)
Non-current liabilities - compensation and benefits	(1,743)	(2,557)
Net amount recorded	747	234
Prior service cost (credit)	(42)	(52)
Net loss (gain)	1,787	2,012
Total recorded in Accumulated other comprehensive loss (income)	1,745	1,960
Principal retiree benefit plans
Change in benefit obligations
Balance at January 1	4,308	5,019
Service cost for benefits earned	39	44	59
Interest cost on benefit obligations	108	103	150
Participant contributions	54	60
Plan amendments	0	0
Actuarial loss (gain) - net	(778)	(446)
Benefits paid	(438)	(472)
Curtailments	0	0
Dispositions/acquisitions/other - net	11	0
Exchange rate adjustments	0	0
Balance at December 31	3,304	4,308	5,019
Change in plan assets
Balance at January 1	42	134
Actual gain (loss) on plan assets	0	41
Employer contributions	352	279
Participant contributions	54	60
Benefits paid	(438)	(472)
Dispositions/acquisitions/other - net	0	0
Exchange rate adjustments	0	0
Balance at December 31	10	42	$ 134
Funded status - surplus (deficit)	(3,294)	(4,266)
Amounts recorded in Statement of Financial Position
Non-current assets - other	0	0
Current liabilities - other	(355)	(362)
Non-current liabilities - compensation and benefits	(2,939)	(3,904)
Net amount recorded	(3,294)	(4,266)
Prior service cost (credit)	(1,677)	(1,912)
Net loss (gain)	(1,705)	(1,042)
Total recorded in Accumulated other comprehensive loss (income)	(3,382)	(2,954)
Retiree health plans
Change in benefit obligations
Balance at January 1	2,548
Balance at December 31	$ 1,991	$ 2,548

POSTRETIREMENT BENEFIT PLANS _8

POSTRETIREMENT BENEFIT PLANS - Composition of Plan Assets, Pension Plans (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 59,666	$ 83,522
Principal pension plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	44,993	60,990	$ 58,843
Principal pension plans | Fair Value, Inputs, Level 1, 2 and 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	28,135	37,123
Principal pension plans | Global equities | Fair Value, Inputs, Level 1, 2 and 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	3,918	7,778
Principal pension plans | Global equities | Plan assets measured at net asset value
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	3,285	9,517
Principal pension plans | Fixed income and cash investment funds | Fair Value, Inputs, Level 1, 2 and 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	4,918	7,665
Principal pension plans | U.S. corporate | Fair Value, Inputs, Level 1, 2 and 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	8,715	10,324
Principal pension plans | Other debt securities | Fair Value, Inputs, Level 1, 2 and 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	7,853	7,331
Principal pension plans | Debt securities | Plan assets measured at net asset value
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	3,469	5,269
Principal pension plans | Real estate | Fair Value, Inputs, Level 1, 2 and 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,486	2,510
Principal pension plans | Real estate | Plan assets measured at net asset value
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,624	1,408
Principal pension plans | Private equities and other investments | Fair Value, Inputs, Level 1, 2 and 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,245	1,515
Principal pension plans | Private equities and other investments | Plan assets measured at net asset value
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	8,480	7,673
Other pension plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	14,663	22,490	$ 21,506
Other pension plans | Fair Value, Inputs, Level 1, 2 and 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	8,845	16,108
Other pension plans | Global equities | Fair Value, Inputs, Level 1, 2 and 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,097	3,589
Other pension plans | Global equities | Plan assets measured at net asset value
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,029	1,172
Other pension plans | Fixed income and cash investment funds | Fair Value, Inputs, Level 1, 2 and 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	6,506	10,527
Other pension plans | U.S. corporate | Fair Value, Inputs, Level 1, 2 and 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	382	468
Other pension plans | Other debt securities | Fair Value, Inputs, Level 1, 2 and 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	443	492
Other pension plans | Debt securities | Plan assets measured at net asset value
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,024	1,287
Other pension plans | Real estate | Fair Value, Inputs, Level 1, 2 and 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	53	89
Other pension plans | Real estate | Plan assets measured at net asset value
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,976	2,126
Other pension plans | Private equities and other investments | Fair Value, Inputs, Level 1, 2 and 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	364	943
Other pension plans | Private equities and other investments | Plan assets measured at net asset value
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 1,789	$ 1,797

POSTRETIREMENT BENEFIT PLANS _9

POSTRETIREMENT BENEFIT PLANS - Composition of Plan Assets, Pension Plans (Narrative) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 59,666	$ 83,522
Principal pension plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	44,993	60,990	$ 58,843
Principal pension plans | GE Pension Plan | Level 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2,255	3,872
Principal pension plans | GE Pension Plan | Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	6,759	12,377
Principal pension plans | GE Pension Plan | Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	18,606	20,942
Other pension plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	14,663	22,490	21,506
Other pension plans | Level 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	81	138
Other pension plans | Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	841	1,312
Other pension plans | Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	7,580	13,802
Principal retiree benefit plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 10	$ 42	$ 134

POSTRETIREMENT BENEFIT PLANS_10

POSTRETIREMENT BENEFIT PLANS - Asset Allocation (Details)	Dec. 31, 2022
Principal pension plans | Global equities
Defined Benefit Plan Disclosure [Line Items]
Actual allocation	16%
Principal pension plans | Global equities | Minimum
Defined Benefit Plan Disclosure [Line Items]
Target allocation	14%
Principal pension plans | Global equities | Maximum
Defined Benefit Plan Disclosure [Line Items]
Target allocation	34%
Principal pension plans | Debt securities (including cash equivalents)
Defined Benefit Plan Disclosure [Line Items]
Actual allocation	55%
Principal pension plans | Debt securities (including cash equivalents) | Minimum
Defined Benefit Plan Disclosure [Line Items]
Target allocation	31%
Principal pension plans | Debt securities (including cash equivalents) | Maximum
Defined Benefit Plan Disclosure [Line Items]
Target allocation	81.50%
Principal pension plans | Real estate
Defined Benefit Plan Disclosure [Line Items]
Actual allocation	7%
Principal pension plans | Real estate | Minimum
Defined Benefit Plan Disclosure [Line Items]
Target allocation	1%
Principal pension plans | Real estate | Maximum
Defined Benefit Plan Disclosure [Line Items]
Target allocation	10%
Principal pension plans | Private equities and other investments
Defined Benefit Plan Disclosure [Line Items]
Actual allocation	22%
Principal pension plans | Private equities and other investments | Minimum
Defined Benefit Plan Disclosure [Line Items]
Target allocation	6%
Principal pension plans | Private equities and other investments | Maximum
Defined Benefit Plan Disclosure [Line Items]
Target allocation	30%
Other pension plans | Global equities
Defined Benefit Plan Disclosure [Line Items]
Target allocation	17%
Actual allocation	14%
Other pension plans | Debt securities (including cash equivalents)
Defined Benefit Plan Disclosure [Line Items]
Target allocation	60%
Actual allocation	57%
Other pension plans | Real estate
Defined Benefit Plan Disclosure [Line Items]
Target allocation	8%
Actual allocation	14%
Other pension plans | Private equities and other investments
Defined Benefit Plan Disclosure [Line Items]
Target allocation	15%
Actual allocation	15%

POSTRETIREMENT BENEFIT PLANS_11

POSTRETIREMENT BENEFIT PLANS - Asset Allocation (Narrative) (Details)	Dec. 31, 2022	Dec. 31, 2021
GE Pension Plan | Principal pension plans | Qualifying employer securities (GE securities)
Defined Benefit Plan Disclosure [Line Items]
Plan assets (as a percent)	0.70%	0.60%

POSTRETIREMENT BENEFIT PLANS_12

POSTRETIREMENT BENEFIT PLANS - Annualized Returns (Details) - Principal pension plans - GE Pension Plan	Dec. 31, 2022
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
1 year	(20.50%)
5 years	2.70%
10 years	5.40%
25 years	5.80%

POSTRETIREMENT BENEFIT PLANS_13

POSTRETIREMENT BENEFIT PLANS - Estimated Future Benefit Payments, Benefit Plans (Details) $ in Millions	Dec. 31, 2022 USD ($)
Principal pension plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
2023	$ 3,830
2024	3,865
2025	3,890
2026	3,910
2027	3,920
2028-2032	19,510
Other pension plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
2023	850
2024	845
2025	855
2026	870
2027	885
2028-2032	4,585
Principal retiree benefit plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
2023	375
2024	360
2025	345
2026	330
2027	325
2028-2032	$ 1,375

POSTRETIREMENT BENEFIT PLANS_14

POSTRETIREMENT BENEFIT PLANS - Defined Contribution Plan (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Retirement Benefits [Abstract]
Defined contribution plan costs	$ 444	$ 418	$ 318

POSTRETIREMENT BENEFIT PLANS_15

POSTRETIREMENT BENEFIT PLANS - Cost of Postretirement Benefit Plans and Changes in Other Comprehensive Income (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Principal pension plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Plans cost (income)	$ 575	$ 2,650	$ 3,559
Prior service cost (credit) - current year	0	0	0
Net loss (gain) - current year	(1,533)	(4,959)	1,124
Reclassifications out of AOCI
Curtailment/settlement gain (loss)	0	0	0
Dispositions	0	0	0
Amortization of net gain (loss)	(1,422)	(3,483)	(3,399)
Amortization of prior service credit (cost)	(5)	(28)	(146)
Total changes in other comprehensive loss (income)	(2,960)	(8,470)	(2,421)
Cost (income) of postretirement benefit plans and changes in other comprehensive loss (income)	(2,385)	(5,820)	1,138
Other pension plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Plans cost (income)	(396)	(102)	30
Prior service cost (credit) - current year	0	(1)	27
Net loss (gain) - current year	(128)	(2,104)	529
Reclassifications out of AOCI
Curtailment/settlement gain (loss)	6	(68)	(3)
Dispositions	0	(68)	(166)
Amortization of net gain (loss)	(101)	(403)	(434)
Amortization of prior service credit (cost)	8	3	(1)
Total changes in other comprehensive loss (income)	(215)	(2,641)	(48)
Cost (income) of postretirement benefit plans and changes in other comprehensive loss (income)	(611)	(2,743)	(18)
Principal retiree benefit plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Plans cost (income)	(203)	(168)	(118)
Prior service cost (credit) - current year	0	0	(7)
Net loss (gain) - current year	(778)	(488)	119
Reclassifications out of AOCI
Curtailment/settlement gain (loss)	0	0	0
Dispositions	0	0	0
Amortization of net gain (loss)	115	79	82
Amortization of prior service credit (cost)	235	236	234
Total changes in other comprehensive loss (income)	(428)	(173)	428
Cost (income) of postretirement benefit plans and changes in other comprehensive loss (income)	$ (631)	$ (341)	$ 310

ALL OTHER LIABILITIES (Details)

ALL OTHER LIABILITIES (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Other Liabilities Disclosure [Abstract]
Sales discounts and allowances	$ 4,042	$ 4,020
Equipment projects and other commercial liabilities	1,652	1,618
Product warranties (Note 24)	1,268	1,091
Employee compensation and benefit liabilities	4,662	4,677
Interest payable	400	276
Taxes payable	743	500
Environmental, health and safety liabilities (Note 24)	282	386
Derivative instruments (Note 22)	589	212
Other	847	1,196
All other current liabilities	14,485	13,977
Equipment projects and other commercial liabilities	2,229	2,451
Product warranties (Note 24)	885	800
Operating lease liabilities (Note 6)	2,393	2,848
Uncertain and other income taxes and related liabilities	2,581	3,041
Alstom legacy legal matters (Note 24)	455	567
Environmental, health and safety liabilities (Note 24)	2,404	2,274
Redeemable noncontrolling interests (Note 16)	132	148
Interest payable	0	179
Other	1,076	934
All other non-current liabilities	12,154	13,240
Total All other liabilities	$ 26,639	$ 27,217

INCOME TAXES - Consolidated Ear

INCOME TAXES - Consolidated Earnings (Loss) from Continuing Operations Before Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
U.S. earnings (loss)	$ (238)	$ (2,959)	$ (4,823)
Non-U.S. earnings (loss)	1,650	(724)	10,793
Earnings (loss) from continuing operations before income taxes	$ 1,412	$ (3,683)	$ 5,970

INCOME TAXES - Provision (Benef

INCOME TAXES - Provision (Benefit) for Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Current
U.S. Federal	$ 62	$ (1,347)	$ 865
Non-U.S.	1,040	1,154	1,276
U.S. State	4	(85)	152
Deferred
U.S. Federal	(956)	(567)	(1,898)
Non-U.S.	466	608	(810)
U.S. State	(141)	(50)	(72)
Total	$ 476	$ (286)	$ (487)

INCOME TAXES - Narrative (Detai

INCOME TAXES - Narrative (Details) $ in Millions	1 Months Ended		12 Months Ended
	Sep. 30, 2021 USD ($)	Dec. 31, 2020 USD ($)	Dec. 31, 2022 USD ($) jurisdiction tax_return	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Income Tax Contingency [Line Items]
Income taxes paid (recovered)			$ 1,128	$ 1,330	$ 1,291
Number of income tax returns filed annually | tax_return			2,600
Number of taxing jurisdictions throughout the globe where we file tax returns on an annual basis | jurisdiction			270
Tax benefit					140
Interest expense (income)			$ 36	17	(30)
Tax expense (income) related to penalties			(26)	(29)	$ (13)
Undistributed earnings of foreign affiliates and associated companies			14,000
Tax reconciliation related to repatriation of earnings				$ 66
Deferred tax asset, capitalized research and development costs			714
GE HealthCare spin-off
Income Tax Contingency [Line Items]
Reasonably possible reduction to the balance of unrecognized tax benefits in succeeding 12 months			552
GE Healthcare
Income Tax Contingency [Line Items]
Deferred tax asset, capitalized research and development costs			$ 279
Continuing operations
Income Tax Contingency [Line Items]
Tax benefit		$ 140
Net interest benefits		96
Discontinued operations
Income Tax Contingency [Line Items]
Tax benefit		130
Net interest benefits		$ 25
Her Majesty's Revenue and Customs (HMRC) | Foreign Tax Authority
Income Tax Contingency [Line Items]
Potential impact on disallowance of interest deductions	$ 1,100
Tax adjustment	$ 112

INCOME TAXES - Reconciliation o

INCOME TAXES - Reconciliation of U.S. Federal Statutory Income Tax Rate to Actual Income Tax Rate (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Amount
U.S. federal statutory income tax rate	$ 297	$ (773)	$ 1,254
Tax on global activities including exports	342	155	(47)
U.S. business credits	(246)	(189)	(169)
Debt tender and related valuation allowances	30	940	0
Deductible stock and restructuring losses	0	(583)	(203)
Sale of Biopharma business	(13)	(5)	(1,447)
Goodwill impairments	0	0	184
All other – net	66	169	(59)
Total income tax reconciliation items	179	487	(1,741)
Total	$ 476	$ (286)	$ (487)
Rate
U.S. federal statutory income tax rate	21%	21%	21%
Tax on global activities including exports	24.20%	(4.20%)	(0.80%)
U.S. business credits	(17.40%)	5.10%	(2.80%)
Debt tender and related valuation allowances	2.10%	(25.50%)	0%
Deductible stock and restructuring losses	0%	15.80%	(3.40%)
Sale of Biopharma business	(0.90%)	0.10%	(24.20%)
Goodwill impairments	0%	0%	3.10%
All other – net	4.70%	(4.50%)	(1.10%)
Total income tax reconciliation items	12.70%	(13.20%)	(29.20%)
Actual income tax rate	33.70%	7.80%	(8.20%)
Tax reconciliation related to separation income tax costs	$ 134
Tax reconciliation related to repatriation of earnings		$ 66
Tax reconciliation related to resolution of IRS audit			$ (140)

INCOME TAXES - Unrecognized Tax

INCOME TAXES - Unrecognized Tax Benefits (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]
Unrecognized tax benefits	$ 3,951	$ 4,224	$ 4,191	$ 4,169
Portion that, if recognized, would reduce tax expense and effective tax rate	3,072	3,351	2,986
Accrued interest on unrecognized tax benefits	614	597	628
Accrued penalties on unrecognized tax benefits	111	146	179
Minimum
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]
Reasonably possible reduction to the balance of unrecognized tax benefits in succeeding 12 months	0	0	0
Portion that, if recognized, would reduce tax expense and effective tax rate	0	0	0
Maximum
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]
Reasonably possible reduction to the balance of unrecognized tax benefits in succeeding 12 months	650	250	350
Portion that, if recognized, would reduce tax expense and effective tax rate	$ 600	$ 200	$ 250

INCOME TAXES - Unrecognized T_2

INCOME TAXES - Unrecognized Tax Benefits Reconciliation (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns
Balance at beginning of period	$ 4,224	$ 4,191	$ 4,169
Additions for tax positions of the current year	62	396	836
Additions for tax positions of prior years	120	327	326
Reductions for tax positions of prior years	(393)	(585)	(863)
Settlements with tax authorities	(8)	(33)	(127)
Expiration of the statute of limitations	(54)	(71)	(151)
Balance at end of period	$ 3,951	$ 4,224	$ 4,191

INCOME TAXES - Deferred Income

INCOME TAXES - Deferred Income Taxes (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Total assets	$ 12,325	$ 11,587
Total liabilities	(620)	(732)
Net deferred income tax asset (liability)	$ 11,705	$ 10,855

INCOME TAXES - Components of Ne

INCOME TAXES - Components of Net Deferred Income Tax Assets (Liability) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Deferred tax assets
Accrued expenses and reserves	$ 2,538	$ 2,635
Progress collections, contract assets and deferred items	2,520	2,093
Deferred expenses	1,925	1,597
Principal pension plans	1,806	2,375
Insurance company loss reserves	1,782	1,700
Non-U.S. loss carryforwards	1,240	1,354
Other compensation and benefits	975	1,397
Investment securities	516	(1,278)
Principal retiree benefit plans	692	896
Other	703	1,329
Total deferred tax assets	14,697	14,098
Deferred tax liabilities
Investment in global operations	(1,011)	(1,775)
Other	(1,981)	(1,468)
Total deferred tax liabilities	(2,992)	(3,243)
Net deferred income tax asset (liability)	11,705	10,855
Valuation allowances	7,171	7,081
Valuation allowances related to assets other than non-U.S. loss carryforwards	3,325	$ 1,653
Net Operating Loss Carryforwards Expiring in Various Years Ending from 2022 Through 2024
Deferred tax assets
Non-U.S. loss carryforwards	8
Net Operating Loss Carryforwards Expiring in Various Years Ending from 2025 Through 2041
Deferred tax assets
Non-U.S. loss carryforwards	427
Net Operating Loss Carryforwards That May be Carried Forward Indefinitely
Deferred tax assets
Non-U.S. loss carryforwards	$ 805

SHAREHOLDERS' EQUITY (Details)

SHAREHOLDERS' EQUITY (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance				$ 41,612				$ 37,073	$ 41,612	$ 37,073
Ending balance	$ 37,582				$ 41,612				$ 37,582	$ 41,612	$ 37,073
Dividends declared per common share (in dollars per share)	$ 0.08	$ 0.08	$ 0.08	$ 0.08	$ 0.08	$ 0.08	$ 0.08	$ 0.08	$ 0.32	$ 0.32	$ 0.32
Adjustments to investment securities before reclassifications									$ 2,674	$ 3,535	$ (1,979)
BioPharma
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Reclass from AOCI, net of taxes											836
Currency translation, net of taxes											688
Accumulated other comprehensive income (loss)
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance				$ 1,582				$ (9,749)	1,582	(9,749)	(11,732)
Ending balance	$ (1,311)				$ 1,582				(1,311)	1,582	(9,749)
Currency translation adjustments including noncontrolling interests
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance				(4,562)				(4,386)	(4,562)	(4,386)	(4,818)
AOCI before reclass, net of taxes									(1,355)	(104)	(255)
Reclass from AOCI, net of taxes									0	(71)	691
Other comprehensive income (loss)									(1,355)	(174)	435
Ending balance					(4,562)					(4,562)	(4,386)
AOCI before reclass, taxes									127	(91)	(25)
Reclass from AOCI, taxes									0	87	0
Currency translation adjustments attributable to noncontrolling interests
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Other comprehensive income (loss)									(2)	2	2
Currency translation adjustments
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance				(4,562)				(4,386)	(4,562)	(4,386)
Other comprehensive income (loss)									(1,353)	(177)	433
Ending balance	(5,915)				(4,562)				(5,915)	(4,562)	(4,386)
Benefit plans including noncontrolling interests
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance				3,646				(5,395)	3,646	(5,395)	(7,024)
AOCI before reclass, net of taxes									2,117	6,225	(1,256)
Reclass from AOCI, net of taxes									772	2,819	2,888
Other comprehensive income (loss)									2,889	9,044	1,632
Ending balance					3,646					3,646	(5,395)
AOCI before reclass, taxes									597	1,643	(283)
Reclass from AOCI, taxes									216	793	805
Benefit plans attributable to noncontrolling interests
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Other comprehensive income (loss)									3	3	4
Benefit plans
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance				3,646				(5,395)	3,646	(5,395)
Other comprehensive income (loss)									2,886	9,041	1,628
Ending balance	6,531				3,646				6,531	3,646	(5,395)
Investment securities and cash flow hedges
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance				$ 2,498				$ 32	2,498	32	109
AOCI before reclass, net of taxes									(4,461)	2,422	(39)
Reclass from AOCI, net of taxes									36	44	(39)
Other comprehensive income (loss)									(4,425)	2,466	(78)
Ending balance	$ (1,927)				$ 2,498				(1,927)	2,498	32
AOCI before reclass, taxes									(1,141)	615	21
Reclass from AOCI, taxes									$ (20)	$ 23	$ (25)

SHAREHOLDERS' EQUITY - Narrativ

SHAREHOLDERS' EQUITY - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions		3 Months Ended	12 Months Ended
	Jan. 21, 2021	Dec. 31, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Noncontrolling Interest [Line Items]
Preferred stock, shares authorized		50,000,000	50,000,000
Preferred stock, par value (in dollars per share)		$ 1	$ 1
Preferred stock, shares outstanding		5,795,444	5,795,444	5,939,875	5,939,875
Preferred stock, liquidation value		$ 5,795	$ 5,795
Dividends, preferred stock			289	$ 237	$ 474
Dividends, preferred stock, cash			284	220	$ 295
Stock repurchased			$ 1,000	$ 36
Common stock, shares authorized		1,650,000,000	1,650,000,000
Common stock, par value (in dollars per share)		$ 0.01	$ 0.01	$ 0.01	$ 0.06
Common stock, shares issued		1,462,000,000	1,462,000,000
Common stock, shares outstanding		1,089,107,878	1,089,107,878	1,099,027,213
Stock repurchased (in shares)			13,600,000	500,000
Redeemable noncontrolling interests		$ 132	$ 132	$ 148
Series D Preferred Stock
Noncontrolling Interest [Line Items]
Preferred stock, value outstanding		5,550	5,550
Preferred stock, fixed dividend rate	5%
Series D Preferred Stock | LIBOR
Noncontrolling Interest [Line Items]
Preferred stock, basis spread on variable rate	3.33%
Series D Preferred Stock | Preferred stock
Noncontrolling Interest [Line Items]
Stock repurchased		144
Series A, B And C Preferred Stock
Noncontrolling Interest [Line Items]
Preferred stock, value outstanding		$ 245	$ 245

SHARE-BASED COMPENSATION - Narr

SHARE-BASED COMPENSATION - Narrative (Details) $ / shares in Units, shares in Thousands, $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 $ / shares shares	Dec. 31, 2020 $ / shares
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Expiration period	10 years
Risk-free interest rate (as a percent)	1.60%	1.10%	1%
Dividend yield (as a percent)	0.40%	0.30%	0.40%
Expected volatility (as a percent)	37%	40%	36%
Expected lives (in years)	6 years 9 months 18 days	6 years 2 months 12 days	6 years 1 month 6 days
Strike price (in dollars per share)	$ 92.33	$ 105.12	$ 84.48
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
RSU/common stock conversion ratio	1
Outstanding (in shares) | shares	9,687	8,057
Outstanding (in dollars per share)	$ 79.82	$ 77.90
Intrinsic value, outstanding | $	$ 812
Weighted average remaining contractual term, outstanding	1 year 2 months 12 days
PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding (in shares) | shares	3,667
Outstanding (in dollars per share)	$ 78.31
Intrinsic value, outstanding | $	$ 307
Weighted average remaining contractual term, outstanding	1 year 8 months 12 days

SHARE-BASED COMPENSATION - Weig

SHARE-BASED COMPENSATION - Weighted Average Grant Date Fair Value (Details) - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average grant date fair value of stock options (in dollars per share)	$ 34.03	$ 40.64	$ 28.64
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average grant date fair value (in dollars per share)	87.68	104.98	63.28
PSUs/Performance shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average grant date fair value (in dollars per share)	$ 95.40	$ 108.51	$ 63.28

SHARE-BASED COMPENSATION - Stoc

SHARE-BASED COMPENSATION - Stock-Based Compensation Activity (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Shares, Stock options
Outstanding at beginning of period (in shares)	38,414
Granted (in shares)	435
Exercised (in shares)	(951)
Forfeited (in shares)	(266)
Expired (in shares)	(6,609)
Outstanding at end of period (in shares)	31,023	38,414
Exercisable (in shares)	28,723
Expected to vest (in shares)	2,151
Weighted average exercise price, Stock options
Outstanding at beginning of period (in dollars per share)	$ 144.97
Granted (in dollars per share)	92.33
Forfeited (in dollars per share)	64.45
Exercised (in dollars per share)	95.12
Expired (in dollars per share)	165.67
Outstanding at end of period (in dollars per share)	142.68	$ 144.97
Exercisable (in dollars per share)	146.94
Expected to vest (in dollars per share)	$ 90.14
Weighted average contractual term (in years)
Stock options, weighted average remaining contractual term, outstanding	3 years 9 months 18 days
Stock options, weighted average remaining contractual term, exercisable	3 years 4 months 24 days
Stock options, weighted average remaining contractual term, expected to vest	7 years 8 months 12 days
Intrinsic value
Stock options, intrinsic value, outstanding	$ 88
Stock options, intrinsic value, exercisable	83
Stock options, intrinsic value, expected to vest	$ 5
RSUs
Shares
Outstanding at beginning of period (in shares)	8,057
Granted (in shares)	4,110
Exercised (in shares)	(1,630)
Forfeited (in shares)	(850)
Outstanding at end of period (in shares)	9,687	8,057
Expected to vest (in shares)	8,476
Weighted average grant date fair value
Outstanding at beginning of period (in dollars per share)	$ 77.90
Granted (in dollars per share)	87.68	$ 104.98	$ 63.28
Exercised (in dollars per share)	89.08
Forfeited (in dollars per share)	81.92
Outstanding at end of period (in dollars per share)	79.82	$ 77.90
Expected to vest (in dollars per share)	$ 80.03
Weighted average contractual term (in years)
Weighted average remaining contractual term, outstanding	1 year 2 months 12 days
Weighted average remaining contractual term, expected to vest	1 year 2 months 12 days
Intrinsic value
Intrinsic value, outstanding	$ 812
Intrinsic value, expected to vest	$ 710

SHARE-BASED COMPENSATION - Sche

SHARE-BASED COMPENSATION - Schedule of Compensation Expense, Cash Proceeds and Intrinsic Value (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense (after-tax)	$ 305	$ 361	$ 353
Intrinsic value of stock options exercised and RSU/PSUs vested	170	217	81
Unrecognized compensation expense related to unvested equity awards	$ 420
Amortization period of unrecognized compensation expense	1 year
Income tax benefit recognized in earnings	$ 17	9	10
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cash received from stock options exercised	$ 62	$ 93	$ 6

EARNINGS PER SHARE INFORMATIO_2

EARNINGS PER SHARE INFORMATION (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Diluted
Earnings (loss) from continuing operations									$ 869	$ (3,326)	$ 6,601
Preferred stock dividends									(289)	(237)	(474)
Accretion of redeemable noncontrolling interests, net of tax									0	(9)	(151)
Accretion of preferred share repurchase									4	0	0
Earnings (loss) from continuing operations attributable to common shareholders									584	(3,571)	5,975
Earnings (loss) from discontinued operations									(644)	(3,195)	(909)
Net earnings (loss) attributable to GE common shareholders									$ (60)	$ (6,766)	$ 5,066
Total average equivalent shares (in shares)									1,096	1,098	1,094
Employee compensation-related shares (including stock options) (in shares)									6	0	1
Total average equivalent shares (in shares)									1,101	1,098	1,095
Earnings per share from continuing operations (in dollars per share)	$ 1.99	$ (0.14)	$ (0.59)	$ (0.74)	$ (3.24)	$ 0.54	$ (0.57)	$ 0.02	$ 0.53	$ (3.25)	$ 5.46
Earnings (loss) per share from discontinued operations (in dollars per share)	(0.06)	(0.08)	(0.19)	(0.26)	(0.31)	0.54	(0.51)	(2.63)	(0.58)	(2.91)	(0.83)
Net earnings (loss) per share (in dollars per share)	1.93	(0.21)	(0.78)	(0.99)	(3.55)	1.08	(1.08)	(2.61)	$ (0.05)	$ (6.16)	$ 4.63
Potentially dilutive securities									44	41	56
Basic
Earnings (loss) from continuing operations									$ 869	$ (3,326)	$ 6,601
Preferred stock dividends									(289)	(237)	(474)
Accretion of redeemable noncontrolling interests, net of tax									0	(9)	(151)
Accretion of preferred share repurchase									4	0	0
Earnings (loss) from continuing operations attributable to common shareholders									584	(3,571)	5,975
Earnings (loss) from discontinued operations									(644)	(3,195)	(909)
Net earnings (loss) attributable to GE common shareholders									$ (60)	$ (6,766)	$ 5,066
Earnings per share from continuing operations (in dollars per share)	2.01	(0.14)	(0.59)	(0.74)	(3.24)	0.54	(0.57)	0.02	$ 0.53	$ (3.25)	$ 5.46
Earnings (loss) per share from discontinued operations (in dollars per share)	(0.06)	(0.08)	(0.19)	(0.26)	(0.31)	0.55	(0.51)	(2.64)	(0.59)	(2.91)	(0.83)
Net earnings (loss) per share (in dollars per share)	$ 1.95	$ (0.21)	$ (0.78)	$ (0.99)	$ (3.55)	$ 1.09	$ (1.08)	$ (2.62)	$ (0.06)	$ (6.16)	$ 4.63

OTHER INCOME (LOSS) (Details)

OTHER INCOME (LOSS) (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchases and sales of business interests		$ 66	$ (40)	$ 12,468
Licensing and royalty income		203	192	161
Equity method income		386	215	46
Realized and unrealized gain (loss)		(144)	1,656	(2,085)
Unrealized gain (loss)		(65)	1,656	(1,670)
Other net interest and investment income (loss)(b)		456	621	590
Other items		226	497	207
Total other income (loss)		1,231	$ 2,823	11,396
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal, Statement of Income or Comprehensive Income [Extensible Enumeration]			Total other income (loss)
Interest income		162	$ 167	146
Disposed of by sale, not discontinued operations | Boiler manufacturing business
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Pre-tax gain (loss) on sale	$ (170)		(170)
Disposed of by sale, not discontinued operations | BioPharma
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Pre-tax gain (loss) on sale				12,362
Other (income) loss
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Equity method income		233	(96)	7
Baker Hughes
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Realized and unrealized gain (loss)		912	938	(2,037)
AerCap
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Unrealized gain (loss)		$ (865)	$ 711	$ 0

RESTRUCTURING CHARGES AND SEP_3

RESTRUCTURING CHARGES AND SEPARATION COSTS - Restructuring and Other Charges (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	$ 993	$ 819	$ 1,254
Restructuring and other charges cash expenditures	492	781	1,175
Cost of equipment/services
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	250	394	570
SG&A
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	774	499	697
Other (income) loss
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	(31)	(75)	(13)
Operating segments | Aerospace
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	20	70	397
Operating segments | Renewable Energy
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	177	204	213
Operating segments | Power
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	155	369	236
Operating segments | HealthCare
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	148	155	137
Corporate
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	494	20	270
Workforce reductions
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	348	695	856
Plant closures & associated costs and other asset write-downs
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	615	145	332
Acquisition/disposition net charges and other
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	$ 30	$ (21)	$ 66

RESTRUCTURING CHARGES AND SEP_4

RESTRUCTURING CHARGES AND SEPARATION COSTS - Changes in Restructuring Liability (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Restructuring Reserve [Roll Forward]
Beginning balance	$ 1,026	$ 1,337	$ 1,746
Additions	578	655	860
Payments	(385)	(670)	(997)
Remeasurement	(4)	(245)	(212)
Effect of foreign currency and other	(31)	(52)	(60)
Ending balance	1,183	1,026	1,337
Restructuring reserve	1,183	1,026	1,337
Post-employment severance benefits
Restructuring Reserve [Roll Forward]
Beginning balance	464	722
Ending balance	475	464	722
Restructuring reserve	$ 475	$ 464	$ 722

RESTRUCTURING CHARGES AND SEP_5

RESTRUCTURING CHARGES AND SEPARATION COSTS - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	$ 993	$ 819	$ 1,254
Restructuring and other charges cash expenditures	492	781	1,175
Separation costs	973	0	0
Payments for restructuring costs	385	670	997
Non-cash asset impairment, accelerated depreciation and other charges
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	416	164	394
Employee workforce reduction and contract related charges
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	578	$ 655	$ 860
Separation costs
Restructuring Cost and Reserve [Line Items]
Separation costs	973
Restructuring, incurred net tax benefit	71
Payments for restructuring costs	$ 261

FAIR VALUE MEASUREMENTS - Asset

FAIR VALUE MEASUREMENTS - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Assets
Gross derivatives	$ 1,341	$ 1,374
Netting adjustment	(859)	(637)
Derivative asset	482	684
Liabilities
Gross derivatives	1,451	893
Netting adjustment	(862)	(639)
Net derivative liabilities	589	212
Recurring
Assets
Investment securities with a fair value	43,657	54,506
Netting adjustment	(859)	(691)
Derivative asset	482	684
Total assets	44,139	55,189
Liabilities
Netting adjustment	(862)	(681)
Net derivative liabilities	589	212
Other	627	863
Total liabilities	1,216	1,075
Recurring | Level 1
Assets
Investment securities with a fair value	6,754	11,434
Gross derivatives	0	0
Total assets	6,754	11,434
Liabilities
Gross derivatives	0	0
Other	0	0
Total liabilities	0	0
Recurring | Level 2
Assets
Investment securities with a fair value	30,483	35,849
Gross derivatives	1,340	1,357
Total assets	31,823	37,207
Liabilities
Gross derivatives	1,444	891
Other	627	863
Total liabilities	2,071	1,754
Recurring | Level 3
Assets
Investment securities with a fair value	6,421	7,222
Gross derivatives	1	17
Total assets	6,421	7,239
Liabilities
Gross derivatives	7	1
Other	0	0
Total liabilities	7	1
Recurring | Level 3 | U.S. corporate
Assets
Investment securities with a fair value	3,548	4,228
Recurring | Level 3 | Mortgage and asset-backed
Assets
Investment securities with a fair value	1,386	1,427
Recurring | Level 3 | Senior note | AerCap
Assets
Investment securities with a fair value	$ 900	$ 993

FAIR VALUE MEASUREMENTS - Sched

FAIR VALUE MEASUREMENTS - Schedule of Level 3 Instruments (Details) - Level 3 - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Fair Value, Assets Measured on Recurring Basis, Level 3 Reconciliation
Net unrealized gain (losses) in other comprehensive income	$ (994)	$ (288)
Investment securities
Fair Value, Assets Measured on Recurring Basis, Level 3 Reconciliation
Beginning balance	7,222	5,866
Net realized/ unrealized gains (losses)	(1,002)	(261)
Purchases	973	2,589
Sales and settlements	(628)	(943)
Transfers into Level 3	57	6
Transfers out of Level 3	(201)	(35)
Ending balance	6,421	7,222
U.S. corporate
Fair Value, Assets Measured on Recurring Basis, Level 3 Reconciliation
Purchases	508
Mortgage and asset-backed
Fair Value, Assets Measured on Recurring Basis, Level 3 Reconciliation
Purchases	$ 302	1,084
Senior note | AerCap
Fair Value, Assets Measured on Recurring Basis, Level 3 Reconciliation
Purchases		$ 1,000

FINANCIAL INSTRUMENTS - Assets

FINANCIAL INSTRUMENTS - Assets and Liabilities Not Carried at Fair Value (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Liabilities
Investment contracts	$ 1,771	$ 1,909
Carrying amount (net)
Assets
Loans and other receivables	2,695	2,706
Liabilities
Borrowings	32,350	35,186
Investment contracts	1,771	1,909
Estimated fair value
Assets
Loans and other receivables	2,560	2,853
Liabilities
Borrowings	31,410	41,207
Investment contracts	$ 1,822	$ 2,282

FINANCIAL INSTRUMENTS - Fair Va

FINANCIAL INSTRUMENTS - Fair Value of Derivatives (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Derivative [Line Items]
Gross Notional	$ 66,392	$ 76,425
All other assets
Derivative asset, statement of financial position	All other assets (Note 9)	All other assets (Note 9)
Gross derivatives	$ 1,341	$ 1,374
Netting and credit adjustments	(859)	(637)
Cash collateral adjustments	0	(54)
Net derivatives recognized in statement of financial position	482	684
Net accrued interest	0	10
Securities held as collateral	0	(2)
Net amount	$ 482	$ 691
All other liabilities
Derivative liability, statement of financial position	All other liabilities (Note 14)	All other liabilities (Note 14)
Gross derivatives	$ 1,451	$ 893
Netting and credit adjustments	(862)	(639)
Cash collateral adjustments	0	(42)
Net derivatives recognized in statement of financial position	589	212
Net accrued interest	(4)	5
Securities held as collateral	0	0
Net amount	585	217
Derivatives accounted for as hedges
Derivative [Line Items]
Gross Notional	8,484	9,285
All other assets
Gross derivatives	164	188
All other liabilities
Gross derivatives	312	126
Derivatives accounted for as hedges | Currency exchange contracts
Derivative [Line Items]
Gross Notional	8,484	7,214
All other assets
Gross derivatives	164	114
All other liabilities
Gross derivatives	312	122
Derivatives accounted for as hedges | Interest rate contracts
Derivative [Line Items]
Gross Notional		2,071
All other assets
Gross derivatives		75
All other liabilities
Gross derivatives		4
Derivatives not accounted for as hedges
Derivative [Line Items]
Gross Notional	57,907	67,140
All other assets
Gross derivatives	1,178	1,186
All other liabilities
Gross derivatives	1,139	767
Derivatives not accounted for as hedges | Currency exchange contracts
Derivative [Line Items]
Gross Notional	56,950	64,097
All other assets
Gross derivatives	977	794
All other liabilities
Gross derivatives	1,118	756
Derivatives not accounted for as hedges | Interest rate contracts
Derivative [Line Items]
Gross Notional	43	1,369
All other assets
Gross derivatives	0	5
All other liabilities
Gross derivatives	1	1
Derivatives not accounted for as hedges | Other contracts
Derivative [Line Items]
Gross Notional	914	1,674
All other assets
Gross derivatives	200	387
All other liabilities
Gross derivatives	$ 20	$ 10

FINANCIAL INSTRUMENTS - Fair _2

FINANCIAL INSTRUMENTS - Fair Value Hedges, Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Cumulative amount of fair value hedging adjustments	$ 1,240	$ 2,072
Cumulative amount of fair value hedging on discontinued hedging relationships	1,240	2,073
Hedged liability	$ 9,933	$ 16,819

FINANCIAL INSTRUMENTS - Effects

FINANCIAL INSTRUMENTS - Effects of Derivatives on AOCI (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Derivative [Line Items]
Gain (loss) recognized in AOCI, cash flow hedges	$ (206)	$ (86)	$ (61)
Gain (loss) recognized in AOCI, net investment hedges	230	487	(675)
Reclassified from AOCI into earnings, investment hedges	0	(87)	$ 0
Foreign currency debt
Derivative [Line Items]
Carrying value designated as net investment hedges	$ 3,329	$ 4,061

FINANCIAL INSTRUMENTS - Cash Fl

FINANCIAL INSTRUMENTS - Cash Flow and Net Investment Hedges, Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($)
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Pre-tax gain (loss) included in AOCI related to cash flow hedges of forecasted transactions	$ (111)
Loss expected to be transferred to earnings as an expense	$ 106
Maximum term of hedged forecasted transactions	12 years

FINANCIAL INSTRUMENTS - Effec_2

FINANCIAL INSTRUMENTS - Effects of Derivatives on Earnings (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Total revenues	$ 21,786	$ 19,084	$ 18,646	$ 17,040	$ 20,303	$ 18,569	$ 18,253	$ 17,071	$ 76,555	$ 74,196	$ 75,833
Debt extinguishment costs									465	6,524	301
Interest and other financial charges									1,607	1,876	2,068
SG&A									12,781	11,716	$ 12,628
Other									56,766	56,719
Revenues
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) reclassified to earnings									(23)	27
Fair Value Hedges
Total effect of derivatives not designated as hedges									7	(5)
Debt Extinguishment Costs
Fair Value Hedges
Hedged items										70
Derivatives designated as hedging instruments										(66)
Total effect of fair value hedges										3
Total effect of derivatives not designated as hedges									159	35
Interest Expense
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) reclassified to earnings									(20)	(40)
Fair Value Hedges
Hedged items									127	1,413
Derivatives designated as hedging instruments									(143)	(1,549)
Total effect of fair value hedges									(16)	(135)
Total effect of derivatives not designated as hedges									(4)	(22)
SG&A
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) reclassified to earnings									(2)	1
Fair Value Hedges
Total effect of derivatives not designated as hedges									(269)	56
Other
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) reclassified to earnings									(34)	(67)
Fair Value Hedges
Total effect of derivatives not designated as hedges									(575)	235
Currency exchange contracts | Revenues
Fair Value Hedges
Total effect of derivatives not designated as hedges									5	(6)
Currency exchange contracts | Debt Extinguishment Costs
Fair Value Hedges
Total effect of derivatives not designated as hedges										(16)
Currency exchange contracts | Interest Expense
Fair Value Hedges
Total effect of derivatives not designated as hedges										(18)
Currency exchange contracts | SG&A
Fair Value Hedges
Total effect of derivatives not designated as hedges									(133)	(127)
Currency exchange contracts | Other
Fair Value Hedges
Total effect of derivatives not designated as hedges									(737)	44
Interest rate, commodity and equity contracts | Revenues
Fair Value Hedges
Total effect of derivatives not designated as hedges									1	1
Interest rate, commodity and equity contracts | Debt Extinguishment Costs
Fair Value Hedges
Total effect of derivatives not designated as hedges									159	52
Interest rate, commodity and equity contracts | Interest Expense
Fair Value Hedges
Total effect of derivatives not designated as hedges									(4)	(3)
Interest rate, commodity and equity contracts | SG&A
Fair Value Hedges
Total effect of derivatives not designated as hedges									(135)	183
Interest rate, commodity and equity contracts | Other
Fair Value Hedges
Total effect of derivatives not designated as hedges									$ 161	$ 191

FINANCIAL INSTRUMENTS - Counter

FINANCIAL INSTRUMENTS - Counterparty Credit Risk, Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Derivative [Line Items]
Net amount	$ 585	$ 217
Counterparty credit risk
Derivative [Line Items]
Exposure to counterparties including interest net collateral, excluding embedded derivatives	308	564
Net amount	$ 505	$ 159

VARIABLE INTEREST ENTITIES (Det

VARIABLE INTEREST ENTITIES (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Variable Interest Entity [Line Items]
Assets	$ 187,788	$ 198,874
Liabilities	150,206	157,262
Consolidated VIE
Variable Interest Entity [Line Items]
Assets	401	491
Liabilities	206	206
Unconsolidated VIEs
Variable Interest Entity [Line Items]
Assets	5,917	5,034
Unconsolidated VIEs | Energy Financial Services
Variable Interest Entity [Line Items]
Assets	1,481	1,481
Unconsolidated VIEs | Insurance
Variable Interest Entity [Line Items]
Assets	$ 4,219	$ 3,333

COMMITMENTS, GUARANTEES, PROD_3

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES - Commitments (Details) $ in Millions	Dec. 31, 2022 USD ($)
Investment Commitments
Long-term Purchase Commitment [Line Items]
Commitments	$ 3,877
Run-off Insurance Operations
Long-term Purchase Commitment [Line Items]
Commitments	3,778
Run-off insurance operations, unconsolidated VIE investment commitment
Long-term Purchase Commitment [Line Items]
Commitments	3,773
Aerospace | Financial Assistance
Long-term Purchase Commitment [Line Items]
Commitments	$ 2,390

COMMITMENTS, GUARANTEES, PROD_4

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES - Guarantees (Details) $ in Millions	Dec. 31, 2022 USD ($)
Guarantee of indebtedness of others
Guarantor Obligations [Line Items]
Maximum exposure	$ 1,143
Guarantee obligations, liability	32
Indemnification agreements | Continuing operations
Guarantor Obligations [Line Items]
Maximum exposure	534
Guarantee obligations, liability	80
Indemnification agreements | Discontinued operations
Guarantor Obligations [Line Items]
Maximum exposure	717
Related reserves	$ 77

COMMITMENTS, GUARANTEES, PROD_5

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES - Product Warranties (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Movement in Standard Product Warranty Accrual
Balance at beginning of period	$ 1,891	$ 2,054	$ 2,165
Current-year provisions	1,319	862	788
Expenditures	(967)	(945)	(913)
Other changes	(90)	(81)	14
Balance at end of period	$ 2,153	$ 1,891	$ 2,054

COMMITMENTS, GUARANTEES, PROD_6

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES - Alstom Legacy Matters (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Alstom Legacy Matters
Loss Contingencies [Line Items]
Loss contingency accrual	$ 455	$ 567

COMMITMENTS, GUARANTEES, PROD_7

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES - Shareholder and Related Lawsuits (Details)	1 Months Ended
	Feb. 28, 2019 defendant	Mar. 31, 2019 claim	Nov. 30, 2018	Feb. 28, 2018 claim
Lindsey and Priest/Tola Cases
Loss Contingencies [Line Items]
Number of lawsuits				2
The Touchstone Case
Loss Contingencies [Line Items]
Number of institutional investors in lawsuit | defendant	6
Baker Hughes Case
Loss Contingencies [Line Items]
Number of lawsuits		2
Baker Hughes Case | Baker Hughes
Loss Contingencies [Line Items]
Ownership interest			12%

COMMITMENTS, GUARANTEES, PROD_8

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES - GE Retirement Savings Plan Class Actions (Details)	Dec. 31, 2022 lawsuit
GE retirement savings plan class actions
Loss Contingencies [Line Items]
Number of putative class actions	4

COMMITMENTS, GUARANTEES, PROD_9

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES - Bank BPH (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Discontinued operations
Related Party Transaction [Line Items]
Financing receivables held for sale (Polish mortgage portfolio)	$ 1,199	$ 1,799
Discontinued operations | Bank BPH
Related Party Transaction [Line Items]
Percentage indexed to or denominated in foreign currencies	85%
Financing receivables held for sale (Polish mortgage portfolio)	$ 1,199
Bank BPH | Bank BPH
Related Party Transaction [Line Items]
Estimate loss	$ 1,359	$ 755

COMMITMENTS, GUARANTEES, PRO_10

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES - Environmental, Health and Safety Matters (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Total reserves related to environmental remediation, nuclear decommissioning and worker exposure claims	$ 2,686	$ 2,660
Expenditures for site remediation, nuclear decommissioning and worker exposure claims	231	$ 193	$ 180
Expected expenditures for site remediation, nuclear decommissioning and worker exposure claims, 2023	250
Expected expenditures for site remediation, nuclear decommissioning and worker exposure claims, 2024	$ 300
Environmental remediation expense, Statement of income location not disclosed, extensible enumeration	Expenditures	Expenditures	Expenditures

OPERATING SEGMENTS - Reconcilia

OPERATING SEGMENTS - Reconciliation of Revenues (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting Information [Line Items]
Total revenues	$ 21,786	$ 19,084	$ 18,646	$ 17,040	$ 20,303	$ 18,569	$ 18,253	$ 17,071	$ 76,555	$ 74,196	$ 75,833
Aerospace
Segment Reporting Information [Line Items]
Total revenues									25,390	20,274	20,597
Renewable Energy
Segment Reporting Information [Line Items]
Total revenues									12,896	15,559	15,523
Power
Segment Reporting Information [Line Items]
Total revenues									15,995	16,558	17,237
HealthCare
Segment Reporting Information [Line Items]
Total revenues									18,461	17,724	18,008
Operating segments
Segment Reporting Information [Line Items]
Total revenues									73,749	71,635	73,306
Operating segments | Aerospace
Segment Reporting Information [Line Items]
Total revenues									26,050	21,310	22,042
Operating segments | Renewable Energy
Segment Reporting Information [Line Items]
Total revenues									12,977	15,697	15,666
Operating segments | Power
Segment Reporting Information [Line Items]
Total revenues									16,262	16,903	17,589
Operating segments | HealthCare
Segment Reporting Information [Line Items]
Total revenues									18,461	17,725	18,009
Corporate items and eliminations
Segment Reporting Information [Line Items]
Total revenues									2,806	2,561	2,528
Intersegment revenues
Segment Reporting Information [Line Items]
Total revenues									1,008	1,520	1,941
Intersegment revenues | Aerospace
Segment Reporting Information [Line Items]
Total revenues									(660)	(1,036)	(1,445)
Intersegment revenues | Renewable Energy
Segment Reporting Information [Line Items]
Total revenues									(80)	(138)	(142)
Intersegment revenues | Power
Segment Reporting Information [Line Items]
Total revenues									(267)	(345)	(352)
Intersegment revenues | HealthCare
Segment Reporting Information [Line Items]
Total revenues									0	(1)	(1)
Corporate
Segment Reporting Information [Line Items]
Total revenues									$ 3,814	$ 4,081	$ 4,468

OPERATING SEGMENTS - Equipment

OPERATING SEGMENTS - Equipment and Services Revenues Classification (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting Information [Line Items]
Total revenues	$ 21,786	$ 19,084	$ 18,646	$ 17,040	$ 20,303	$ 18,569	$ 18,253	$ 17,071	$ 76,555	$ 74,196	$ 75,833
Aerospace
Segment Reporting Information [Line Items]
Total revenues									25,390	20,274	20,597
Renewable Energy
Segment Reporting Information [Line Items]
Total revenues									12,896	15,559	15,523
Power
Segment Reporting Information [Line Items]
Total revenues									15,995	16,558	17,237
HealthCare
Segment Reporting Information [Line Items]
Total revenues									18,461	17,724	18,008
Operating segments
Segment Reporting Information [Line Items]
Total revenues									73,749	71,635	73,306
Operating segments | Aerospace
Segment Reporting Information [Line Items]
Total revenues									26,050	21,310	22,042
Operating segments | Renewable Energy
Segment Reporting Information [Line Items]
Total revenues									12,977	15,697	15,666
Operating segments | Power
Segment Reporting Information [Line Items]
Total revenues									16,262	16,903	17,589
Operating segments | HealthCare
Segment Reporting Information [Line Items]
Total revenues									18,461	17,725	18,009
Equipment | Operating segments
Segment Reporting Information [Line Items]
Total revenues									32,413	34,894	38,140
Equipment | Operating segments | Aerospace
Segment Reporting Information [Line Items]
Total revenues									7,842	7,531	8,582
Equipment | Operating segments | Renewable Energy
Segment Reporting Information [Line Items]
Total revenues									10,191	13,224	12,859
Equipment | Operating segments | Power
Segment Reporting Information [Line Items]
Total revenues									4,737	5,035	6,707
Equipment | Operating segments | HealthCare
Segment Reporting Information [Line Items]
Total revenues									9,643	9,104	9,992
Services | Operating segments
Segment Reporting Information [Line Items]
Total revenues									41,336	36,741	35,166
Services | Operating segments | Aerospace
Segment Reporting Information [Line Items]
Total revenues									18,207	13,780	13,460
Services | Operating segments | Renewable Energy
Segment Reporting Information [Line Items]
Total revenues									2,785	2,473	2,807
Services | Operating segments | Power
Segment Reporting Information [Line Items]
Total revenues									11,526	11,868	10,883
Services | Operating segments | HealthCare
Segment Reporting Information [Line Items]
Total revenues									$ 8,818	$ 8,620	$ 8,017

OPERATING SEGMENTS - Segment Re

OPERATING SEGMENTS - Segment Revenues (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting Information [Line Items]
Total revenues	$ 21,786	$ 19,084	$ 18,646	$ 17,040	$ 20,303	$ 18,569	$ 18,253	$ 17,071	$ 76,555	$ 74,196	$ 75,833
Aerospace
Segment Reporting Information [Line Items]
Total revenues									25,390	20,274	20,597
Renewable Energy
Segment Reporting Information [Line Items]
Total revenues									12,896	15,559	15,523
Power
Segment Reporting Information [Line Items]
Total revenues									15,995	16,558	17,237
HealthCare
Segment Reporting Information [Line Items]
Total revenues									18,461	17,724	18,008
Operating segments
Segment Reporting Information [Line Items]
Total revenues									73,749	71,635	73,306
Operating segments | Aerospace
Segment Reporting Information [Line Items]
Total revenues									26,050	21,310	22,042
Operating segments | Renewable Energy
Segment Reporting Information [Line Items]
Total revenues									12,977	15,697	15,666
Operating segments | Power
Segment Reporting Information [Line Items]
Total revenues									16,262	16,903	17,589
Operating segments | HealthCare
Segment Reporting Information [Line Items]
Total revenues									18,461	17,725	18,009
Corporate
Segment Reporting Information [Line Items]
Total revenues									2,806	2,561	2,528
Commercial Engines & Services | Operating segments | Aerospace
Segment Reporting Information [Line Items]
Total revenues									18,665	14,360	14,479
Military | Operating segments | Aerospace
Segment Reporting Information [Line Items]
Total revenues									4,410	4,136	4,572
Systems & Other | Operating segments | Aerospace
Segment Reporting Information [Line Items]
Total revenues									2,975	2,814	2,991
Onshore Wind | Operating segments | Renewable Energy
Segment Reporting Information [Line Items]
Total revenues									8,373	11,026	10,881
Grid Solutions equipment and services | Operating segments | Renewable Energy
Segment Reporting Information [Line Items]
Total revenues									3,086	3,207	3,585
Hydro, Offshore Wind and Hybrid Solutions | Operating segments | Renewable Energy
Segment Reporting Information [Line Items]
Total revenues									1,518	1,464	1,200
Gas Power | Operating segments | Power
Segment Reporting Information [Line Items]
Total revenues									12,072	12,080	12,655
Steam Power | Operating segments | Power
Segment Reporting Information [Line Items]
Total revenues									2,643	3,241	3,557
Power Conversion, Nuclear and other | Operating segments | Power
Segment Reporting Information [Line Items]
Total revenues									1,547	1,582	1,378
Healthcare Systems | Operating segments | HealthCare
Segment Reporting Information [Line Items]
Total revenues									16,489	15,694	15,387
Pharmaceutical Diagnostics | Operating segments | HealthCare
Segment Reporting Information [Line Items]
Total revenues									1,972	2,031	1,792
BioPharma | Operating segments | HealthCare
Segment Reporting Information [Line Items]
Total revenues									$ 0	$ 0	$ 830

OPERATING SEGMENTS - Geographic

OPERATING SEGMENTS - Geographic Revenues (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting Information [Line Items]
Total revenues	$ 21,786	$ 19,084	$ 18,646	$ 17,040	$ 20,303	$ 18,569	$ 18,253	$ 17,071	$ 76,555	$ 74,196	$ 75,833
U.S.
Segment Reporting Information [Line Items]
Total revenues									33,036	32,838	35,217
Europe
Segment Reporting Information [Line Items]
Total revenues									16,284	14,946	14,342
China region
Segment Reporting Information [Line Items]
Total revenues									6,062	6,744	6,978
Asia (excluding China region)
Segment Reporting Information [Line Items]
Total revenues									8,324	8,107	8,241
Americas
Segment Reporting Information [Line Items]
Total revenues									5,788	4,476	4,064
Middle East and Africa
Segment Reporting Information [Line Items]
Total revenues									7,060	7,085	6,991
Non-U.S.
Segment Reporting Information [Line Items]
Total revenues									$ 43,519	$ 41,358	$ 40,616
Non-U.S. | Revenue benchmark | Geographic Concentration Risk
Segment Reporting Information [Line Items]
Concentration risk (as a percentage)									57%	56%	54%
Aerospace
Segment Reporting Information [Line Items]
Total revenues									$ 25,390	$ 20,274	$ 20,597
Renewable Energy
Segment Reporting Information [Line Items]
Total revenues									12,896	15,559	15,523
Power
Segment Reporting Information [Line Items]
Total revenues									15,995	16,558	17,237
HealthCare
Segment Reporting Information [Line Items]
Total revenues									18,461	17,724	18,008
Operating segments
Segment Reporting Information [Line Items]
Total revenues									73,749	71,635	73,306
Operating segments | Aerospace
Segment Reporting Information [Line Items]
Total revenues									26,050	21,310	22,042
Operating segments | Aerospace | U.S.
Segment Reporting Information [Line Items]
Total revenues									10,722	9,675	11,239
Operating segments | Aerospace | Europe
Segment Reporting Information [Line Items]
Total revenues									6,013	3,920	4,288
Operating segments | Aerospace | China region
Segment Reporting Information [Line Items]
Total revenues									2,154	2,419	2,078
Operating segments | Aerospace | Asia (excluding China region)
Segment Reporting Information [Line Items]
Total revenues									2,731	1,758	1,842
Operating segments | Aerospace | Americas
Segment Reporting Information [Line Items]
Total revenues									1,713	1,310	882
Operating segments | Aerospace | Middle East and Africa
Segment Reporting Information [Line Items]
Total revenues									2,719	2,228	1,713
Operating segments | Aerospace | Non-U.S.
Segment Reporting Information [Line Items]
Total revenues									$ 15,328	$ 11,635	$ 10,803
Operating segments | Aerospace | Non-U.S. | Revenue benchmark | Geographic Concentration Risk
Segment Reporting Information [Line Items]
Concentration risk (as a percentage)									59%	55%	49%
Operating segments | Renewable Energy
Segment Reporting Information [Line Items]
Total revenues									$ 12,977	$ 15,697	$ 15,666
Operating segments | Renewable Energy | U.S.
Segment Reporting Information [Line Items]
Total revenues									6,265	7,275	7,846
Operating segments | Renewable Energy | Europe
Segment Reporting Information [Line Items]
Total revenues									3,023	3,651	3,047
Operating segments | Renewable Energy | China region
Segment Reporting Information [Line Items]
Total revenues									216	464	1,156
Operating segments | Renewable Energy | Asia (excluding China region)
Segment Reporting Information [Line Items]
Total revenues									1,396	1,959	1,484
Operating segments | Renewable Energy | Americas
Segment Reporting Information [Line Items]
Total revenues									1,120	1,009	819
Operating segments | Renewable Energy | Middle East and Africa
Segment Reporting Information [Line Items]
Total revenues									956	1,340	1,314
Operating segments | Renewable Energy | Non-U.S.
Segment Reporting Information [Line Items]
Total revenues									$ 6,711	$ 8,422	$ 7,820
Operating segments | Renewable Energy | Non-U.S. | Revenue benchmark | Geographic Concentration Risk
Segment Reporting Information [Line Items]
Concentration risk (as a percentage)									52%	54%	50%
Operating segments | Power
Segment Reporting Information [Line Items]
Total revenues									$ 16,262	$ 16,903	$ 17,589
Operating segments | Power | U.S.
Segment Reporting Information [Line Items]
Total revenues									5,121	6,186	6,186
Operating segments | Power | Europe
Segment Reporting Information [Line Items]
Total revenues									3,484	3,621	2,895
Operating segments | Power | China region
Segment Reporting Information [Line Items]
Total revenues									1,173	1,145	1,253
Operating segments | Power | Asia (excluding China region)
Segment Reporting Information [Line Items]
Total revenues									2,101	2,090	2,707
Operating segments | Power | Americas
Segment Reporting Information [Line Items]
Total revenues									1,931	1,239	1,483
Operating segments | Power | Middle East and Africa
Segment Reporting Information [Line Items]
Total revenues									2,453	2,622	3,064
Operating segments | Power | Non-U.S.
Segment Reporting Information [Line Items]
Total revenues									$ 11,142	$ 10,717	$ 11,403
Operating segments | Power | Non-U.S. | Revenue benchmark | Geographic Concentration Risk
Segment Reporting Information [Line Items]
Concentration risk (as a percentage)									69%	63%	65%
Operating segments | HealthCare
Segment Reporting Information [Line Items]
Total revenues									$ 18,461	$ 17,725	$ 18,009
Operating segments | HealthCare | U.S.
Segment Reporting Information [Line Items]
Total revenues									8,078	7,229	7,611
Operating segments | HealthCare | Europe
Segment Reporting Information [Line Items]
Total revenues									3,697	3,702	3,952
Operating segments | HealthCare | China region
Segment Reporting Information [Line Items]
Total revenues									2,525	2,700	2,455
Operating segments | HealthCare | Asia (excluding China region)
Segment Reporting Information [Line Items]
Total revenues									2,225	2,345	2,264
Operating segments | HealthCare | Americas
Segment Reporting Information [Line Items]
Total revenues									1,038	923	879
Operating segments | HealthCare | Middle East and Africa
Segment Reporting Information [Line Items]
Total revenues									897	826	848
Operating segments | HealthCare | Non-U.S.
Segment Reporting Information [Line Items]
Total revenues									$ 10,383	$ 10,496	$ 10,398
Operating segments | HealthCare | Non-U.S. | Revenue benchmark | Geographic Concentration Risk
Segment Reporting Information [Line Items]
Concentration risk (as a percentage)									56%	59%	58%
Corporate
Segment Reporting Information [Line Items]
Total revenues									$ 2,806	$ 2,561	$ 2,528
Corporate | U.S.
Segment Reporting Information [Line Items]
Total revenues									2,850	2,473	2,336
Corporate | Europe
Segment Reporting Information [Line Items]
Total revenues									68	52	159
Corporate | China region
Segment Reporting Information [Line Items]
Total revenues									(5)	16	35
Corporate | Asia (excluding China region)
Segment Reporting Information [Line Items]
Total revenues									(129)	(45)	(55)
Corporate | Americas
Segment Reporting Information [Line Items]
Total revenues									(14)	(4)	1
Corporate | Middle East and Africa
Segment Reporting Information [Line Items]
Total revenues									36	69	52
Corporate | Non-U.S.
Segment Reporting Information [Line Items]
Total revenues									$ (44)	$ 88	$ 192

OPERATING SEGMENTS - Narrative

OPERATING SEGMENTS - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting Information [Line Items]
Performance obligations expected to be satisfied	$ 250,997
U.S.
Segment Reporting Information [Line Items]
Property, plant and equipment - net	7,508	$ 8,411
Non-U.S.
Segment Reporting Information [Line Items]
Property, plant and equipment - net	6,970	$ 7,198
Equipment
Segment Reporting Information [Line Items]
Performance obligations expected to be satisfied	$ 48,936
Equipment | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01 | Performance obligation satisfaction, period one
Segment Reporting Information [Line Items]
Performance obligation expected to be satisfied (as a percent)	59%
Performance obligations expected to be satisfied, expected timing	1 year
Equipment | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01 | Performance obligation satisfaction, period two
Segment Reporting Information [Line Items]
Performance obligation expected to be satisfied (as a percent)	81%
Performance obligations expected to be satisfied, expected timing	2 years
Equipment | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01 | Performance obligation satisfaction, period three
Segment Reporting Information [Line Items]
Performance obligation expected to be satisfied (as a percent)	98%
Performance obligations expected to be satisfied, expected timing	5 years
Services
Segment Reporting Information [Line Items]
Performance obligations expected to be satisfied	$ 202,061
Services | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01 | Performance obligation satisfaction, period one
Segment Reporting Information [Line Items]
Performance obligation expected to be satisfied (as a percent)	13%
Performance obligations expected to be satisfied, expected timing	1 year
Services | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01 | Performance obligation satisfaction, period two
Segment Reporting Information [Line Items]
Performance obligation expected to be satisfied (as a percent)	46%
Performance obligations expected to be satisfied, expected timing	5 years
Services | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01 | Performance obligation satisfaction, period three
Segment Reporting Information [Line Items]
Performance obligation expected to be satisfied (as a percent)	70%
Performance obligations expected to be satisfied, expected timing	10 years
Services | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01 | Performance obligation satisfaction, period four
Segment Reporting Information [Line Items]
Performance obligation expected to be satisfied (as a percent)	84%
Performance obligations expected to be satisfied, expected timing	15 years
Revenue benchmark | Agencies of the U.S. Government | Customer Concentration Risk
Segment Reporting Information [Line Items]
Concentration risk (as a percentage)	6%	6%	7%
Revenue benchmark | Defense-related | Customer Concentration Risk | Aerospace
Segment Reporting Information [Line Items]
Concentration risk (as a percentage)	5%	5%	6%

OPERATING SEGMENTS - Reconcil_2

OPERATING SEGMENTS - Reconciliation of Profit and Earnings (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting Information [Line Items]
Interest and other financial charges	$ (1,607)	$ (1,876)	$ (2,068)
Debt extinguishment costs	(465)	(6,524)	(301)
Non-operating benefit income (cost)	532	(1,782)	(2,430)
Goodwill impairments	0	0	(877)
Benefit (provision) for income taxes	(476)	286	487
Preferred stock dividends	(289)	(237)	(474)
Earnings (loss) from continuing operations attributable to GE common shareholders	581	(3,562)	6,141
Earnings (loss) from discontinued operations attributable to GE common shareholders	(644)	(3,195)	(911)
Net earnings (loss) attributable to GE common shareholders	(64)	(6,757)	5,230
Operating segments
Segment Reporting Information [Line Items]
Gross Profit	6,456	5,778	3,848
Operating segments | Aerospace
Segment Reporting Information [Line Items]
Gross Profit	4,775	2,882	1,229
Operating segments | Renewable Energy
Segment Reporting Information [Line Items]
Gross Profit	(2,240)	(795)	(715)
Operating segments | Power
Segment Reporting Information [Line Items]
Gross Profit	1,217	726	274
Operating segments | HealthCare
Segment Reporting Information [Line Items]
Gross Profit	2,705	2,966	3,060
Corporate
Segment Reporting Information [Line Items]
Gross Profit	(3,413)	892	8,061
Corporate | Energy Financial Services
Segment Reporting Information [Line Items]
Interest and other financial charges	(54)	(63)	(50)
Benefit (provision) for income taxes	213	162	154
Segment reconciling items
Segment Reporting Information [Line Items]
Interest and other financial charges	(1,552)	(1,813)	(2,018)
Debt extinguishment costs	(465)	(6,524)	(301)
Non-operating benefit income (cost)	532	(1,782)	(2,430)
Goodwill impairments	0	0	(877)
Benefit (provision) for income taxes	(689)	124	333
Preferred stock dividends	$ (289)	$ (237)	$ (474)

OPERATING SEGMENTS - Reconcil_3

OPERATING SEGMENTS - Reconciliation of Assets, Property, Plant and Equipment Additions and Depreciation and Amortization (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting Information [Line Items]
Assets	$ 187,788	$ 198,874
Continuing operations
Segment Reporting Information [Line Items]
Assets	184,896	195,697	$ 215,463
Property, plant and equipment additions	1,371	1,286	1,579
Depreciation and amortization	3,543	3,009	3,464
Operating segments | Aerospace | Continuing operations
Segment Reporting Information [Line Items]
Assets	39,243	38,298	38,634
Property, plant and equipment additions	543	445	737
Depreciation and amortization	1,037	1,074	1,142
Operating segments | Renewable Energy | Continuing operations
Segment Reporting Information [Line Items]
Assets	15,719	14,804	15,927
Property, plant and equipment additions	275	349	302
Depreciation and amortization	412	432	413
Operating segments | Power | Continuing operations
Segment Reporting Information [Line Items]
Assets	22,173	23,569	24,453
Property, plant and equipment additions	210	189	245
Depreciation and amortization	506	692	749
Operating segments | HealthCare | Continuing operations
Segment Reporting Information [Line Items]
Assets	26,070	24,770	22,229
Property, plant and equipment additions	310	278	256
Depreciation and amortization	640	641	628
Corporate | Continuing operations
Segment Reporting Information [Line Items]
Assets	81,692	94,256	114,220
Property, plant and equipment additions	34	25	40
Depreciation and amortization	$ 948	$ 168	$ 531

OPERATING SEGMENTS - Assets by

OPERATING SEGMENTS - Assets by Geographic Area (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting Information [Line Items]
Assets	$ 187,788	$ 198,874
Continuing operations
Segment Reporting Information [Line Items]
Assets	184,896	195,697	$ 215,463
Continuing operations | U.S.
Segment Reporting Information [Line Items]
Assets	126,005	130,956
Continuing operations | Total Non-U.S.
Segment Reporting Information [Line Items]
Assets	58,892	64,741
Continuing operations | Europe
Segment Reporting Information [Line Items]
Assets	36,603	42,213
Continuing operations | Asia
Segment Reporting Information [Line Items]
Assets	11,317	11,534
Continuing operations | Americas
Segment Reporting Information [Line Items]
Assets	6,405	6,406
Continuing operations | Other Global
Segment Reporting Information [Line Items]
Assets	$ 4,566	$ 4,588

SUMMARIZED FINANCIAL INFORMAT_3

SUMMARIZED FINANCIAL INFORMATION (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions		1 Months Ended	3 Months Ended								10 Months Ended	12 Months Ended
	Nov. 01, 2021	Jan. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Nov. 03, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Schedule of Equity Method Investments [Line Items]
Realized and unrealized gain (loss)												$ (144)	$ 1,656	$ (2,085)
Sales of retained ownership interests												4,717	4,145	417
Total revenues			$ 21,786	$ 19,084	$ 18,646	$ 17,040	$ 20,303	$ 18,569	$ 18,253	$ 17,071		76,555	74,196	75,833
Net earnings (loss)			2,238	(160)	(771)	(1,014)	(3,843)	1,184	(1,135)	(2,798)		292	(6,591)	5,546
Net earnings (loss) attributable to the Company			2,222	$ (165)	$ (790)	$ (1,042)	(3,843)	$ 1,257	$ (1,131)	$ (2,802)		225	(6,520)	5,704
Unrealized gain (loss)												(65)	1,656	(1,670)
Current assets			66,234				66,348					66,234	66,348
Right-of-use operating lease assets			2,137				2,606					2,137	2,606
Other assets			18,520				20,973					18,520	20,973
Total assets			187,788				198,874					187,788	198,874
Current liabilities			56,947				51,953					56,947	51,953
Debt			28,593				30,824					28,593	30,824
Other			26,639				27,217					26,639	27,217
Total liabilities			150,206				157,262					150,206	157,262
Baker Hughes
Schedule of Equity Method Investments [Line Items]
Total revenues											$ 16,997	0		20,705
Gross Profit											3,276	0		3,199
Net earnings (loss)											(546)	0		(15,761)
Net earnings (loss) attributable to the Company											$ (407)	0		(9,940)
AerCap
Schedule of Equity Method Investments [Line Items]
Total revenues												6,627
Net earnings (loss)												(1,128)
Net earnings (loss) attributable to the Company												(1,132)
Right-of-use operating lease assets			54,611									54,611
Other assets			15,200									15,200
Total assets			69,811									69,811
Debt			47,350									47,350
Other			6,817									6,817
Total liabilities			54,167									54,167
Noncontrolling interests			77									77
Commercial Aerospace Joint Ventures
Schedule of Equity Method Investments [Line Items]
Total revenues												23,317	17,118	15,931
Gross Profit												312	284	359
Net earnings (loss)												249	(123)	327
Net earnings (loss) attributable to the Company												237	(140)	312
Current assets			13,328				8,845					13,328	8,845
Total assets			14,327				9,941					14,327	9,941
Current liabilities			12,828				8,435					12,828	8,435
Total liabilities			12,887				8,470					12,887	8,470
Noncontrolling interests			$ 153				147					$ 153	147
Baker Hughes
Schedule of Equity Method Investments [Line Items]
Remaining interest (in shares)			7									7
Equity securities, ownership percentage			1%									1%
Fair value of investment			$ 207				$ 4,010					$ 207	4,010
Realized and unrealized gain (loss)												912	938	(2,037)
Net after-tax gain (loss)												$ 702	$ 696	$ (1,562)
Share price (in dollars per share)			$ 29.53				$ 24.06					$ 29.53	$ 24.06	$ 20.85
Derivative gain (loss) on sale												$ 109	$ 129	$ (54)
Shares sold (in shares)												160	183	28
Sales of retained ownership interests												$ 4,717	$ 4,145	$ 417
Baker Hughes | Subsequent event
Schedule of Equity Method Investments [Line Items]
Shares sold (in shares)		7
Sales of retained ownership interests		$ 216
AerCap
Schedule of Equity Method Investments [Line Items]
Fair value of investment			$ 7,403				$ 8,287					$ 7,403	$ 8,287
Share price (in dollars per share)			$ 58.32				$ 65.42					$ 58.32	$ 65.42
Unrealized gain (loss)												$ (865)	$ 711	$ 0
Net after-tax unrealized gain (loss)												$ (1,052)	$ 711
AerCap | Discontinued operations | GECAS
Schedule of Equity Method Investments [Line Items]
Equity securities, ownership percentage	46%
Consideration, stock transaction (in shares)	111.5

QUARTERLY INFORMATION (UNAUDI_3

QUARTERLY INFORMATION (UNAUDITED) (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Net Income (Loss) Attributable to Parent [Abstract]
Total revenues	$ 21,786	$ 19,084	$ 18,646	$ 17,040	$ 20,303	$ 18,569	$ 18,253	$ 17,071	$ 76,555	$ 74,196	$ 75,833
Sales of equipment and services	21,011	18,438	17,880	16,272	19,492	17,813	17,470	16,316
Cost of equipment and services sold	15,467	14,371	13,244	12,453	14,338	13,401	13,618	12,538
Earnings (loss) from continuing operations	2,302	(76)	(561)	(729)	(3,504)	582	(571)	97	936	(3,396)	6,457
Earnings (loss) from discontinued operations, net of taxes	(64)	(85)	(210)	(286)	(339)	602	(564)	(2,894)	(644)	(3,195)	(911)
Net earnings (loss)	2,238	(160)	(771)	(1,014)	(3,843)	1,184	(1,135)	(2,798)	292	(6,591)	5,546
Less: net earnings (loss) attributable to noncontrolling interests	16	4	19	28	1	(73)	(3)	5	67	(71)	(158)
Net earnings (loss) attributable to the Company	$ 2,222	$ (165)	$ (790)	$ (1,042)	$ (3,843)	$ 1,257	$ (1,131)	$ (2,802)	$ 225	$ (6,520)	$ 5,704
Per-share amounts – earnings (loss) from continuing operations
Diluted earnings (loss) per share (in dollars per share)	$ 1.99	$ (0.14)	$ (0.59)	$ (0.74)	$ (3.24)	$ 0.54	$ (0.57)	$ 0.02	$ 0.53	$ (3.25)	$ 5.46
Basic earnings (loss) per share (in dollars per share)	2.01	(0.14)	(0.59)	(0.74)	(3.24)	0.54	(0.57)	0.02	0.53	(3.25)	5.46
Per-share amounts – earnings (loss) from discontinued operations
Diluted earnings (loss) per share (in dollars per share)	(0.06)	(0.08)	(0.19)	(0.26)	(0.31)	0.54	(0.51)	(2.63)	(0.58)	(2.91)	(0.83)
Basic earnings (loss) per share (in dollars per share)	(0.06)	(0.08)	(0.19)	(0.26)	(0.31)	0.55	(0.51)	(2.64)	(0.59)	(2.91)	(0.83)
Per-share amounts – net earnings (loss)
Diluted earnings (loss) per share (in dollars per share)	1.93	(0.21)	(0.78)	(0.99)	(3.55)	1.08	(1.08)	(2.61)	(0.05)	(6.16)	4.63
Basic earnings (loss) per share (in dollars per share)	1.95	(0.21)	(0.78)	(0.99)	(3.55)	1.09	(1.08)	(2.62)	(0.06)	(6.16)	4.63
Dividends declared (in dollars per share)	$ 0.08	$ 0.08	$ 0.08	$ 0.08	$ 0.08	$ 0.08	$ 0.08	$ 0.08	$ 0.32	$ 0.32	$ 0.32

SUBSEQUENT EVENT (Details)

SUBSEQUENT EVENT (Details) $ in Millions	Jan. 03, 2023 USD ($)	Dec. 31, 2022 USD ($)
Guarantee of indebtedness of others
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Maximum exposure		$ 1,143
Guarantee obligations, liability		$ 32
Subsequent event | Guarantee of indebtedness of others
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Maximum exposure	$ 500
Subsequent event | Indemnification agreements
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Guarantee obligations, liability	$ 100
Spinoff | Subsequent event
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Ownership interest disposed of	80.10%
Ownership interest after disposal	19.90%
Stock conversion ratio	0.33
Postretirement and pension plan benefit obligation	$ 4,000
Deferred compensation and benefit obligations	700
Proceeds from business dispositions	1,500
Term loan, aggregate principal amount	$ 2,000